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ABSTRACT
The use of opioids for the treatment of chronic non-cancer pain (CNCP) remains
controversial (Manchikanti, 2008; McQuay, 1999). Controversy surrounds the type of
conditions that should be treated with opioids, whether the treatment can be generally
safe and effective, and what the clinical goals should be. If providers can predict those
patients who will be most at risk for aberrant drug-related behavior, efficacious changes
in chronic pain management could be initiated and fewer patients potentially at risk for
addiction. The current study explored the role of self-efficacy of pain, severity of
depressive symptoms, perceived social support, and ethnic identity as predictors for the
risk of aberrant drug-related behavior in CNCP patients. 102 CNCP patients being
treated at a large, metropolitan health care clinic were invited to participate in this study.
Qualitative data were conducted with the use of grounded theory methodology and data
were collected from 10 participants out of the total sample.
A two-way ANOVA found non-significant effects of sex, ethnicity and the
interaction between sex and ethnicity for both groups of participants, CNCP patients
prescribed opioids and those who were not. This suggests that all other statistical
findings are generalizable across gender and across white and Hispanic populations. A
hierarchical logistic regression analysis predicted group membership in participants
prescribed opioids and those who were not. Participants’ level of pain self-efficacy was
ii

the only statistically significant predictor for distinguishing whether participants were
prescribed opioids. Results from a hierarchical multiple regression, the main foci of this
study, indicated that two predictor variables (level of depression and level of pain selfefficacy) in participants on opioids contributed significantly to the explanation of patients
being at risk for opioid misuse. Additionally, three predictor variables (level of
depression, level of perceived social support, and level of ethnic identity) in participants
not prescribed opioids, contributed significantly to the explanation of patients being at
risk for aberrant drug-related behavior.
Following in-depth analyses of 10 interviews, 43 open, 9 axial, and 5 selective
grounded theory categories emerged. Three domains found described the grounded
theory. These three domains include (1) The Nature of Chronic Pain, (2) Professional
Treatments used for the Management of Chronic Pain, and (3) Coping with Chronic Pain.
The nature of participants' chronic pain included onset, pain sites, diagnoses, longevity,
description of sensations, associated mood, and the impact of stress on levels of pain. All
of these aspects contributed to patients' descriptions of pain, satisfaction with treatments
for pain and the management of chronic pain. Patients' relationships with physical health
and mental health providers contributed to their satisfaction of pain management.
Injections, physical therapy and psychotherapy were found to be the most valuable
professional treatment methods. Moreover, self-coping strategies for chronic pain
management included drug treatments and non-medication treatments. The most
efficacious non-medication strategies found were social support, heat, exercise, physical
therapy, pleasant activities and distraction. Drug treatments found to be the most
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beneficial included opioids, nonsteroidal anti-inflammatory drugs, antidepressants and
cannabis.
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CHAPTER ONE: INTRODUCTION
What predicts aberrant drug-related behavior in chronic pain patients?
Chronic pain is a leading cause of disability and aggregates roughly $100 billion
dollars a year in health care costs. The prevalence rates of chronic pain in the general
population are high. An estimated prevalence of chronic pain affects roughly 10%
(Verhaak, Kerssens, Dekker, Sorbi & Bensing, 1998) to almost 20% (Gureje, Simon, &
Von Korff, 2001) of Americans. Chronic noncancer pain (CNCP) has been found to
negatively impact patients’ functional capacity and quality of life (Stewart, Ricci, Chee,
Morganstein & Lipton, 2003; Verhaak et al., 1998), cause devastating consequences to
patients and families, produce high rates of health care utilization, and develop huge
societal costs related to lost work productivity (Chou, Ballantyne, Fanciullo, Fine &
Miasowski, 2009; Dworkin & Sherman, 2001). Major medical associations designated
pain severity as the “fifth vital sign” due to the widespread recognition that pain can have
such an influence on health (Fishman, 2005). Moreover, to further signify the importance
of the assessment and management of pain in the U.S., the first decade of the 21st century
was declared the Decade of Pain Control and Research in a joint effort made by the Pain
Care Coalition (the American Pain Society, the American Academy of Pain Medicine,
and the American Headache Society) Senator Orrin Hatch, and was signed by President
Clinton in a bill in 2000 (Chou et al., 2009; Gatchel et al., 2007).
The use of opioids for the treatment of CNCP remains controversial
(Manchikanti, 2008; McQuay, 1999). Despite the advances in pain medicine, decrease in
1

pain severity and improvements in physical functioning in some patients with CNCP
(Furlan, Sandoval, Mailis-Gagnon & Tunks, 2006; Kalso, Edwards, Moore & McQuay,
2004), there is still considerable controversy surrounding the type of conditions that
should be treated with opioids, whether the treatment can be generally safe and effective
in selected patients, and what the clinical goals should be (Ballantyne & LaForge, 2007;
Rosenblum, Marsch, Joseph & Portenoy, 2008; Streltzer & Johansen, 2006; Stretzler &
Kosten, 2003). Uncertainty remains in understanding long-term benefits and harm of
opioids for CNCP (Chou et al., 2009; Noble, Tregear, Treadwell, & Schoelles, 2008).
Opioids are not always effective and are affiliated with important potential physiologic
harm and adverse side effects such as hyperalgesia (Angst & Clark, 2006), hypogonadism
and sexual dysfunction (Abs, Verhelst, Maeyaert, et al., 2000), and most notably, drug
misuse, abuse, and diversion (Bernstein, Stowerr, Haggard et al., 2007; Department of
Health and Human Services, 2005; Robinson, Gatchel, Polatin et al., 2001; Turk
Swanson, & Gatchel, 2008).
The term opioid refers to all compounds that bind to specific proteins called opiod
receptors. The term opiate, is conventionally used to describe opioids that are derived
from the opium poppy plant, such as morphine and codeine. Opioids include all drugs
that are synthesized from naturally occurring opiates (such as heroin from morphine and
oxycodone from thebaine), as well as synthetic opioids such as methadone, fentanyl, and
propoxyphene. A plethora of opioids have been commercialized for oral, transdermal
and intravenous administration. Oral and transdermal formulations include combination
products; for example, hydrocodone and acetaminophen (Vicodin or Lorset) or
oxycodone and acetaminophen (Percocet or Percodan). In addition, there are a number of
2

single entity formulations: morphine (Kadian, MS Contin), oxycodone (OxyContin),
fentanyl, hydromorphone, oxymorphone and methadone (Rosenblum, Marsch, Joseph &
Portenoy, 2008).
Opioid receptors are widely distributed and the receptors most involved in pain
modulation are located in the central nervous system and the peripheral nervous system.
When an opioid for pain binds to receptors, analgesia occurs and may also be
accompanied by a diverse array of side effects. The most common side effects include:
reduced peristalsis (leading to constipation) and itch, pupillary constriction, drowsiness,
mental clouding, and respiratory depression (Jaffe & Jaffe, 2004; Jaffe & Martin, 1990).
Central nervous mechanisms also lead to changes associated with hyperalgesia and
decreased responsiveness to opioids, known as tolerance (Rosenblum, Marsch, Joseph &
Portenoy, 2008). Researchers speculate that opioid-induced hyperalgesia leads to
increased pain severity in some situations (DeLeo, Tanga, & Tawfik, 2004).
Additionally, activation of other central nervous system pathways from opioid use have
been found to produce mood effects of dysphoria or euphoria (Rosenblum, Marsch,
Joseph & Portenoy, 2008).
Concerns about addiction have apparently contributed to the undertreatment of
disorders widely considered to be appropriate for opioid therapy, including cancer pain,
palliative care, and acute pain (Breitbart et al., 1998; Field & Cassel, 1997; Portenoy &
Lesage, 1999; Schnoll & Weaver, 2003; Smith et al., 2008). A major shift occurred and
the pendulum swung during the 1990s as the use of opioids for CNCP began to increase,
showing a substantial year-to-year rise that continues today. Prescriptions for opioids
continue to rise in the U.S. due to their increased use in patients with CNCP (Caudill3

Slosberg, Schwartz, & Woloshin, 2004; Olsen, Daumit, & Ford, 2006). This increased
use of opioids for legitimate medical purposes has been accompanied by a substantial
increase in the prevalence of nonmedical use of prescription opioids (Zacny et al., 2003).
The National Survey on Drug Use and Health reported that the number of first time
abusers of prescription opioids increased from 628,000 in 1990 to 2.4 million in 2004,
emergency room visits involving prescription opioid abuse increased by 45% from 2000
to 2002, and that treatment admissions for primary abuse of prescription opioids
increased by 186% between 1997 and 2002 (Rosenblum, Marsch, Joseph & Portenoy,
2008; SAMHSA, 2004a, 2004b).
Since the beginning of the 20th century advances in pain research have been
ignited and new developments in the way opioids are being used for the treatment of pain
and addiction are burgeoning (Ballantyne, 2006; Corbett, Henderson, McKnight, &
Paterson, 2006). These include attempts among several nations and international
organizations to control the distribution and use of opioids (Musto, 1999), the
introduction of opioid maintenance therapy for the treatment of opioid addiction
(Courtwright, Joseph, & DesJarlais, 1989; Strain & Stitzer, 2006), the recognition that
pain is a debilitating and destructive disease, and that opioids are the most effective drugs
for the relief of pain and suffering (Portenoy et al., 2004; Rosenbum, Marsch, Joseph &
Portenoy, 2008).
Research suggests that 2.8% to 62.2% of CNCP patients may exhibit problematic
opioid use, including seeking prescriptions from multiple prescribers, forging
prescriptions, preoccupation with obtaining more opioids despite evidence of adequate
analgesia of pain, and unsanctioned dose escalations (Ballantyne & Laforge, 2007;
4

Chabal, Erjavec, Jacobson et al., 1997; Cowan, Wilson-Barnett, Griffiths, et al,, 2003;
Fishbain, 1996; Katz & Fanciullo, 2002; Martell, O’Conner, Kerns et al., 2007; Michna,
Jamison, Pham et al., 2007). Abuse of prescription opioids is increasing concurrently as
the number of prescriptions rise (Reid, Engles-Horton, Weber et al., 2002; Soderstrom,
Dischinger, Kerns et al., 2001). Notably, abuse of prescription opioids rose 71% between
1997 and 2002 (Gilson, Ryan, Joranson et al., 2004). Despite the growing number of
prescriptions for CNCP (Joranson, Carrow, Ryan et al., 2002; Joranson, Gilson, Dahl et
al., 2002) many physicians prescribe opioids without adequate understanding of the risks
for misuse and abuse (Ballantyne & Mao, 2003; Turk, Swanson, & Gatchel, 2008). Reid
and colleagues (2002) reported that prevalence rates of opioid dependence at two primary
care clinics were between 24% and 31%. On the basis of urine toxicology screens, Katz
and Fanciullo (2002) determined that the rates of opioid misuse in CNCP were
comparable to Reid et al (2002) ranging from 20% to 40%. Moreover, retrospective
studies indicate that more than 43% of CNCP patients who were prescribed long-term
opioids misused their medication (Fishbain, Cutler, Rosomoff, 1999; Katz, Sherburne,
Beach et al. 2003; Michna, Jamison, & Pham et al., 2007).
While the increase in prescription drug abuse is likely multifactorial, Compton
and Volkow (2006) suggested that changes in available drug formulations and
prescribing practices of opioid medications most likely have had a great impact. This
link between increased medical use and increased abuse has spurred reexamination of the
medical role of these drugs. It has been suggested that only in the aftermath of the threats
posed by media coverage of oxycodone (Hancock & Burrow, 2002; Spake, 2001) has
greater attention been paid to the urgency and pertinence of these issues. Some
5

researchers infer an unfortunate coincidence that the increased use of opioids occurred at
the same time that reimbursement for psychological and rehabilitative approaches to pain
management were harder to come by. Furthermore, while the development of newer
sustained-release opioids may have in some ways revolutionized the field, for more
complicated patients they are not a stand-alone substitute for comprehensive management
(Passik & Kirsch, 2003).
Physicians accept that it is not considered legal, ethical or good medical practice
to withhold opioids from patients whose lives could be improved with treatment.
Conversely, it is understood that opioid efficacy can diminish over time and that openended dose escalation does not overcome tolerance. Pain research indicates how little is
understood about the complex relationship between pain, analgesia and addiction, which
has prompted the adoption of structured management protocols that aim to minimize
addiction (Ballayntyne, 2006). Concerns about efficacy and addiction have prompted an
urgent search to discover more about the basic mechanisms of opioid analgesia,
tolerance, dependence and addiction. Insidious opioid complications, such as hormonal
suppression, that potentially worsen pain's disability, have emerged as a valid reason for
keeping doses within a moderate range (Ballayntyne, 2006).
Clinicians have reported behaviors that they believe are indicative of opioid
misuse: (1) forging prescriptions, (2) stealing or borrowing drugs, (3) frequently losing
prescriptions, and (4) resisting changes to medication, despite adverse side effects. These
conditions have been found more predictive than (1) aggressive complaining about the
need for more drugs, (2) drug hoarding, and (3) unsanctioned dose escalations or other
forms of noncompliance, as the latter three mentioned may be indicative of poorly
6

controlled pain (Corey, 1996; Portenoy (1996; Turk Swanson, & Gatchel, 2008). Chabal
et al. (1997) developed a checklist of risk behaviors that they reported was indicative of
opioid abuse by CNCP patients being treated at a VA Medical Center. The checklist
consisted of: (1) focus on opioids during treatment; (2) pattern of early refills or
escalating drug use in the absence of clinical change; (3) multiple telephone calls or visits
associated with opioid prescriptions; (4) pattern of prescription ‘‘problems’’ (e.g., lost
and stolen medication); and (5) supplemental sources of opioids.
The majority of randomized clinical trials available on this topic of aberrant drugrelated behaviors have focused primarily on the evaluation of the short-term benefits of
opioids versus placebo in highly selected populations (Furlan et al., 2006; Kalso et al.,
2004). In addition, evidence on other specific areas relevant to opioid prescribing are
diffuse, such as: risk assessment before initiation of a trial of opioids, methods for
initiating and titrating opioids, monitoring of patients on chronic opioid therapy, use of
high-dose opioids, and the treatment of high-risk patients (Chou et al., 2009). Several
recent studies recommended judicious guidelines for the use of opioids in appropriately
selected patients with CNCP patients; however, most of these studies were developed
using a consensus process and lacked strong evidence (Chou et al., 2009).
After conducting a thorough review of the existing literature available on the risk
for opioid misuse, Turk, Swanson, and Gatchel (2008), prominent psychologists and
researchers of chronic pain, found that the following are the most significant predictors: a
history of polysubstance abuse, presence of a mood disorder (especially unipolar
depression), younger age, and a history of legal problems. Turk, Swanson and Gatchel
(2008) implied that being female was not a predictor but that the findings on being male
7

produced mixed results. In addition, Sullivan and fellow researchers (2006) found from a
meta-analytic review that CNCP patients carrying a mental health disorder of major
depression, dysthymia, generalized anxiety disorder or panic disorder in 1998 were more
likely to report opioid use in 2001 than CNCP patients not carrying one of these
diagnoses. Both an increase in initiation of opioid use and the continuation of opioids
were found in this subset of the population. Sullivan et al. (2006) also found that
respondents who reported a history of problem drug use but not problem alcohol use
predicted higher reported use of opioids.
Current literature on CNCP draws a vivid connection between the comorbidity of
depression and chronic pain on aberrant drug-related behaviors in chronic pain patients,
suggesting that patients with depression maintain higher rates of opioid misuse (Edlund,
Steffick, Hudson, Harris, Sulivan & Rick, 2007; Manchikanti et al., 2009; Wasan, Butler,
Budman, & Benoit, 2007). There is a dearth of research, however, connecting ethnic
identity, perceived social support, and self-efficacy to aberrant drug-related behaviors in
chronic pain patients, yet some relevant literature exists. Researchers have found that
cultural group influences such as higher reported levels of ethnic identity may influence
greater drug use (James, Kim & Armijo, 2000; Wong & Longshore, 2008). Others have
found that more positive perceived social support is related to fewer aberrant drug-related
behaviors (Dunbar and Katz ,1996) and less opioid use at one-year follow-up (Wong &
Longshore, 2008). Moreover, researchers have found higher reports of self-efficacy to be
associated with less opioid use at one-year follow-up (Wong & Longshore, 2008), and
decreased use in alcohol and cocaine (Warren, Stein & Grella, 2007).
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Some physicians suggest that they can identify individuals who are vulnerable to
problematic drug behaviors. However, empirical evidence regarding these ‘‘internal gut
feelings’’ has shown otherwise (Michna, Jamison, & Pham et al., 2007; Wasan, Butler,
Budman et al., 2007). For example, Wasan et al. (2007) found that physicians only
judged 13.9% of CNCP patients prescribed opioids as having aberrant drug behaviors,
when approximately 50% had positive urine toxicology screens for illicit drugs, and 8.7%
had no evidence of any opioids in their urine samples.
Urine toxicology screens have been the ‘‘gold standard’’ for detecting substance
use. Routine screening of CNCP before prescribing opioids and ongoing throughout the
course of treatment is highly recommended (Turk Swanson, & Gatchel, 2008). However,
the results must be interpreted with caution because the lack of an initial positive urine
screen cannot be used as a predictor of future aberrant drug-related behaviors in all
patients. Even patients with an initial negative screen may later demonstrate behaviors
indicative of substance misuse (Katz, Sherburne, Beach et al., 2003). Conversely, an
initial positive urine toxicology screen may not predict future aberrant behaviors.
Although urine toxicology screening is effective in detecting drug misuse, the results by
themselves are not sufficient (Turk, Swanson, & Gatchel, 2008). Thus, assessment of
substance abuse history is important when evaluating the potential for long-term opioid
treatment for CNCP patients but it is not sufficient (Turk, Swanson, & Gatchel, 2008).
Current Study
Researchers have suggested that there is a pertinent urgency to learn how to select
CNCP patients for opioid therapy who are likely to achieve improvement in pain,
function and quality of life, without interference from addiction (Ballayntyne, 2006).
9

Experts advocate the use of opioid therapy but in carefully selected patients (Kalso,
Edwards, Moore et al., 2004; Katz & Fanciullo, 2002; Zancy, Bigelow, Compton, et al.,
2003). The medical community aims to learn of common predictors of aberrant drugrelated behaviors and utilize this knowledge through the adequate screening of these
predictors in CNCP patients (Friedman, Li & Mehrotr, 2003; Turk, Swanson, & Gatchel,
2008). The knowledge gained of common predictors will assist providers in more
effectively selecting individuals that will most benefit from opioid therapy and
consequently instill comprehensive non-opioid therapy management to those most at risk
for displaying aberrant drug-related behaviors in the CNCP population. If providers can
predict those patients who will be most at risk, efficacious changes in chronic pain
management could be initiated and fewer patients potentially at risk for addiction.
Turk and colleagues (2008) highlighted that a plea for further research on
predictors of aberrant drug-related behaviors in CNCP patients dates back at least a
quarter of a century (Gatchel, 2001). They claim that “research identifying risk factors
and vulnerable CNCP subgroups have been slow in coming” (Turk, Swanson, & Gatchel,
2008, pg 506). They stated that the majority of research conducted in this area has been
based on retrospective chart reviews and cross-sectional data. These researchers contend
that large-scale, prospective studies are needed to confirm a “best set of predictors to
assist in preventing aberrant behaviors while proving adequate analgesia” (Turk,
Swanson, & Gatchel, 2008, pg 506). They suggested that future studies should carefully
define the criteria that are being used to permit replication and comparison with other
studies and that the population used must also be clearly articulated to permit
determination of the representativeness of the sample and generalizability of results. In
10

general, published studies have not been representative, including small proportions of
women and minority populations. A significant limitation is that the settings used were
predominately outpatient clinics specializing in pain management. There were no studies
examining solely new referrals to pain clinics or patients who were not already taking
opioids. Thus, the results of these studies were only generalizable to patients who were
already prescribed opioids (Turk, Swanson, & Gatchel, 2008).
Moreover, Turk and colleagues (2008) stated that most research thus far has not
indicated the overall validity of the instruments in predicting those patients who were at
risk for opioid misuse, and that out of the nine instruments reviewed, the researchers
found only the SOAPP and COMM accurately assessed all of the psychometric and
diagnostic domains outlined (Turk, Swanson, & Gatchel, 2008). The inclusion criteria
used in many retrospective trials, and before opioid prescribing, were not always clearly
specified in research (Rowbotham & Lindsey, 2007; Turk, Swanson, & Gatchel, 2008)
and premature termination from such studies has been a problem, averaging over 30%
(Turk, 2002). Little is known about the characteristics of those patients lost at follow-up.
“Researchers must carefully describe the measures, questions, and descriptions of the
variables included, and not only report on the best set of predictors, but also those
variables that failed to predict misuse and abuse”, (Turk, Swanson, & Gatchel, 2008 pg
506).
The current study seeks to explore the role of self-efficacy of pain, severity of
depressive symptoms, perceived social support, and ethnic identity as predictors for the
risk of aberrant drug-related behaviors in CNCP patients. This is the first study of its
kind that assesses this particular constellation of psychological variables as predictors for
11

the risk of aberrant drug-related behaviors in CNCP patients. In addition, it is the first
study to assess these variables with the support of quantitative and qualitative data
methods. CNCP patients being treated at a large metropolitan family health care clinic
will be invited to participate in this study. Patients who have yet to be provided opioid
therapy for CNCP will be provided with the Screener and Opioid Assessment for Patients
with Pain-Revised (SOAPP®-R) to assess for the risk of opioid misuse and patients
already prescribed opioid medications will take the Current Opioid Misuse Measure
(COMM) to assess for aberrant drug-related behaviors. Qualitative data conducted with
grounded theory methods will assess the impact of the psychological variables on a
deeper level and assess thoughts, feelings and fears behind the use of opioid therapy for
chronic pain management of CNCP patients.
As aforementioned, there is a great need to assess the predictors for the risk of
aberrant drug-related behaviors in CNCP patients. The next chapter of this thesis will
cover the extent to which the psychological variables being explored in this study have
been assessed and presented in the literature. Furthermore, chapter two will address the
ways the variables have, if at all, been associated with the outcome variables, aberrantdrug related behaviors or the risk of opioid abuse.
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CHAPTER TWO: LITERATURE REVIEW
Chronic Pain
Chronic pain is defined as a pain experience that persists for at least three months
following the usual course of healing time for an acute injury, non-healing lesion, or an
illness (Rosenblum, Marsch, Joseph & Portenoy, 2008; Verhaak, Kerssens, Dekker,
Sorbi, & Sensing, 1998). Chronic pain has been found to affect over 50 million
Americans, with musculoskeletal pain causing the greatest impact. The chronic pain
experience is a highly complex phenomenon including biopsychosocial elements which
may or may not be primarily driven by a tissue injury. The most common forms of
chronic pain are divided into “nociceptive” and “neuropathic” pain categories.
“Nociceptive” pain stems from repeated stimulation of pain receptors caused from tissue
damage, and “neuropathic” pain is a term suggesting that there has been damage or
dysfunction of the central or peripheral nervous system. Both acute and chronic pain
experiences are activated by multiple peripheral and central mechanisms interacting with
each other and with pain modulating systems. The experience of pain is subjective and
profoundly influenced by psychological processing (Turk & Melzack, 2001). Chronic
pain patients with identical diseases have been found to differ greatly in their reports of
pain severity and pain behaviors (Aronoff, 1999). The perception and subjective
experience of pain is thus caused by a neurophysiological process. In further support of
this, Delou (2006) found the role of neuorimmune activation following a tissue injury as
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an important mechanism in the development of chronic pain (Rosenblum, Marsch, Joseph
& Portenoy, 2008).
Psychosocial and psychiatric factors such as the level of social support, cultural
influences, comorbid mood disorders, and drug abuse (Gatchel, Peng, Peters, Fuchs, &
Turk, 2007) have been found to play a role in the development of chronic pain.
Psychological factors have been reported to be predictive of long-term disability for
many pain syndromes as well as for pain severity, emotional distress, and seeking
treatment (Boothby, Thorn, Stroud, & Jensen, 1999; Johansson & Lindberg, 2000;
Pfingsten, Hildebrandt, Leibing, Franz, & Saur, 1997). For example, in one study,
psychosocial variables accounted for 59% of the variance in disability associated with
chronic pain (Burton, Tillotson, Main, & Hollis, 1995). When studies of predictors of
recovery versus continued disability were reviewed, maladaptive attitudes and beliefs,
lack of social support, heightened emotional reactivity, job dissatisfaction, substance
abuse, compensation status, the prevalence of pain behaviors (Turk, 1997) and
psychiatric diagnosis (Gatchel & Epker, 1999) appeared to be among the best predictors
of the transition from acute injury to chronic disability. It is interesting to note that
physical factors, including severity of injury and physical demands of the job, did not
appear to contribute as much to the prediction of chronicity (Turk & Okifuji, 2002).
Pain behavior research suggests that the social/environmental context of pain
(Beecher, 1959) and cultural differences in the beliefs and attitudes toward pain
(Zbrowski, 1969) have a significant impact on pain behaviors. These psychological,
social, and psychiatric influences should not lead to the conclusion that a pain syndrome
is primarily psychogenic. Pain conditions related to primarily psychological factors exist,
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but are far less prevalent than CNCP associated with natural processes influenced by
psychosocial mediators and psychiatric comorbidities (Portenoy, Payne, & Passik, 2004).
Clinicians commonly apply an acute care model to a chronic condition. There are
no treatments that cure chronic pain and expecting a cure from a drug, injection, or
operation has been considered “wishful thinking” (Deyo, Mirza, Turner, & Martin, 2009).
These approaches risk overlooking the psychosocial, occupational, and lifestyle
dimensions of chronic pain. Although evidence remains incomplete and the magnitude of
benefits may be modest, data support the benefits of interventions that promote patient
involvement and activity such as exercise programs and group support (Deyo, 2001;
Deyo, Mirza, Turner, & Martin, 2009; Hayden, Van Tulder, Malmivaara, & Koes, 2005;
Hoffman, Papas, Chatkoff, & Kerns, 2007; Lorig, Laureny, Deyo, Marnell, Minor &
Ritter, 2002; Staal, Hiobil, Twisk, Koke, & Van Mechelen, 2004). These therapies also
have the advantage of being low risk.
A chronic care management model acknowledges that chronic pain, like diabetes
or asthma, is a condition we can treat but rarely cure. As with other chronic conditions,
care of chronic pain may benefit from: sustained commitment from health care providers,
involvement of patients as partners in their care, education in self-care strategies,
coordination of care, and involvement of community resources to promote exercise,
provide social support, and facilitate a return to work (Bodenheimer, Wagner, &
Grumbach, 2002). Patients require realistic expectations despite product marketing,
media reports, and medical rhetoric that promise a pain-free life. Deyo et al. (2009)
made a call for future research to clarify a treatment's safety and its effects on pain,
function, and return to work instead of measuring only technical successes such as solid
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bony fusion or properly placed injections. These researchers made the request that
providers inform CNCP patients about available treatment options, including the best
available evidence for effectiveness, uncertainties, and risks, and encourage patients to
collaborate in therapeutic decision making (Deyo, 2001; Deyo et al., 2009).
Depression and Chronic Pain
One of the most challenging byproducts of CNCP is emotional distress. The most
prevalent emotional reactions include depression, anxiety, fear, guilt, anger and
frustration. The degree to which patients can regulate their emotions has implications for
their perception of pain. Negative affect is a key reason individuals associate pain with
suffering. Pain activates negative emotions that range from tolerable to miserable (Craig,
2003). Negative affect is strongly associated with poor treatment outcomes and the
development of disability from pain (Linton, 1976; Linton & Shaw, 2011; Main,
Sullivan, & Watson, 2008).
Depression is defined as a psychological problem characterized by negative
mood, hopelessness, and despair. 52% of patients with pain have been found to fulfill the
criteria for depression (Bair, Robinson, Katon & Kroenke, 2003). Higher rates of
patients experience depressive symptoms but do not fulfill the diagnostic criteria for
major depression (Clyde & Williams, 2002). The presence of depression in a pain
condition is associated with higher levels of pain intensity and is a major risk factor for
disability (Bair, Robinson, Katon & Kroenke, 2003). Moreover, patients who have
musculoskeletal pain and are depressed have been found to have twice the sick leave
duration compared to those who have pain but are not depressed (Currie & Wang, 2004;
Druss, Rosenheck & Sledge, 2000). Potential risk of long-term disability and treatment
16

outcome are also affected negatively (Bair, Robinson, Katon & Kroenke, 2003; Pincus,
Burton, Vogel & Field, 2002; Shaw, Linton & Pransky, 2006). Research has shown that
high levels of reported pretreatment depression are affiliated with poor rehabilitation
outcomes (Linton & Shaw, 2011; Nicholas, 2007; Sullivan, Adams, & Thibault, 2006;
Vowles, Gross & Sorella, 2004).
Successful development of self-management skills for CNCP may be more
challenging for patients who concurrently experience depression. Comorbidity of
depression and CNCP has been found to be present in 30% to 50% of patients (Center for
Substance Abuse Treatment, 2003; Department of Health and Human Services, 2005).
Depression may interfere with CNCP patients’ ability to self-manage their pain (Centers
for Disease Control and Prevention, 2007). Depression has been hypothesized to lead to
reduced self-efficacy and lower expectations of self-management efforts of CNCP.
However, there is a dearth of research on pain self-management among patients with
medical and psychiatric comorbidity and little is known about the challenges these
patients with comorbid conditions face (Cepeda, Camargo, Zea, & Valencia, 2006).
Although some studies (Chou, Clark, & Helfand, 2003; Chou et al., 2009; Chou &
Huffman, 2009) have identified barriers to effective self-management, the literature is
significantly limited on the potential facilitators to self-management of CNCP.
In addition, pain patients diagnosed with major depression and other psychiatric
disorders are more likely than their counterparts to initiate and continue opioid therapy
(Sullivan, Edlund, Zhanf, Unutzer, & Wells, 2006) and are found to more likely misuse
medication (Wasan, Butler, Budman, & Benoit, 2007; Edlund, Steffick, Hudson, Harris,
Sullivan & Rick, 2007). These individuals are less likely to experience analgesic benefits
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from opioid therapy (Wasan, Davar & Jamison, 2005). While depression and other
psychiatric disorders are common among patients with chronic back pain (Bair,
Robinson, Katon & Kroenke, 2003; Carragee, 2001; Demyttenenaere, Bruffaerts, & Lee
et al. 2007; Sullivan, Edlund, Zhanf, Unutzer, & Wells, 2006), patients with such
disorders are commonly excluded from trials of opioid therapy which raises questions
about the generalizability of efficacy studies to routine practice (Sullivan, Edlund, Zhanf,
Unutzer, & Wells, 2006).
Manchikanti and colleagues (2007) found from an assessment of 500 CNCP
patients prescribed and receiving stable doses of opioids that drug abuse was significantly
higher in patients with depression as compared to patients without depression (12% with
depression versus 5% without). In the same study, current illicit drug use was higher in
women with depression (22%) than women without depression (14%). Among men in
the study, with or without depression, illicit drug use was found in 12%. The patients
were evaluated for psychopathology, opioid abuse, and illicit drug use during the course
of regular pain management treatment.
Ethnic Identity and Chronic Pain
Ethnic identity has been defined by prominent researchers as “the subjective sense
of ethnic group membership that involves self-labeling, sense of belonging, preference
for the group, positive evaluation of the ethnic group, ethnic knowledge, and involvement
in ethnic group activities” (Cokely, 2007; Phinney, 1992). Ethnic identity has historically
been examined in psychological research from two major theoretical frameworks: social
identity and developmental theory. Social identity is driven by a desire to belong to a
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social group while developmental theory postulates that individuals are motivated to
explore their own identity over time (Phinney & Ong, 2007).
There is a strong need for clinicians and researchers to better understand the
health and health behaviors of ethnic minorities in the United States due to the prevalence
of health disparities (Anderson, 1995; Cokely, 2007). In a recent review of ethnic and
racial identity literature, Ponterotto and Park-Taylor (2007) proposed that it is important
for researchers conducting ethnic and racial identity research to clearly define constructs
used, describe rationale for appropriate instrument selection, and carefully consider
sample collection.
Oyserman (2007) theorized ethnic identity from the social identity perspective,
and suggested that when a behavior is adopted and leads to inclusion and acceptance of
the in-group, that behavior becomes regularly espoused and integrated into identity.
Behaviors can have a negative or positive health consequence depending on the specific
health habit adopted. This model suggests that health behaviors are engaged in less for
health consequences than for their identity inferences. Hence, health promotion activities
are viewed from this model as social identity-infused habits rather than personal choices.
Social identity models suggest that individuals view their world from the perspective of
others from their in-group (Haslam & Reicher, 2006; Oyserman, Fryberg & Yoder,
2007). Moreover, groups may compete for self-defining characteristics and the groups
with more resources are likely to have the upper hand in claiming values and in-group
identifying characteristics (Blanton, Christie & Dye, 2002; Oyserman, Fryberg & Yoder,
2007).
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Research indicates that ethnic identity and self-esteem are correlated and that a
greater sense of belonging and pride in one’s ethnic group can increase self-esteem
(Phinney, 1992) and lead to a positive sense of self and higher self-confidence (UmañaTaylor and Updegraff, 2007). A greater ethnic identity has been correlated with greater
positive mood, lower anxiety, and less depressive symptoms (Kiang et al., 2006;
Mossakowski, 2003; Phinney et al., 1997; Roberts et al., 1999; Umaña-Taylor &
Updegraff, 2007). When individuals maintain negative attitudes or are unclear about
their ethnic identity they tend to have lower self-esteem (Phinney et al., 1997).
Individuals with a strong ethnic identity and high self-esteem have better coping
strategies for dealing with adverse experiences, such as discrimination (HolcombMcCoy, 2005; Mossakowksi, 2003) or a pain experience. In addition, in a recent study,
Corral and Landrine (2008) found that health behaviors that have a low prevalence
among traditional minorities increase with acculturation with the dominant culture.
Alternatively, it was indicated in this study that health behaviors with a high prevalence
amongst traditional minorities decrease with acculturation (Corral & Landrine, 2008).
Americans from lower socio-economic statuses have been found to engage in
fewer health promoting behaviors and to experience more health consequences (Bolman,
Murphy & Gleeson, 2004). Research indicates that African Americans, Mexican
Americans, and American Indians reported that they engage in fewer health-promoting
behaviors, (U.S Department of Health and Human Services, 1996) and seemingly
experience more disease and death rates than White middle class Americans (Bell, Quant,
Acrury, McDonald, & Vitolins, 2000; King et al., 2000; Thompson et al., 2001).
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Cultural affiliation has been found to have an important influence on the
perception of and response to pain. However, research is diffuse in examining how
cultural differences influence a pain experience. Bates, Edwards & Anderson (1993)
found the role of ethnic identity and cultural experiences out of an array of
biopsychosocial factors, most influential in the experience of chronic pain in 372 chronic
pain patients. In this study, the best predictors of pain intensity were ethnic group
affiliation and locus of control. It appears that variations in pain intensity may be
affected by differences in attitudes, beliefs, emotional and psychological states associated
with subset ethnic groups. While it is common knowledge that intense pain affects
attitudes and emotions, it is also very likely that attitudes and emotions influence reported
perceptions of pain intensity (Bates, Edwards & Anderson, 1993).
The study of the association between ethnic identity and opioid use in CNCP
patients is limited in present research. Wong and Longshore (2008) assessed the impact
of ethnic identity spirituality, and self-efficacy on methadone treatment outcomes for
heroin use among Hispanic Americans. Researchers found that greater levels of ethnic
identity were related to a greater number of drugs used at one-year follow-up. In
addition, James, Kim and Armijo (2000) assessed the impact of ethnic identity on drug
use among ethnic minority adolescents. James, Kim and Armijo (2000) found the ethnic
minority sample reported higher levels of ethnic identity and that higher ethnic identity
levels were associated with heavy drug use. Furthermore, in the same study researchers
found that white adolescent group members scored lower on ethnic identity than
members in the four ethnic minority groups.
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Social Support and Chronic Pain
Terrence, Amick and Judith (1994) defined social support as the degree to which
an individual’s basic social needs are met through an interaction with others involving
resources both tangible and intangible. According to Cohen and Wills (1985) social
support is a multidimensional construct which includes structural and functional qualities.
Structural social support refers to the existence and form of a social network while
functional (also known as perceived social support) is concerned with how the network
serves to provide multifarious kinds of support. Wills and Filer (2001) further explained
that perceived social support is the subjective judgment that family and friends are able to
provide quality assistance during life stressors or times of need. This assistance may
include listening, expressing warmth and affection, offering advice or another way of
looking at the problem, providing specific assistance such as looking after the children, or
simply spending time with the stressed individual (Lakey & Cohen, 2000).
The dominant theoretical perspective in social support research draws from stress
and coping theory (Lakey & Cohen, 2000). According to this theory (Folkman &
Moskowitz, 2004; Lazarus & Folkman, 1984), stress occurs when people interpret
situations negatively, do not employ adequate coping responses (such as problem solving
or emotional regulation) and the experience of stress leads to health complications.
Social support promotes health by buffering stress and protecting individuals from the
adverse affects of stress (Cohen & Wills, 1985). This occurs through an adoption of
adaptive appraisals and/or effective coping strategies. From this perspective, social
support is most efficacious when appraisals and coping skills are enhanced and the
particular type of social support matches the demands of the stressor (Cohen &
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Hoberman, 1983; Cutrona & Russell, 1990). Moreover, when an individual's perception
of support reflects his or her history of the receipt of effective support this perception
directly reduces negative appraisals of stressors (Lakey & Cohen, 2000).
The Social Provisions Theory of Weiss (1974) has also made a significant
contribution to the conceptualization of social support. According to Weiss’s theory,
there are six different social provisions that may be obtained from relationships. These
provisions include guidance (advice or information), reliable alliance (assurance that
others can be counted on in times of stress), reassurance of worth (recognition of one’s
competence), attachment (emotional closeness), social integration (a sense of belonging
to a group of friends), and opportunity for nurturance (providing assistance to others;
Rizwan & Syed, 2010; Weiss, 1974). Among the most common measures of social
support are measures of perceived support, and the two most notable and widely used are
the Interpersonal Support Evaluation List and the Social Provisions Scale. The Social
Provisions Scale was developed from Social Provisions theory as created by Weiss
(1974), and was the measure utilized in the current study. In general, these measures
show consistent and strong relations to mental health, and are often related to many
indices of physical health (Lakey & Cohen, 2000; Sarason, Sarason & Gurung, 2001;
Uchino, 2004; Wills & Filer, 2001).
Social support is a psychological construct that has been associated with
psychological health (Cohen & Wills, 1985; Kertesz, Larson, Horton, Winter, Saitz, &
Samet, 2005), psychological well-being (Cohen, Underwood, & Gottlieb, 2000;
Henderson & Brown, 1988), higher levels of psychopathology (Kilbourne, McCarthy,
Post, Welsh, & Blow, 2007; Pierce, Frone, Russell, Cooper, & Mudar, 2000), depression
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(Bayat, Erdem, & Kuzueu, 2008; Talaei, Ardani, & Saghebi, 2008), suicidal ideation
(Kimbrough, Molock, & Walton, 1996), anxiety (Bayat, Erdem, & Kuzueu, 2008), and
self-esteem (Eckenrode & Wethington, 1990; Gottlieb, 2009). Numerous researchers
have found a negative relationship between social support and depression (Barrera, 2000;
Berkman & Glass, 2000; Israel & Schurman, 1990) as well as between depression and
perceived social support (Cutrona & Russell, 1987; Weinert & Tilden, 1990; Yang &
Clum, 1995). Levels of severity of depression in both males and females have also been
associated with social support (Rizwad & Syed, 2010; Zlotnick, Shea, Pilkonis, Elkin, &
Ryan, 1996).
Interpersonal relationships that provide social support in terms of information,
help, and expressions of caring, promote health by imparting feelings that one is being
cared for, beliefs that one is esteemed, and a sense of belonging to a reciprocal network
(Cutrona & Russell, 1990). Consistent with this view, cognitive constructs such as
internal control beliefs, dysfunctional attitudes, and self-esteem are more highly
correlated with perceived support than they are with the actual help people provide
(Lakey & Cassady, 1990). Several theorists (Campbell, 1984; Cohen & Syme, 1985;
Cohen & Wills, 1985) have suggested that social support is a precursor to self-esteem.
McNicholas (2002) found a positive influence of social support on self-esteem, and an
association between these two variables has been reported in many other studies
(Hubbard, Muhlenkamp, & Brown, 1984; Mahon, Yarcheski, & Yarcheski, 1998;
McCloskey, 2008; Rizwad & Syed, 2010).
Social support can be a double-edged sword for people with CNCP (LopezMartinez Esteve-Zarazaga, Ramirez-Maestre, 2008). Lopez-Martinez and colleagues
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(2008) found that high levels of social support correlate with less pain and distress while
solicitous attention from spouses regarding pain behavior may actually increase pain
interference. CNCP patients who reported more satisfaction with their social support
network also reported lower levels of depression and less pain. Patients with satisfactory
levels of social support were more likely to choose active coping strategies for dealing
with their pain, such as trying to distract themselves by doing something pleasant, rather
than passive strategies like complaining about their pain to others. Active coping
strategies were also linked to lower levels of depressed mood and better functioning,
while patients who coped with their pain passively tended to be more depressed and to
have more severe pain (Lopez-Martinez et al., 2008).
Recent conceptualizations of pain catastrophizing (a negative exaggerated focus
on pain) have focused on the interpersonal (Sullivan et al., 2000, 2001) nature of this
construct. Researchers suggest that individuals with CNCP may communicate distress
and garner support from interpersonal relationships by verbalizing catastrophic thoughts
or engaging in pain or catastrophizing behaviors (Sullivan et al., 2000, 2001; Thorn et al.,
2003). Research supports a relationship between catastrophizing as assessed by the Pain
Catastrophizing Scale (Sullivan et al., 1995) and solicitous responses from others
(Giardino et al., 2003). Further study of the catastrophizing-support association may
provide additional insight into the consistent relationship between others’ responses and
CNCP negative outcomes (e.g. psychological distress, disability; Cano, 2004; Cano et
al., 2000, 2004; Flor et al., 1987; Kerns et al., 1990; Romano et al., 1995; Turk et al.,
1992).
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The study of the association between perceived social support and opioid use in
CNCP patients is limited in present research. Dunbar and Katz (1996) examined the
relationship between social support and aberrant drug-related behaviors in CNCP patients
with a history of substance abuse receiving opioid therapy. Researchers found that
patients in the group that was compliant with drug treatment versus the group that was
not, had good social support, were in solid drug-free recovery, and had more remote
polysubstance abuse histories. The group of patients displaying aberrant drug-related
behavior were not participatory, had poor social support, and were not in 12-step
programs (Dunbar & Katz, 1996). In a more recent study, Warren, Stein & Grella (2007)
assessed the role of social support and self-efficacy in treatment outcomes among patients
with co-occurring substance abuse and psychiatric disorders in residential drug treatment
programs. It was found that greater reports of social support at baseline predicted better
mental health and less heroin and cocaine use.
Self-Efficacy of Chronic Pain
Self-efficacy has been defined as the belief in one’s capacity to execute courses of
action required to produce certain goals (Bandura, 1997). Bandura (1977) also proposed
that expectations of efficacy determine the amount of effort individuals expend and how
long they will persist in the face of obstacles and aversive experiences. Furthermore,
Bandura (1989) built beyond this idea contending that self-efficacy beliefs relate to
specific behaviors and argued that people could hold efficacy beliefs about their ability to
cope in the face of adversity. In this context Bandura (1989) referred to strong selfefficacy beliefs as a ‘‘resilient self belief system’’ whereby ‘‘people who believe they can
exercise control over potential threats do not conjure up apprehensive cognitions and,
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hence, are not perturbed by them’’ (p. 419). Ozer & Bandura (1990) demonstrated links
between coping efficacy beliefs, avoidance behaviors and anxiety (Nicholas, 2007).
Self-efficacy has been an important psychological construct underlying research
in arthritis and other sources of chronic pain (Allegrante & Marks, 2003; Lorig &
Holman, 1989). The study of pain self-efficacy expectations (or self-efficacy beliefs)
have been used to explain a plethora of behaviors and aspects of the experience of pain
(Altmaier et al., 1993; Anderson et al., 1995; Arnstein et al., 1999; Asghari and Nicholas,
2001; Jensen et al., 1991; Keefe et al., 2004; Lackner and Carosella, 1993; Pincus and
Morley, 2002; Rudy et al., 2003; Turk, 2002). Confidence in the ability to perform
specified activities for CNCP patients has been correlated with the subsequent
performance of those activities (Council et al., 1988; Nicholas, 2007).
The awareness of the significance of self-efficacy beliefs has contributed to the
development of self-management interventions for chronic pain that focus on teaching
pain coping skills, educating patients about pain, and providing social support (Foster,
Taylor, Eldridge, et al., 2007; Nicholas, Molloy, Tonkin, & Beeston, 2003). Low pain
self-efficacy is characterized by a feeling that pain is uncontrollable and unmanageable,
given the physical demands of daily life (Linton & Shaw, 2011). Linton and Shaw
(2011) found that greater reported levels of anxiety and depression in CNCP patients
were correlated with fewer patient expectations about being able to control their
symptoms of pain and physical function. In addition, patients with fewer expectations
about controlling their symptoms and physical function expressed greater intensity and
severity of pain, greater anxiety of pain and greater catastrophizing (Linton & Shaw,
2011). In the case of self-efficacy expectations for coping with symptoms, Linton and
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Shaw (2011) observed that depression and pain intensity were identified as significant
predictors for the self-efficacy beliefs for coping with pain symptoms, revealing a close
relationship between symptoms of depression and the perception of self-efficacy of pain.
Arnstein et al. (1999) found that both pain intensity and self-efficacy contribute
to the development of incapacity and depression in CNCP patients. This suggests that the
lack of self-efficacy expectations for pain management, as well as being able to function
despite persistent pain, is a significant predictor of the degree of incapacity and/or
disability, as well as the level of depression experienced in chronic pain patients. MartínAragón et al. (2001) observed that self-efficacy expectations were negatively and
significantly correlated with pain, anxiety and depression in Spanish speaking CNCP
patients.
The study of the association between self-efficacy and opioid use in CNCP
patients is diffuse in present research. Wong and Longshore (2008) assessed the impact
of ethnic identity spirituality, and self-efficacy on methadone treatment outcomes for
heroin use among Hispanic Americans. Researchers found that higher levels of selfefficacy reported at intake were related to increased odds of abstinence of heroin use and
a lower number of drugs used at one-year follow-up. In addition, Warren, Stein and
Grella (2007) assessed the role of social support and self-efficacy in treatment outcomes
among patients with co-occurring substance abuse and psychiatric disorders in residential
drug treatment programs. These researchers found that greater reports of self-efficacy
predicted less alcohol and cocaine use.
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RESEARCH HYPOTHESES
Hypotheses for research in Partnership with Salud Family Health Care Clinics
1) Group A (CNCP patients prescribed opioids) and Group B (CNCP patients not
prescribed opioids) will be statistically significantly differentiated when gender,
age, ethnicity, level of education, perceived social support, self-efficacy of pain,
depression, and level of ethnic identity are used as predictors.
2) Gender, ethnicity and the interaction between gender and ethnicity will be
significant predictors of aberrant drug-related behaviors (positive screening on the
COMM in Group A) or high risk of opioid misuse (high results on the SOAPP®R in Group B).
3) After controlling for contributions of demographic variables (age, gender,
ethnicity and level of education), perceived social support, self-efficacy of pain,
depression, and level of ethnic identity will be significant predictors of aberrant
drug-related behaviors (positive screening on the COMM in Group A) or high risk
of opioid misuse (high results on the SOAPP®-R in Group B).
Qualitative research questions were employed to gain further comprehension of
what high risk of opioid misuse and drug-related aberrant behaviors in CNCP patients
encompasses. Chronic pain patients’ experiences of chronic pain, expectations of pain
management, expectations of the use of opioids, and coping skills for chronic pain were
explored. Grounded theory methodology was used as a basis of analyzing qualitative
data collected.
The next chapter, the third chapter of this dissertation, will describe the methods
utilized. This chapter will cover the population, instruments, metholodologies, and
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procedures. In addition, the analyses processes, ethical considerations, and possible
limitations of this study will be explained.
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CHAPTER THREE: METHOD
Research Design
Mixed methods research has increased in popularity in the social sciences
(Creswell, 2002, 2003; Greene, Caracelli, & Graham, 1989; Tashakkori & Teddlie, 1998,
2003). Mixed methods research has been defined as “the collection or analysis of both
quantitative and qualitative data in a single study in which the data are collected
concurrently or sequentially, are given a priority, and involve the integration of the data
at one or more stages in the process of research” (Creswell, Plano Clark, Gutmann, &
Hanson, 2003, p. 212). Researchers infer that when both quantitative and qualitative
data are included in a study, researchers may enrich their results in ways that one form of
data does not allow (Brewer & Hunter, 1989; Hanson, Cresswell, Plano Clark, Petska &
Cresswell, 2005; Tashakkori & Teddlie, 1998).
Mixed methods researchers have expanded the reasons for conducting mixed
methods designs in counseling psychology research. Mixed methods designs have been
found beneficial in identifying variables/constructs that may be evaluated through the use
of existing instruments or the development of new ones. Statistical data obtained from a
sample of a population has also been used to identify individuals who may expand on
those results through qualitative data. Mixed methods have been found to provide a
better understanding of a research problem by combining numeric results with specific
details from qualitative data. Furthermore, mixed methods designs have been used to
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convey the needs of individuals or groups of individuals who are marginalized or
underrepresented (Mertens, 2003; Newman & Benz, 1998).
Pragmatism has been noted as one of the best paradigms for mixed methods
research (Tashakkori & Teddlie, 2003) and draws on diverse approaches valuing both
objective and subjective knowledge (Cherryholmes, 1992). Many prominent mixed
methods researchers and scholars believe that pragmatism is the best philosophical basis
of mixed methods research (Tashakkori & Teddlie, 2003). Specifically from this lens,
quantitative and qualitative methods can be combined to use results from one method to
elaborate on results from the other method in a complementary fashion (Beck, 2005;
Goodyear et al., 2005; Hanson et al., 2005). Tashakkori and Teddlie (2003) also argued,
however, that the research questions should be of primary importance, perhaps even more
important than either the method or the theoretical lens that underlies methods used.
It has been suggested for counseling psychology researchers utilizing a mixed
methods approach, to analyze the quantitative and qualitative data separately and then
compare and contrast the two sets of results in the discussion. The interview data can be
used to corroborate, refute, or augment findings from the survey data. Data analysis
occurs by analyzing the data separately, transforming them, and by connecting the
analyses in some way (Caracelli & Green, 1993; Hanson et al., 2005; Onwuegbuzie &
Teddlie, 2003; Tashakkori & Teddlie, 1998). A mixed methods design has been selected
for the present study.
Participants
Patients 18 years of age and older experiencing a chronic non-cancer pain
(CNCP) experience were eligible to participate in this study. A convenience sampling
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method was employed. Patients prescribed opioid medications for CNCP and those who
were in consideration for opioid medications or not prescribed opioids for CNCP, were
invited to participate in this study. Participants were patients being treated at a Salud
Family Health Care Center. Data from 102 chronic pain patients were collected and
included in this study.
10 participants from the total sample were chosen for the qualitative leg of this
research. The number of participants included in the qualitative portion of this study was
dependent on when the saturation of data occurred. "In trying to reach saturation she
(researcher) maximizes differences in her groups in order to maximize the varieties of
data bearing on the category, and thereby develops as many diverse properties of the
category as possible" (Glasser & Strauss, pg. 62). Participants were interviewed for as
long as new ideas or insights continued to emerge. In addition, participants were
described fully under the guiding premise of thick description. Thick description,
“…does more than record what a person is doing. It goes beyond mere fact and surface
appearances. It presents detail, context, emotion, and the webs of social relationships that
join persons to one another...” (Denzin, 1989, p. 83). Thick description was utilized in
the qualitative portion of this study while maintaining anonymity of participants
(Ponterotto, 2006).
Theoretical sampling is a process of grounded theory by which continued
sampling occurs concurrently with data analysis. This is the technique that was utilized
in this study. The introduction of new data from participants was used to verify
categories, and to gain greater clarity and comprehensiveness. Initially a more
homogeneous sample was used during the coding process, and after new categories
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emerged, a more diverse heterogeneous sample was used to become aware of what
additional categories and properties still hold true. Criterion-based sampling was ignited
in order to develop a sample that is diverse across gender, age and ethnicity (Glaser &
Strauss, 1967)
Participant Demographics
This study sought to explore the experiences of a diverse group of chronic pain
patients. Demographic information related to the sample will be presented in Chapter
Four. Ten chronic pain patients participated in both the qualitative and quantitative
aspects of this research. Information about this specific group will also be presented in
Chapter Four.
The Research Team
Lead Researcher
The lead researcher is a doctoral candidate at the University of Denver. As the
primary investigator, she was solely responsible for conducting all of the interviews with
patients. This measure was put in place to allow for consistency, and also to provide the
lead researcher with significant in-depth exposure to the data. Grounded theory
methodology allows the researcher to become “lost” in the data (Glaser & Strauss, 1967).
The lead researcher became engrossed in the data in an effort to generate a grounded
theory.
Secondary Researchers
Three secondary researchers along with the lead researcher comprised the
research team. Dr. Cynthia McRae, the dissertation mentor, provided consistent support,
encouragement, and knowledge from the study’s inception, and throughout the data
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collection, analysis, and formulation of the grounded theory process. Paul Grimsley,
MS.Ed and Lexi Heringer were secondary researchers from the beginning of data
collection. These secondary researchers and the lead researcher met regularly, and
communicated electronically in between meetings, and throughout the study. The
secondary researchers were extremely dedicated to the project, and committed
considerable time, energy, and effort to the research from the start of the research until its
completion. They aided in transcribing and analyzing data and in contributing to the
generation of theory.
Instruments
Current Opioid Misuse Measure (COMM)
Permission to utilize this measure was granted by Dr. Kevin L. Zacharoff, the
Vice President of Medical Affairs for Inflexxion Inc., on September 14, 2011. The
primary researcher signed a licensing agreement to gain approval for its use (see
Appendix K). The COMM originated from an original 40-item questionnaire developed
out of input from a panel of experts and concept mapping analyses. 17 of the items from
the original COMM were found to show good reliability and adequate validity in
identifying which chronic pain patients currently on long-term opioid therapy would
show evidence of medication misuse or abuse after an extensive assessment process. The
COMM consists of these 17 items and is a self-report questionnaire which assesses the
risk for aberrant medication-related behaviors among chronic pain patients. It was
developed to complement predictive screeners of opioid misuse and to improve a
clinician's ability to periodically assess a patient's risk for opioid misuse. Unlike other
measures that were designed to identify risk potential for substance abuse, like the
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SOAPP®-R, the COMM is designed to address ongoing medication misuse by asking
patients to describe how they are currently using their opioid medication. Each question
asks the relative frequency of a thought or behavior over the past 30 days on a 4-point
Likert scale ranging from 0 = “Never” to 4 = “Very Often” and total scores range from 0
to 68. Two sample items of this measure are: “In the past 30 days, how often have you
had to take more of your medication than prescribed?” and “In the past 30 days, how
often have you been worried about how you’re handling your medications?” One-week
test-retest reliability for the total COMM score was excellent (intraclass correlation
coeeficient = 0.86). The coefficient alpha found for the 17-item COMM was 0.86 which
suggested excellent internal reliability (Butler et al., 2007).
The COMM assesses current behaviors and cognition. While it may be common
for CNCP patients taking opioids for pain who misuse their medication to be prone to be
less than truthful when completing a current medication misuse questionnaire, many of
the items on the COMM are subtly related to misuse of medication and are not so
transparent. Researchers found that patients are commonly willing to admit to certain
items if they have an option to rate them as 1 = “Seldom” on a 0 to 4 scale (Butler et al.,
2004). By providing this option, the chance that patients will falsify all answered
responses decreases. The COMM low cut-off score of nine was selected to over-identify
misuse. Any endorsement of COMM items results in greater likelihood of identifying
current medication misuse. It is just as important to identify patients who have a
possibility of misusing their medication as those actually abusing. This scale may result
in false positives indicating patients identified as misusing their medication when they
were not. Similar to past measures this may help to predict substance abuse. Moreover,
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the COMM may also be valuable as a scale to identify those who are not having problems
with their use of opioids when patients receive very low scores. However, since there are
no objective means by which to identify substance abusers, errors can be made.
Clinicians are encouraged to practice caution when interpreting the results of the COMM
and other similar measures like the SOAPP®-R and to consider extenuating
circumstances. As with all screening measures, the COMM is a single indicator of
possible medication misuse (Butler et al., 2007). Additional information should be used
in making a diagnosis of a substance abuse disorder (Savage, 2002).
Screener and Opioid Assessment for Patients with Pain-Revised (SOAPP®-R)
Permission to utilize this measure was granted by Dr. Kevin L. Zacharoff, the
Vice President of Medical Affairs for Inflexxion Inc., on September 14, 2011. The
primary researcher signed a licensing agreement to gain approval for its use (see
Appendix K). The SOAPP®-R is a 24-item self-report questionnaire with a five-point
Likert scale ranging from 0 = “Never” to 4 = “Very often” and total scores range from 0
to 96. Two sample items of this measure are: “How often have you had to borrow pain
medications from your family or friends?” and “How often have you felt consumed by
the need to get pain medication?” A participant receiving a score of 18 or higher indicates
a positive screening (Butler et al., 2008).
The SOAPP®-R was developed to complement current risk assessment practices
and improve a clinician's ability to assess a patient's risk for opioid abuse. The
assessment takes participants less than ten minutes to complete. The measure has been
validated with 500 chronic pain patients. The estimate of reliability was found to be 0.74
on internal consistency and 0.71 on test-retest reliability (Butler et al., 2008). The
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measure addresses some of the limitations of the original SOAPP V.1 by containing more
subtle and socially acceptable items that were conceptually and empirically examined.
The SOAPP®-R was found to have good psychometric properties in a cross-validation
test with an additional sample of 284 CNCP patients on long-term opioid therapy. This
cross-validation study which also included the Aberrant Drug Related Index (ABDI)
resulted with a reliability of 0.86 on internal consistency and 0.94 on test-retest reliability
(Butler et al., 2008).
CNCP patients scoring above 22 on the SOAPP®-R have been identified as
individuals most at risk for opioid misuse. Some examples of these behaviors or beliefs
include a current or recent history of alcohol or drug abuse, being discharged from
another physician’s care because of his/her behavior, and regular noncompliance with
physicians’ orders. In addition, these patients may have misused other prescription
medications in the past. The measure can predict aberrant medication-related behaviors
six months after initial testing (Butler et al., 2008).
Pain Self-Efficacy Questionnaire (PSE-Q)
Approval to use this measure was granted by the primary author, Dr. Michael
Nicholas, on August 16th of 2011 in an email. The PSE-Q is a 10-item self-report
measure which utilizes a seven-point Likert scale ranging from 0 = “Not at all confident”
to 6= “Completely confident” with total scores ranging from 0 to 60. The PSE-Q is a
measure designed for chronic pain patients to assess their expectations and level of
confidence in performing a particular behavior or task despite their experience of pain.
This is one of the only measures of its kind that assesses self-efficacy beliefs for people
experiencing chronic pain while “in the face of their obstacles” as Bandura (1977)
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initially proposed. Bandura (1977) contended that “efficacy expectations determine how
much effort people will expend and how long they will persist in the face of obstacles and
aversive experiences’’(p. 194). Most other published measures of self-efficacy beliefs
used in pain samples do not explicitly ask the patient to take their pain into account when
describing their confidence in performing specific tasks (e.g., Jensen, Anderson et al.,
1995; Lorig et al., 1989; Nicholas, 2007; Rudy et al., 2003). Some examples of these
questions include: ‘‘I can do most of the household chores (e.g., tidying-up, washing
dishes), despite the pain’’ and ‘‘I can gradually increase my activity level, despite the
pain’’ (Nicholas, 2007).
The PSE-Q has been utilized in a plethora of clinical settings and in multiple
countries (e.g., Adams and Williams, 2003; Asghari and Nicholas, 2001; Ayer and
Tyson, 2001; Cohen et al., 2000; Coughlan et al., 1995; Dehghani et al., 2004; Estlander
et al., 1994; Frost et al., 1993; Gibson and Strong, 1996; Nicholas et al., 1992; Ralphs et
al., 1994; Strong et al., 2002; Watson et al., 1997; Williams et al., 1993, 1996, 1999).
Some of the items were derived from existing measures (namely the Pain Beliefs
Questionnaire: Gottlieb, 1984) and modified to fit the variant revised scale while further
additional items were created from the author’s experience in working with chronic pain
patients (Nicholas, 2007).
Validity of the PSE-Q is reflected in high correlations with measures of painrelated disability. The measure of internal consistency of items, Cronbach’s alpha
coefficient, was calculated as 0.92. This value is very high and indicates the instrument
has excellent internal consistency (Nunnally & Bernstein, 1984). Test–retest reliability
was assessed on a different sample of 145 chronic pain patients treated at the Royal North
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Shore Hospital in Sydney from 1995-1996 (Asghari & Nicholas, 2001). For comparison
purposes, this sample had a test–retest period from initial assessment to three months
later. During this time, all patients received some form of ongoing treatment (mainly
medication), but reported no changes in their average rates of disability or pain. The
test– retest correlation from baseline to three months was 0.73. Interestingly, similar
findings were reported by Williams et al. (1996) with a wait-list control group of 31
chronic pain patients who were tested 12-weeks apart. Williams et al. (1996) found that
patients continued with whatever treatments their doctors had prescribed. Results
showed the mean PSE-Q baseline score was 26.3 and after 12 weeks the mean score was
26.7. Thus, no significant change was found and researchers indicated that no change in
pain or disability was found either. These findings suggest that the PSE-Q has
demonstrated a high degree of reliability, both internally and across a period of at least
three months under conditions of no change in either pain or disability (Nicholas, 2007).
In some studies, results of the PSE-Q were also found to indicate the likelihood of
behavioral maintenance or even likelihood of returning to work given the presence of
pain. Scores of around 40 post-treatment were found in injured workers who returned to
work (Adams & Williams, 2003; Cohen et al., 2000) and in patients who generally
maintained their treatment gains at 6 and 12-month follow ups (Williams et al., 1993,
1996). Findings obtained with the PSE-Q across a number of studies with different pain
populations provide support for the idea originally proposed by Bandura (1989) that it is
useful to conceptualize self-efficacy as a resilient self-belief system operating in the face
of obstacles. By specifying the nature of the obstacles to be faced, albeit pain, the PSE-Q
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provides more clinically useful information than asking individuals to rate their level of
confidence in performing an activity in isolation (Nicholas, 2007).
Multi Ethnic Identity Measure-Revised (MEIM-R)
The author of this measure (Phinney, 1992) allows researchers to utilize this
instrument without prior permission or approval. The MEIM was first published almost
15 years ago and since that time it has been widely used and reported in the literature.
The measure is based on the developmental theories of Erikson (1968) and Marcia
(1980), as well as the social identity theory of Taijfel (1981). Phinney (1992) created the
MEIM based on the belief that ethnic identity is a general phenomenon with elements
that are common across all ethnic group members. She indicated that the scale would
allow for the assessment and comparison of ethnic identity across ethnic groups
(Phinney, 1992). According to Phinney, the label an individual uses to self-identify
should be distinguished from parents’ ethnic heritage, which forms the basis for one’s
objective group membership. Gathering this information helps to avoid confusion
between ethnicity and ethnic identity. The MEIM is the dominant measure of ethnic
identity utilized in multicultural research (Cokely, 2007) and the revised MEIM (Phinney
& Ong, 2007) has been described as a measure to be used for best practices (Ponterotto &
Park-Taylor, 2007).
The MEIM-R maintains stronger reliability and higher alpha coefficients than
multidimensional measures of ethnic identity in the literature. The MEIM-R
demonstrated moderately high internal consistency with a Cronbach’s alpha of 0.87 and
confirmatory factor analyses estimates resulted from 0.71 to 0.90. The MEIM-R is a
unified construct with three interrelated components of ethnic identity that load onto one
41

factor: affirmation, achievement, and behaviors (Cokely, 2007; Phinney, 1992). The
measure is a 14-item self-report questionnaire that assesses three components of ethnic
identity: affirmation and belonging (five items), ethnic identity achievement (seven
items) and ethnic behaviors (two items). Items are rated on a 4-point Likert scale ranging
from 1 = “Strongly disagree” to 4 = “Strongly agree”. High scores indicate strong ethnic
identity (Phinney, 1992). Affirmation refers to a sense of belonging and positive attitudes
toward one’s ethnic group. Achievement refers to the exploration and resolution of
ethnic identity issues. Behaviors refer to engaging in behaviors and practices that are
specific to or representative of one’s ethnic group (Phinney, 1992).
The MEIM-R was developed on samples of high school and college students.
The high school sample consisted of 134 Asian Americans, 131 African Americans, 89
Latinos, 41 students with mixed ethnic backgrounds, 12 European Americans, and 10
individuals identified as other. The college sample consisted of 58 Latinos, 35 Asian
Americans, 23 European Americans, 11 African Americans, 8 students with mixed ethnic
backgrounds, and 1 American Indian. Ethnic groups were operationally defined on the
basis of students’ self-report. Some examples of sample items include, “I feel a strong
attachment toward my ethnic group”, “I am not very clear about the role of my ethnicity
in my life”, “I have a clear sense of my ethnic background and what it means to me”.
Higher scores on the MEIM-R reflect a greater emphasis placed on ethnicity as an
important part of participants’ identities (Phinney, 1992).
Social Provisions Scale
Permission to use this instrument was granted by the primary author of this
measure, Dr. Carolyn Cutrona, on August 22, 2011 in an email message. The most
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commonly used measures of social support are measures of perceived support. In
general, these measures show consistent and strong relations to mental health, and are
often related to many indices of physical health (Sarason, Sarason & Gurung, 2001;
Uchino, 2004; Wills & Filer, 2001). Among the most common measures is the Social
Provisions Scale (Lakey & Cohen, 2000). The Social Provisions Scale assesses
participants’ perceived general social support from participants’ social network (Cutrona,
1989; Cutrona and Russell, 1987). The measure is a 24-item, 4-point Likert scale which
evaluates six provisions of social relationships described by Weiss (1974). Scores range
from with a 1 = “Strongly disagree” to 4 = “Strongly agree” with total scores ranging
from 0 to 96. The six provisions include guidance (advice or information), reliable
alliance (belief that others can be counted on in times of stress), reassurance of worth
(recognition of one’s competence), attachment (emotional closeness), social integration
(a sense of belonging to a group of friends), and opportunity for nurturance (rendering
assistance to others). Scores can be determined for each of the six provisions as well as
for a global social support score. Research supports the reliability and validity of the
Social Provisions Scale, as well as the factor structure of the measure (Cutrona & Russell,
1987; Rizwa & Syed, 2010).
The Social Provisions Scale yields reliable measurements of each social
provision. Analyses were conducted on a sample of 1792 respondents, which included
1183 students from introductory psychology courses (Cutrona & Russell, 1987), 303
public school teachers (Russell et al., 1987), and 306 nurses from a military hospital
(Constable & Russell, 1986). The reliabilities of the individual social provision subscales
have coefficient alphas ranging from 0.65 to 0.76. Reliability of the total Social
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Provisions score was 0.91 based on the formula for the reliability of a linear combination
of scores given by Nunnally (1978, p. 248). In addition, a confirmatory factor analysis
was conducted on responses to the instrument to evaluate factor structure (Cutrona &
Russell, 1987), and all of the item loadings on the respective factors were statistically
significant and sizeable in magnitude (ranging from .39 to .79). Each item adequately
represents the construct that it was designed to assess. Some examples of sample items
include: “There are people I can depend on to help me if I really need help,” “I have close
relationships that provide me with a sense of emotional security and well-being,” and
“There are people I can count on in an emergency.”
Patient Health Questionnaire (PHQ-9)
The Patient Health Questionnaire (PHQ) is a three page self-report questionnaire
commonly used in primary care. Typically, the clinician scans the completed
questionnaire, verifies positive responses, and applies diagnostic algorithms that are
abbreviated at the bottom of each page. The PHQ assesses criteria for eight diagnoses,
divided into threshold and subthreshold disorders that correspond to specific DSM-IV
diagnoses. The threshold disorders are Major Depressive Disorder, Panic Disorder, Other
Anxiety Disorder, and Bulimia Nervosa, and subthreshold disorders whose criteria
encompass fewer symptoms than are required for any specific DSM-IV diagnoses are
Other Depressive Disorder, probable Alcohol Abuse/Dependence, Somatoform, and
Binge Eating Disorder (Kroenke, Spitzer & Williams, 2001).
The PHQ-9 is a nine item depression module taken from the full PHQ. The
PHQ-9 is already the dominant depression screening measure utilized at Salud Family
Health Care Clinics, which influenced the decision to use this measure versus other
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published measures to assess for depression. In the PHQ-9 Major Depression is
diagnosed if five or more of the nine depressive symptom criteria have been present at
least “more than half the days” in the past two weeks, and if one of the symptoms is
depressed mood or anhedonia. Other depression is diagnosed if two, three or four
depressive symptoms have been present at least “more than half the days” in the past two
weeks, and one of the symptoms is depressed mood or anhedonia. One of the nine
symptom criteria (“thoughts that you would be better off dead or of hurting yourself in
some way”) counts if present at all, regardless of duration. As a severity measure, the
PHQ-9 score can range from 0 to 27, since each of the nine items can be scored from 0 =
“Not at all” to 3 = “Nearly every day”. An item was also added to the end of the
diagnostic portion of the PHQ-9 asking patients who checked off any problems on the
questionnaire, “How difficult have these problems made it for you to do your work, take
care of things at home, or get along with other people?” (Kroenke, Spitzer & Williams,
2001).
The internal reliability of the PHQ-9 was excellent with a Cronbach's alpha of
0.89. Test-retest reliability of the PHQ-9 was also excellent. Correlation between the
PHQ-9 completed by the patient in the clinic and then administered telephonically by
Mental health physicians within 48 hours, in a primary care study, was 0.84. The vast
majority of patients (93%) with no depressive disorder had a PHQ-9 score less than 10,
while most patients (88%) with major depression had scores of 10 or greater. Scores less
than five almost always signified the absence of a depressive disorder; scores of five to
nine predominantly represented patients with either no depression or subthreshold (i.e.,
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other) depression; scores of 10 to 14 represented a spectrum of patients; and scores of 15
or greater usually indicated Major Depression (Kroenke, Spitzer & Williams, 2001).
Qualitative Methodology
Since Glaser and Strauss (1967) created grounded theory while working on the
study “Awareness of Dying,” the sociologically based theory has been adapted by
researchers in many fields and has been described as the most influential qualitative
research paradigm of the social sciences (Ponterotto, 2005). Grounded theory’s four
major features include: 1) theory grounded in data 2) constant comparative method 3)
memo writing, and 4) theoretical sampling (Glaser & Strauss, 1967). These methods
were utilized throughout the study.
Under the qualitative constructivist-interpretivist paradigm of grounded theory,
in-depth, one-on-one interviews were conducted with an equal number of chronic pain
patients from “the already prescribed opioid medication” group as well as the “being
considered for opioid therapy” group. In grounded theory literature it is recommended
that researchers be flexible in their design and plans (Haverkamp & Young, 2007). To
this end, an open, unbiased and flexible approach to interviews was taken. Data derived
from the interviews were interpreted using the constant comparative method. This
method is a comparative coding process including three types of coding: open, axial and
selective coding. The basic units for creating grounded theory derive not from “raw
data,” but from analyzing the indicators of phenomena. These phenomena are given
conceptual labels or concepts that are grouped into categories. This process is done by a
trained researcher who ascribes context and meaning to data in a relevant way for those it
will impact (Fassinger, 2005).
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Elliott, Fischer, and Rennie (1999) discussed the importance of owning one’s
perspective in qualitative research. Authors advise that researchers should disclose their
theoretical orientation and own personal relationship to the topic and study. Because the
analysis of the data requires conceptualization of categories and themes, it is important to
be aware of one’s own personal assumptions and possible biases. Creswell (1998)
discussed the importance of researchers’ bracketing their expectations prior to their
qualitative inquiry. In keeping with grounded theory tenets and in an effort to bracket my
own experiences and perspectives, I will provide my relevant background below. I am a
counseling psychology doctoral student at the University of Denver. I operate from a
psychodynamic orientation. I am a white, single 32 year-old American female. I have a
MSEd in Counseling Psychology and my interests are in health psychology/primary care,
chronic health conditions, and trauma. I am connected to the topic of the risk of aberrant
drug-related behavior in CNCP patients from my exposure working with chronic pain
veterans receiving treatment in the chronic pain clinic and the opioid pain care clinic at
the Denver VAMC during my practicum placement in 2010. My interest grew as I
realized that controversy remained on how to best decipher those chronic pain patients
that would most likely benefit from opioid medication from those most likely to not. I
recognized how challenging this process of assessing and determining the best
recommendations for chronic pain patients could be while concurrently maintaining
concerns of not wanting to cause further pain or possible malficience by putting some
patients at risk for addiction. I realized how many questions still remained in the medical
community in regards to differentiating factors between those patients in the low risk
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categories versus patients in the high risk categories of opioid misuse and aberrant drugrelated behaviors.
Biases that I withheld going into the study were suspecting that chronic pain
participants without social support and with severe depression may be more likely to be
at risk for opioid misuse. In addition, the secondary researchers were asked to bracket
their training, prior experiences and biases prior to data collection. Both researchers
reported that due to their limited experience with the chronic pain patient population, they
felt they were unaware of any potential biases or prior notions that may originate from
data collection and coding. While both researchers had some addictions training and
experience, both were unfamiliar with opioid addiction and reportedly were entering data
coding and analyses without any knowledge of biases. Paul Grimsely is a 29 year-old,
single, mixed Caucasian/Japanese) male. He is a Certified Addictions Counselor Level II
with a BA in Psychology and an MA in Counseling Psychology. His areas of interest are
substance abuse treatment, group therapy, and rehabilitation psychology. He has 6 years
working in youth corrections, 4 years experience providing substance abuse counseling,
and had a 9 month internship w/ severe and persistent mental illness. Lexi Heringer is a
24 year-old, single, Caucasian female. She is certified in ASIST (Applied Suicide
Intervention Skills Training) has a BA in psychology and is working towards a MA in
Clinical Mental Health Counseling. Her areas of interest include computer-mediated
communication and personality, adolescent trauma treatment, and addictions treatment.
She has 1 year of crisis and suicide hotline counseling experience, 6 months experience
with a counseling practicum, and just starting a 9 month internship with adolescent
trauma survivors.
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Procedure
Patients were screened by the primary investigator to corroborate that inclusion
criteria were met for participants prior to data collection. The primary researcher was
granted access to Salud Family Heatlh Care Center’s database to conduct screening prior
to data collection. The primary researcher conducted screens electronically the morning
of data collection to screen for patient inclusion criteria, which included: 18 years of age
and older and a current diagnosis of a chronic non-cancer pain condition. This allowed
the primary researcher to depict patients eligible for inclusion of this study. CNCP
patients at one large, diverse metropolitan Salud Family Health Care Clinic were
approached by the primary researcher while they waited to be seen by physicians for their
scheduled appointments in the lobby area. The primary researcher described the purpose
of this study to determine if participants would be interested in volunteering. Once
patients agreed to participate, they were provided with an informed consent form to read
and sign (see Appendix A). The participants were then provided with a packet which
included: one demographic questionnaire (Appendix C) four quantitative self-report
measures the PHQ-9, PSE-Q, MEIM-R, Social Provisions Scale, (see Appendix D, E, F,
G) and either the COMM self-report instrument (see Appendix H) or the SOAPP®-R
self-report measure (see Appendix I). Patients already taking opioid medications were
provided with the COMM and patients being considered for opioid therapy but not
currently prescribed these medications completed the SOAPP-®R. All packets of
measures were available in English and Spanish. Participants who spoke English as a
second language and preferred to read in Spanish were provided with measures written in
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Spanish. The COMM, SOAPP®-R, PHQ-9 and MEIM-R were readily available to this
researcher in both English and Spanish. The Informed Consent Forms, Demographic
Questionnaire, Social Provisions Scale and PSE-Q were translated and culturally adapted
based on the principles of good research and processes indicated by the International
Society for Pharmaeconomics and Outcomes Research (ISPOR) in a recent study (Wild
et al., 2005). The process indicated by Wild and Colleagues (2005) were as follows:
preparation (initial work carried out before the translation work begins), forward
translation (translation of the original language version of the instrument into the targeted
language), reconciliation (comparing and integrating more than one forward translation
into a single forward translation), back translation (translation of the new language
version back into the original language), back translation review (comparison of the
back-translated versions of the instrument with the original to highlight and investigate
discrepancies), cognitive debriefing (testing the instrument on a small group of relevant
patients or lay people in test interpretation), review of cognitive debriefing results and
finalization (comparison of the patients’ or lay persons’ interpretation of the translation
with the original version to highlight and amend discrepancies), and proofreading (final
review of the translation to highlight and correct any typographic, grammatical or other
errors; Wild et al., 2005).
Upon completing the packet of measures, participants were asked to participate
in the second, qualitative portion of this study. These participants were chosen based on
scores relatively high or low on both the COMM and SOAPP®-R. The purpose of this
portion of the study was described and patients were offered a twenty dollar card to
Target for their participation. The patients who agreed to volunteer were asked to stay
50

after their scheduled physician appointment for an additional thirty to forty-five minutes
to participate in an interview.
The second data collection process involved in-depth, one-on-one, face-to-face
interviews. Participants were provided with a new informed consent form to read and
sign at the start of the interview (see Appendix B). Interviews were audio-taped and then
transcribed. The qualitative interviews conducted with patients who speak English
fluently were conducted by the primary researcher. The in-depth semi-structured
interview protocol was developed for this study (see Appendix B). However, interview
questions may be altered as subcategories and themes emerge. The interview protocol
was assessed periodically as theories and categories developed and emerged to make
necessary adjustments. In line with a grounded theory approach, participants had the
opportunity to review written transcripts and provide clarification during a follow-up
telephone interview, if deemed beneficial. Participants were informed that they may be
contacted if further clarification would be necessary. Attention was given to the major
tenets of grounded theory, including theory being derived from data and data analysis
using a method of constant comparison (Strauss & Corbin, 1990). The semi-structured
interview protocol included specific interview questions related to chronic pain
management, self-efficacy of pain, and expectations of opioid therapy and treatment for
chronic pain (see Appendix B). For example, two questions included in the initial
interview protocol were: What caused your experience of chronic pain? In what ways do
you cope with your experience of chronic pain?
Self-reflective memos and field notes were used and aggregated to record insight
and facilitate emerging theory. Interviews were coded by the primary researcher and
51

audited by two graduate level researchers who were trained in grounded theory. Coding
from the initial three to four interviews produced the core phenomena (Creswell, Hanson,
Clark Plano, & Morales, 2007). Subsequent interviews were coded and then compared to
the initial themes. From this collaboration new themes were formulated until saturation
occurred. This signified the end of the qualitative data collection.
Quantitative Data Analysis
Before the statistical analysis of the quantitative survey results, the screening of
data was conducted. Data screening helps identify potential multicollinearity in the data,
because multivariate tests are sensitive to extremely high correlations among predictor
variables (Kline, 1998; Tabachnick & Fidell, 2000). Outliers were also excluded from
the analysis. Data screening will include the descriptive statistics for all the variables,
information about the missing data, linearity and homoscedasticity, normality,
multivariate outliers, multicollinearity and singularity. In cases when data does not meet
the underlying assumptions, the transformation procedures of variables were performed
to either reduce skewness, reduce the number of outliers, and improve normality,
linearity, and/or homosedasticity of residuals. Descriptive statistics for the survey items
were summarized in the text and reported. Frequencies analyses were conducted to
identify valid percentages of responses to all the questions in the surveys. Because the
purpose of hypothesis number one is to correctly predict the group membership (either
group A or group B) from a set of eight predictors (gender, age, ethnicity, level of
education, perceived social support, self-efficacy of pain, depression, and level of ethnic
identity) a predictive logistic regression was utilized. The primary goal of logistic
regression is to find the dimension or dimensions along which groups differ, as well as to
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find classification functions to predict group membership (Tabachnick & Fidell, 2000).
The specific underlying assumptions of logistic regression are multivariate normality,
linearity of logit and discrete outcome variables. Discrete outcome variables can be
converted from continuous outcome variables. These assumptions were tested and met
before statistical analyses were executed. All statistical analyses of quantitative results
were conducted with the help of Predictive Analytics Software (PASW) formerly known
as Statistical Package for the Social Sciences (SPSS).
To address hypothesis question number two, a two-way Analysis of Variance
(ANOVA) was employed to compare the statistically significant differences of group
means between three independent variables (sex, ethnicity and the interaction between
sex and ethnicity) and one dependent variable, either high risk of opioid misuse (high
results on the SOAPP®-R in Group B) or aberrant drug related behaviors (positive
screening on the COMM in Group A). Differences in results were assessed in ratio
formats. The underlying assumptions of ANOVA include: independence, normality and
homogeneity of variance. These assumptions were tested and met before the statistical
analyzes were performed.
To address hypothesis number three, a two-block sequential (hierarchical)
regression analysis was performed. Petrocelli (2003) stated that hierarchical regression is
conducted when researchers are interested in testing theoretical assumptions and
examining the influence of several predictor variables on the basis of how much they
each add to the prediction of a criterion over and above that which can be accounted for
by other predictors. Petrocelli (2003) suggested that four major errors persist in
hierarchical regression analyses conducted in the literature: (a) neglect of theoretical
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basis for the use of hierarchical multiple regression, (b) violation of causal priority, (c)
use of hierarchical regression in an exploratory manner, and (d) interpretation of
hierarchical regression results. These possible errors were addressed in the current study
and in the decision-making process of utilizing this procedure in the present study.
The specific underlying assumptions of hierarchical regression are multivariate
normality, homogeneity of variances and linearity. These assumptions were tested and
met before statistical analyses were executed. Block one of the hierarchical regression
consisted of demographic variables which were controlled (age, gender, ethnicity and
level of education) and block two consisted of the four predictor variables: perceived
social support, self-efficacy of pain, level of depression, and level of ethnic identity. The
outcome variables were either high risk of aberrant drug-related behavior (high results on
the SOAPP®-R in Group B) or opioid misuse (positive screening on the COMM in
Group A). All results were provided in the form of a discussion with relevant tables to
support findings. Please see the table below.
Table 1
Hypothesis

Predictors/Independent

Dependent Variables

Variables
1

Analytic Technique
Employed

Gender, age, ethnicity,

Group A (CNCP

Logistic

level of education,

patients already on

Regression

perceived social support,

Opioids) and Group

self-efficacy of pain,

B (CNCP patients

depression, and level of

not already

ethnic identity

prescribed Opioids)
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2

Sex, ethnicity and the

Positive screening on

interaction between sex

the COMM in Group

and ethnicity

A or results of high

Two-Way ANOVA

risk on the
SOAPP®-R in
Group B
3

Perceived social support,

Positive screening on

Hierarchical

self-efficacy of pain,

the COMM in Group

Regression

depression, and level of

A or results of high

ethnic identity (after

risk on the

controlling for age,

SOAPP®-R in

ethnicity, gender and

Group B

level of education)

Qualitative Data Analysis
As aforementioned, interviews were conducted and themes were generated from
the interview data, according to the tenets of grounded theory research (Glaser et al.,
1967). Grounded theory involves analysis as soon as data collection begins. Data
collection and analysis are an interrelated process (Strauss & Corbin, 1990). The
constant comparative method, the root of grounded theory, is a comparative coding
process including three types of coding: open, axial and selective. The constant
comparative process involved comparing phenomena in interviews, integrating them into
categories and properties, and subsequently writing the theory. The stages of grounded
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theory flow into one another. Earlier stages may continue operating simultaneously
through data analysis.
Data analysis began from data reduction of the interviews and subsequent
generation of themes using the open, axial, and selective coding (Creswell, 1998). Data
were continually collected to generate theory around the core phenomena (Creswell et al.,
2007) and data were compared against each other to generate an initial emerging theory.
Data analysis was exploratory in nature and did not seek to prove an already existing
theory. Interview questions were continually refined or adapted as theories emerged so
as to saturate emerging themes for the final generation of theory (Strauss & Corbin,
1990).
Phenomena were initially examined closely in a line by line analysis as part of
open coding (Creswell, 1998). Phenomena were then grouped into categories based on
similarities that surfaced through the constant comparison method. Following open
coding, axial coding was executed to make greater sense of categories and subcategories
that were generated during open coding (Strauss et al., 1990). Upon “fracturing” the data
in the open coding stage, axial coding combined themes for meaningfulness (Strauss et
al., 1990). The themes of this qualitative portion of the research study were derived
throughout the axial coding process. During this stage constant comparison was utilized
and transcripts were continually reviewed in an attempt to explore new ways to make
connections among data. Categories of interview data became linked to the core
phenomena. Categories were analyzed and compared to discover strong versus weak
categories that may or may not have been congruent with the core category. The core
phenomena emerged through these phases until the selective coding phase.
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All emergent categories were related to a core category during the final stage of
coding, known as selective coding. During this phase of analysis, the core construct or
category was identified and linked other categories from earlier phases. This is typically
a culmination of all of the data, including personal reflection on the data, memos, and
prior data analysis. In this way, the story line is formulated, which accounts for the
subcategories adding to the core phenomenon. In this constant comparison method
emerging theory was constantly assessed until saturation of themes occurred and
coherence was achieved. The resulting theory emerged from the data. Results were
presented with rich quotations from participants when possible, in an effort to convey
accurately the experiences of participants. Graphical models were used to demonstrate
the relationship of theoretical codes. Narrative summations were utilized to convey
results. Tables were provided for visual understanding of codes and themes.
Validity and Triangulation
In an effort to ensure the validity of the grounded theory that emerged from the
data, two secondary researchers and the lead researcher all independently examined
transcripts and engaged in coding. During the generation of the grounded theory,
consistent consultation occurred with experts in grounded theory and the study’s mentor,
as a validity measure for the final theory. In addition, all of the researchers participated
in extracting salient quotes to help ensure that the categories truly reflected the data from
the interviews. The research team met on a bi-weekly basis in person and spoke on the
alternate weeks for an hourly conference call, to allow the team to be fully immersed in
the data and to provide a reliability and validity check as themes emerged. Finally, the
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lead researcher engaged in two different forms of memoing, which aided in the
triangulation of the data.
Reading and Memo Writing
As mentioned, two forms of memo writing were employed to aid in validity and
triangulation measures. The lead researcher engaged in memo writing immediately
following each interview, which allowed for personal reflections and objective comments
to be documented once the interview was complete. The following is an example of the
objective type of memos that followed the interview with Participant A: Interview #1:
This patient appeared somewhat passive, apologetic yet very warm and sincere.
She was obese and moved and spoke very slowly and softly. She was Latina and
mentioned God and her faith as main supports. When asked about her experience
of pain she immediately disclosed that her pain originated from domestic
violence. She mentioned how she had been kicked and beaten by her ex-husband.
She mentioned that she is no longer living with him but that her experiences of
pain remain in her back, legs, and knees. She used very violent language to
describe what her pain feelings like (a knife stabbing her, someone kicking
her…etc) which reflect the experiences she has endured. She mentioned
providing for her children as something that is very important to her, and working
through her pain, although she works on her feet on a factory line. She also
mentioned that she knows her weight has increased her experience of pain. She
disclosed that she has other health problems, namely asthma and breathing
difficulties, and shared that she is supposed to carry and use and oxygen tank, but
does not. She said she smokes cigarettes and is not interested in quitting. She
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said that her “stupidity and pride” holds her back from using this regularly. She
said she takes her pain meds and takes hot baths as her main coping strategies.
She said she tried street drugs to cope with pain. She said she would like to get
massages but cannot afford it. She said she used to pace her physical activity but
reported that she more recently has become more sedentary and struggles to even
walk. She said she has limited support and mainly shares her pain experiences
with a close girl friend who has cancer and understands pain and with her mother.
She said doctors just want to “pump you with pills”. She said that she wishes
something would just save her from her problems.
The lead researcher also engaged in an alternate type of memo writing, which is
similar to journaling, and is more process focused. This allows for reflection on the
process of the interviews and the research, in place of summarization of facts, or
recording objective information. In reflecting on the shared process of the interview, it
serves to assist in contextual grounding, which is important for understanding the
meaning that participants’ ascribe to their experiences (Morrow, 2005). The following is
an excerpt of a memo of this kind, in reaction to the previous Participant A interview,
which was recorded on 7/3/12:
I certainly felt like I wanted to rescue her from her problems. I felt myself being
pulled to match her soft spoken volume in speech. I also was being pulled to be
very calm and empathic due to her timid, passive and apologetic presentation and
due to the intensity of her disclosures about her domestic violence history. She
seemed to exemplify someone who feels like a victim and someone who has
endured significant domestic violence. She appeared to have low self-esteem and
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I suspected that she may isolate herself due to her poor relationship history and
trauma symptoms. I suspected that she may suffer from co-morbid PTSD
symptoms. I noticed that her physical health appeared poor due to obesity and
obvious wheezing and COPD/asthma like symptoms. I feared that she may
continue to become more sedentary in her lifestyle and limit her engagement and
effort in physical activities. She mentioned that she drank sodas at work and I
was curious about her diet and nutrition and how her health behaviors may impact
her functioning and may influence her coping with chronic pain. I was curious to
know how her culture may impact her health behaviors. I found it interesting that
she revealed that she smoked even though she has shallow breathing and
difficulty with breathing due to COPD. I wondered what her relationship with
smoking was and her relationship with food, and how these impacted her
experience of chronic pain. She also mentioned how she “should” be using an
oxygen tank but that she does not like how she will then be portrayed as sick and
does not like how people may view her if she uses it in public, even though she
recognized that this would be helpful. She displayed great shame and guilt at
times. I wondered if she just “gives up” in certain areas of her life and then asks
God to heal/care for her and her problems. She mentioned how she puts all her
faith in God to take care of her problems. This is a strong and common Latina
cultural influences and I wondered if this was her reasoning for having these
beliefs. She mentioned how her one friend also had significant chronic health
problems. I wondered if this relationship was fruitful for her because she felt as if
this other person could share in her suffering and validate what her experiences
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were like from having endured similar challenges and because she was female and
not male. Even though I was focused on asking only the interview protocol
questions, I couldn’t help considering if this patient were in clinical treatment
with me what techniques, approaches, and resources might be helpful. I
wondered if motivational interviewing techniques could be useful for her and
considered that since she revealed that she had little social support, that she might
be a good candidate for therapy if she were open to the treatment culturally. She
appeared slow to reveal her difficulties but did build a strong rapport and seemed
to enjoy having someone to talk to. I suspect if I were male this relationship
would have been different, most likely not as open and warm. She seemed to
enjoy the interview and shared that she felt better having shared some of her past
and concerns with someone.
These two forms of memo writing were helpful for the lead researcher in both the
objective recording and chronicling, and the subjective processing of the interviews and
interpretation of the data. They were used for these reasons and as an added measure of
triangulation.
Ethical Considerations
This proposed study was reviewed by the University of Denver’s Internal Review
Board (IRB) prior to data collection, in an effort to maintain the highest standard of ethics
in human subjects research. Informed consent forms were utilized in an effort to clearly
inform all participants as to the nature and purpose of the study. Participants were
informed at that time, both orally and in written format, as to their rights associated with
their participation, including their right to withdraw from the study at any point without
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penalty of any kind. Appropriate contact information was provided to ensure
accountability of this researcher, my mentor, and academic institution. Strict adherence
of confidentiality was employed to protect the identities of participants. Interviews were
arranged the same day as participants’ physician appointments for convenience to reflect
respect for participants’ time and efforts and to ensure completion of data collection.
Given the sensitivity of patient information, such as chronic pain conditions and
prescription use utilized for screening for inclusion criteria, confidentiality of patient
information followed all protocols required by HIPPA guidelines and as stated by Salud
Family Health Care Centers. Upon completion of self-report measures, questionnaire
results were scanned into patients’ charts to ensure continuation of care and assist
physicians in speedily becoming aware of patients that may ethically benefit from an
immediate follow-up. This was noted in the patients’ informed consent forms and was
employed to ensure patients’ rights and APA’s ethical principles of beneficience,
nonmalficience, fidelity, justice, integrity and autonomy.
The issues of researcher as an instrument, researcher subjectivity and reflexivity,
and adequacy of data were addressed in the study (Morrow, 2005; Ponterotto & Grieger,
2007). It is suggested in grounded theory literature that researchers explore their cultural
biases and positionality prior to the interviewing and coding processes. Throughout the
interview and coding process researcher subjectivity and reflexivity were examined.
Managing potential researcher biases is important in qualitative research. I was
cognizant of the importance of “bracketing” my experiences, and setting aside
assumptions and suspending judgments on the experience of phenomena being studied.
Literature suggests it is important for researchers to “own one’s perspective” (Ponterotto
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& Grieger, 2007). This owning one’s perspective will be integrated by my disclosing of
personal and theoretical orientations, values and assumptions that could affect the
research (Morrow, 2005).
This present study included frequent credibility checks and quality control
through the primary researcher’s explorations of biases and through the choice of
operating with two graduate student auditors. Thick description of researcher biases,
participant information and procedures will be employed in an effort to convey the
context and meaningfulness of the research (Ponterotto, 2006; Ponterotto & Grieger,
2007). Attention was paid to Haverkamp’s (2005) three cornerstones necessary for
qualitative research decision making, including the examination of foundational ethical
principles, conscious application of an attitude of care, and consideration of virtuous
character. The adequacy of data was of utmost importance in this study.
Ethical consideration was also given to participants’ discussion of potentially
sensitive information. In an effort to address this, I frequently conducted “check-ins”
with participants to assess their feelings and to establish if they would like to continue.
Participants who may have required additional support were referred to their primary care
physicians.
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CHAPTER FOUR: RESULTS
Chapter IV describes the results of the quantitative and qualitative analyses of the
data. The chapter begins with preliminary analyses including data cleaning, outliers,
descriptive statistics, correlations and reliability of measures. Quantitative results of the
three hypotheses are described and summarized followed by a thorough description of
qualitative results. The three overarching domains are displayed in tables and codes are
revealed and described. Lastly, Figure 1 demonstrates how the selective codes operate
together and integrative findings are described and summarized.
Quantitative Results
Preparing the Data
Descriptive analyses were run using Statistical Package for the Social Sciences
version 16.0 for Windows (SPSS 16.0) to detect non-permissible values. Of the 102
participants’ questionnaires gathered, eleven participants in Group B (CNCP patients not
prescribed opioids) did not complete the reverse side of questionnaires (two MEIM, two
SPQ, two PSE-Q, three PSE-Q, one PHQ-9, and two SOAPP®-R) which contributed to
missing data. One participant in Group A (CNCP patients prescribed opioids) did not
complete the reverse side of the MEIM measure which also contributed to missing data.
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These total score values remained as missing because too few items were
answered. In addition, four participants in Group B (CNCP patients not prescribed
opioids) left one item blank. This was 4% or less of the items, missing at random; thus,
the total score for those four participants were adjusted to account for missing item
responses. No entire cases or variables were deleted from analyses. Eleven outliers
were found, including four cases in Group B (CNCP patients not prescribed opioids) and
six cases in Group A (CNCP patients prescribed opioids). Several methods for handling
outliers are suggested in the literature. In this study, data were transformed into new, less
deviant values by changing the raw scores to one unit larger or smaller than the next most
extreme value, as noted by Tabachnick and Fidell (2007). Moreover, the three
demographic variables, age, ethnicity, and education, were transformed into different
variables due to the limited number of cases in several categories within each variable.
For example, as noted below in the demographic table, the two primary ethnic groups in
this sample were Caucasian and Hispanic and all other ethnic group categories did not
contain enough cases to be included in statistical analyses. Therefore, this variable was
categorized to include only Caucasian and Hispanic participants. Level of education was
collapsed into three versus six categories as shown below, in Table 2, and similarly age
was collapsed into three versus six categories. The additional cases that did not fit into
these main demographic categories were not included in analyses.
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Preliminary Analyses
Table 2
Overview of Demographic Variables
Demographics

Frequency Total
102

Group A: Opioids
46

Group B: No Opioids
56

Gender
Male
Female

34
68

13
30

18
38

Recoded Age
18-35
35-55
55 and older

18
57
26

8
27
11

11
30
15

Pain
Lower Back Pain
Fibromyalgia
Multiple Pain Sites
Other

37
15
36
13

16
6
20
4

21
9
16
9

Longevity of Pain
6 months- 2 Years
3- 5 Years
6- 10 Years
11 Years and Beyond

14
35
27
26

6
13
13
14

8
22
14
12

Language
English
Spanish

96
6

44
2

52
4

Recoded Ethnicity
Hispanic
Caucasian

24
60

10
29

14
31

Marital Status
Married/Partnered
Separated
Divorced
Widowed
Single

13
25
18
7
39

8
9
9
4
16

5
16
9
3
23

66

Roommates
None
One
Two
Three or More

17
29
13
41

9
14
6
17

8
15
7
24

Recoded Education
Under 12 Years
High School Grad
College and Beyond

42
33
27

18
16
12

24
17
15

Employment
Full- Time
Part- Time
Unemployed
Student/Retired
SSI Funds

6
13
28
6
49

0
5
11
2
28

6
8
17
4
21

Medication
None
Marijuana
Neurontin
NSAIDS
Antidepressant
Flexeril
Floricit
Vicodin
Percocet
MS Contin
Oxycontin
Morphine
Methadone
Tramadol
Fetanyl Patch

8
2
1
6
28
7
4
9
18
1
2
7
2
7
1

0
0
0
0
0
0
0
9
18
1
2
7
2
7
1

8
2
1
6
28
7
4
0
0
0
0
0
0
0
0

Descriptive Statistics for Independent and Dependent Variables
Descriptive analyses of the independent, dependent, and control variables
included in the study were performed to determine if the responses were normally
distributed within this sample of chronic pain patients (see Table 3 and Table 4). An
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examination of the data indicated that the responses were normally distributed within the
sample with the exception of the SPS for Group B. As the skewness was not due to
outliers, no transformation of SPS was used.
Table 3
Descriptive Statistics for Group A (CNCP patients prescribed opioids)
Variable
N
Skewness/Kurtosis
Independent Variables
PHQ-9
46
.71
SPS
46
.82
PSE-Q
46
.38
MEIM-R
45
.51
Dependent Variables
COMM
46
.07

Mean

SD

Range

13.30

6.98

0-27

-.04/-

73.07

12.24

45-94

-.11/-

19.04

10.61

0-42

.48/-

31.20

6.86

17-43

-.35/-

11.43

7.34

1-31

.51/-

Note. Patient Health Questionnaire-9 (PHQ-9), Social Provisions Scale (SPS), Pain
Self-Efficacy Questionnaire (PSE-Q), Multi Ethnic Identity Measure-Revised (MEIM-R),
Current Opioid Misuse Measure (COMM)
Table 4
Descriptive Statistics for Group B (CNCP patients not prescribed opioids)
Variable
N
Skewness/Kurtosis
Independent Variables
PHQ-9
55
1.44
SPS
54
1.00
PSE-Q
53
.84

Mean

SD

Range

11.69

7.63

0-25

.13/-

72.30

11.57

52-95

1.30/-

27.25

15.69

2-59

.08/-
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MEIM-R
53
Dependent Variables
SOAPP®-R
54
1.44

29.07

8.68

14-49

.27/.01

23.61

11.60

0-49

.34/-

Note. Patient Health Questionnaire-9 (PHQ-9), Social Provisions Scale (SPS), Pain
Self-Efficacy Questionnaire (PSE-Q), Multi Ethnic Identity Measure-Revised (MEIM-R),
Screener and Opioid Assessment for Patients with Pain-Revised (SOAPP®-R)
Reliability of Measures
Estimates of reliability using a measure of internal consistency (Cronbach’s
alpha) of the measures were strong, .8 and higher, and are displayed in Table 5.

Table 5
Group A: Opioids
Variable

Cronbach’s alpha

1.
2.
3.
4.
5.

.89
.88
.87
.90
.83

SPS
PHQ-9
MEIM-R
PSE-Q
COMM/SOAPP®-R

Group B: not on Opioids
Cronbach’s alpha
.87
.91
.89
.96
.83

Note. Patient Health Questionnaire-9 (PHQ-9), Social Provisions Scale (SPS), Pain
Self-Efficacy Questionnaire (PSE-Q), Multi Ethnic Identity Measure-Revised (MEIMR), Current Opioid Misuse Measure (COMM ), Screener and Opioid Assessment for
Patients with Pain-Revised (SOAPP®-R)
Correlations of Variables
Tables 6 and 7 provide the correlation coefficients for the independent and
dependent variables and two demographic variables included in this study. The Pearson
correlation coefficients of measures were calculated to describe the strength and direction
of the linear relationship between variables.
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Table 6
Correlation Coefficients for Group A (CNCP patients prescribed opioids)

Variable
1
2
3
4
5
6
7
1. COMM
1.00
2. PHQ-9
.35* 1.00
3. PSE-Q
.05
-.51** 1.00
4. MEIM-R
-.09 -.34* .20
1.00
5. SPS
-.39 -.51**. 10
.10
1.00
6. Gender
.18
-.08 .12
-.09 -.07 1.00
7. Recoded Ethnicity
-.09
.03 .06
-.14 -.01 .32* 1.00
Note.	
  	
  *=	
  p	
  ≤	
  .05,	
  **=	
  p	
  ≤	
  .01;	
  Patient Health Questionnaire-9 (PHQ-9), Social
Provisions Scale (SPS), Pain Self-Efficacy Questionnaire (PSE-Q), Multi Ethnic
Identity Measure-Revised (MEIM-R), Current Opioid Misuse Measure (COMM )
Table 7
Correlation Coefficients for Group B (CNCP patients not prescribed opioids)

Variable
1
2
3
4
5
6
7
1. SOAPP®-R
1.00
2. PHQ-9
.57** 1.00
3. PSE-Q
.05
-.47** 1.00
4. MEIM-R
.21
.04 .19
1.00
5. SPS
-.43** .19
.38* .13
1.00
6. Gender
.17
.22 -.20
.12 -.03 1.00
7. Recoded Ethnicity
.18
.19 -.17 -.31 -.29 .21
1.00
Note.	
  	
  *=	
  p	
  ≤	
  .05,	
  **=	
  p	
  ≤	
  .01;	
  Patient Health Questionnaire-9 (PHQ-9), Social
Provisions Scale (SPS), Pain Self-Efficacy Questionnaire (PSE-Q), Multi Ethnic
Identity Measure-Revised (MEIM-R), Screener and Opioid Assessment for Patients
with Pain-Revised (SOAPP®-R)
Hypothesis One:

A hierarchical logistic regression analysis was performed to assess prediction of
membership in one of two group, participants prescribed opioids and those who were not.
The demographic predictors, including gender, recoded age, recoded ethnicity, and
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recoded education, were entered in the first block. The additional four predictors entered
in the second block were depression (total score on the PHQ-9), ethnic identity (total
score on the MEIM-R), perceived social support (SPS) and pain self-efficacy (PSE-Q).
Assumptions of normality and the use of discrete outcome variables were upheld, with
the exception of SPS, which was somewhat skewed. However, the assumption of
linearity in the logit was violated. Pain self-efficacy was a significant individual
predictor in the logistic regression; however, based on the violation of linearity in the
logit, further investigation and transformations of this variable were necessary.
Nonlinear transformations--square root, natural logarithm, and squared transformations
were first attempted with no success. However, the subsequent quartile categorization of
the pain self-efficacy variable was used and was successful in achieving linearity in the
logit in the logistic regression.
The overall pain self-efficacy variable was found non-significant, but one
category of the variable was found to be predictive of chronic pain patients’ being on
opioids or not. It appears that extremely high and low values of reported pain selfefficacy are not predictive but moderate values of pain self-efficacy are predictive in the
regression. According to both chi-square residual and the Hosmer-Lemeshow test, model
fit was adequate at each step. The predictor variables reliably distinguished between
participants prescribed opioids and those who were not. With regard to effect size for the
overall regression, the Nagelkerke R2 was 0.20, p = .70. Table 8 provides regression
coefficients and chi-square tests results, as well as odds ratios. The group of participants
not prescribed opioids for chronic pain were .12 times more likely to report moderate
levels of pain self-efficacy than participants who were not prescribed opioids. A
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subsequent independent samples t-test was run to confirm the difference between the two
group means on pain self-efficacy. The mean difference between the two groups was 8
points, p=.01. Group One, participants on opioids, had a group mean of 19.24 and Group
Two, participants not on opioids had a group mean of 27.24.
Table 8
Logistic Regression Prediction for Participants being on Opioids: Regression
Coefficients, Chi-Square results and Odds Ratios
Variables

B

S.E.

Wald

df

p

Gender

-.42

.59

.52

1

.47

.66

Recethnicity

-.51

.65

.62

1

.43

.60

2
1
1
2
1
1
1
1
1
3
1
1

.98
.93
.92
.51
.66
.55
.98
.13
.10
.09
.08
.01*

1
1

.23
.01

Recodage
Recodage(1)
Recodage(2)
Recoeducation
Recoeducation(1)
Recoeducation(2)
TotalScorePHQ9
TotalScoreMeim
TotalScoreSPQ
Categorized PSEQ
Categorized PSEQ(1)
Categorized PSEQ(2)
Categorized PSEQ(3)
Constant

-.07
.06

.82
.63

.31
-.40
.00
-.05
-.04

.70
.68
.04
.04
.03

-1.74
-2.11

1.00
.85

.04
.01
.01
1.34
.20
.35
.00
2.27
2.74
6.53
2.99
6.23

-1.00
7.39

.84
2.99

1.45
6.10

Exp(B)

.93
1.10
1.37
.67
1.02
.95
.96
.17
.12
.37
1611.17

Note.	
  	
  *=	
  p	
  ≤	
  .05;	
  Patient Health Questionnaire-9 (PHQ-9), Social Provisions Scale
(SPS), Pain Self-Efficacy Questionnaire (PSE-Q), Multi Ethnic Identity Measure-Revised
(MEIM-R)
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Hypothesis Two:
To address Hypothesis Two, a two-way Analysis of Variance (ANOVA) was
employed to compare the group means for categories of two independent variables (sex,
ethnicity and the interaction between sex and ethnicity) with one dependent variable,
either high risk of opioid misuse (high results on the SOAPP®-R in Group B) or aberrant
drug-related behaviors (positive screening on the COMM in Group A). Assumptions of
normality and homogeneity of variance were tested and met for both Group A (CNCP
patients prescribed opioids) and Group B (CNCP patients not prescribed opioids).
Independence was upheld. The 2x2 ANOVA yielded nonsignificant main effects for sex
and ethnicity and a nonsignificant interaction between sex and ethnicity for both the
prescribed and nonprescribed groups. Please see Tables 9 and 10 below for these results.
Table 9
Tests of Effects of Ethnicity and Gender on risk of aberrant drug-related behavior for
Prescribed Group
Source

df

F

p

Recoded Ethnicity
Gender
Ethnicity*Gender

1
1
1

1.27
2.85
.07

.27
.10
.80

Partial Eta2
.03
.08
.00

Table 10
Tests of Effects of Ethnicity and Gender on risk of aberrant drug-related behavior
for Non-prescribed Group
Source
Recoded Ethnicity
Gender
Ethnicity*Gender

df
1
1
1

F
.82
2.61
.089
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p
.37
.12
.77

Partial Eta2
.02
.06
.00

Hypothesis Three:
To examine the unique contribution of predictor variables on whether patients
were at risk of aberrant drug-related behavior, hierarchical multiple regression analyses
were performed. Variables were entered in two steps. In Step 1, demographic variables
(a) recoded age, (b) recoded ethnicity, (c) recoded education, and (d) gender were the
independent variables. In step 2, total score SPS, total score PSE-Q, total score PHQ-9
and total score MEIM-R were entered. In the data set of participants prescribed opioids,
Group A, total score COMM was the dependent variable and in the data set of
participants not prescribed opioids, Group B, total score SOAPP®-R was the dependent
variable. The COMM and SOAPP®-R are screening measures for the risk of aberrant
drug-related behavior in chronic pain patients. Before the hierarchical multiple
regression analyses were performed, the independent variables were examined for
collinearity.
The results of Step 1 for the outcome of total score on the outcome measure in
participants prescribed opioids indicated that the variance accounted for (R2 =.104,
adjusted R2 = -.008), was not significantly different from zero (F(4, 32) = .933, p = .458).
There were no statistically significant predictors in Step 1. In Step 2, the four
independent measures were entered into the regression equation. The change in variance
accounted for (ΔR2) was .28, which was statistically significantly different from zero (F(4,
28) =

3.20, p = .028). The unstandardized regression coefficients (B) and intercept, and

the standardized regression coefficients (β) for the full model are reported in Table 11.
Only two of the predictor variables (level of depression as measured by the total score on
the PHQ-9 and level of pain self-efficacy as measured by the total score on the PSE-Q)
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contributed significantly to the explanation of patients being at risk for aberrant drugrelated behavior in Group A, or patients prescribed opioids. The higher the level of
depression, the more likely the patient displayed risk for opioid misuse. Interestingly, the
higher the level of pain self-efficacy or confidence in engaging in activities despite pain,
the more likely the patient displayed risk for opioid misuse.
The results of Step 1 for the outcome of total score on the outcome measure for
participants not prescribed opioids indicated that the variance accounted for (R2 =.108,
adjusted R2 = .008), was not significantly different from zero (F(4, 36) = 1.085, p = .378).
In step 2, the four independent measures were entered into the regression equation. The
change in variance accounted for (ΔR2) was equal to .50 which was statistically
significantly different from zero (F(4, 32) = 10.31, p < .001). The unstandardized
regression coefficients (B) and intercept, and the standardized regression coefficients (β)
for the full model are reported in Table 12. Three of the predictor variables (level of
depression as measured by the total score on the PHQ-9, level of perceived social support
as measured by the total score on the SPS, and level of ethnic identity as measured by the
total score on the MEIM-R) contributed significantly to the explanation of patients being
at risk for aberrant drug-related behavior in Group B, patients not on or prescribed
opioids. The higher the level of depression and the higher the level of ethnic identity, the
more likely the patient displayed risk for aberrant drug-related behavior. Conversely, the
higher the reported levels of perceived social support, the less likely the patient was at
risk for aberrant drug-related behavior.
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Table 11
Hierarchical Regression Coefficients for the Model and Variables as Predictors of total
COMM- Group A, Participants on Opioids
Variables

B
R

Intercept

β
R2

t
R2adj

27.66

Recoded Age

p
R2 Δ

F

1.99

<.05*

-.29

-.27

-1.65

.11

-4.20

-.25

-1.50

.48

Recoded Education

1.18

.08

1.38

.17

Gender

-1.52

-.09

-1.36

.18

PHQ-9

4.15

.25

3.39

<.01**

PSE-Q

5.28

.27

4.10

<.01 **

SPS

1.28

.09

1.70

.09

MEIM-R

-.88

-.06

.32

Recoded Ethnicity

MODEL 1

.32

.10

-.01

.10 .93 .46

MODEL 2 .62
.39
.21
.28 3.20 .03*
Note.	
  	
  *=	
  p	
  ≤	
  .05,	
  **=	
  p	
  ≤	
  .01;	
  Patient Health Questionnaire-9 (PHQ-9), Social
Provisions Scale (SPS), Pain Self-Efficacy Questionnaire (PSE-Q), Multi Ethnic Identity
Measure-Revised (MEIM-R)
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Table 12
Hierarchical Regression Coefficients for the Model and Variables as Predictors of total
SOAPP®-R- Group B, Participants not on Opioids
Variables

B
R

β
R2

Intercept

19.16

Recoded Age

-1.12

Recoded Ethnicity

t
R2adj

p
R2 Δ

F

1.36

.18

-.01

-.05

.96

2.81

-.11

.68

.50

Recoded Education

-1.34

-.10

-.72

.48

Gender

3.78

.15

1.15

.26

PHQ-9

.81

.53

3.76

<.00**

PSE-Q

.10

.14

.90

.38

SPS

-.37

-.34

- 2.41

.02*

MEIM-R

.47

.35

2.82

.02*

MODEL 1

.33

.11

.01

.11 1.09 .38

MODEL 2 .78
.61
.51
.50 10.31 <.00**
Note.	
  	
  *=	
  p	
  ≤	
  .05,	
  **=	
  p	
  ≤	
  .01;	
  Patient Health Questionnaire-9 (PHQ-9), Social
Provisions Scale (SPS), Pain Self-Efficacy Questionnaire (PSE-Q), Multi Ethnic Identity
Measure-Revised (MEIM-R)

Summary of Quantitative Results
Hypothesis Two, a two-way ANOVA, found non-significant effects of sex,
ethnicity and the interaction between sex and ethnicity, for Group A and Group B. These
results infer that the results of Hypothesis One and Hypothesis Three are generalizable by
sex and White and Hispanic populations. The results from Hypothesis One, a
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hierarchical logistic regression analysis, indicated that participants’ level of pain selfefficacy was found to be a statistically significant predictor for distinguishing whether
participants were prescribed opioids or not. However, the relationship between pain selfefficacy score and group was complex; moderate levels of pain self-efficacy were
predictive of group while low and high levels were not. Participants not prescribed
opioids for chronic pain were .12 times more likely to report moderate levels of pain selfefficacy than participants who were prescribed opioids. Results from Hypothesis Three,
a hierarchical multiple regression, indicated that two predictor variables (level of
depression and level of pain self-efficacy) in participants on opioids, contributed
significantly to the explanation of patients being at risk for aberrant drug-related
behavior. Additionally, three predictor variables (level of depression, level of perceived
social support, and level of ethnic identity) in participants not prescribed opioids,
contributed significantly to the explanation of patients being at risk for aberrant drugrelated behavior. The higher the level of depression and the higher the level of pain selfefficacy, the more likely the patient displays risk for opioid misuse, in patients already
prescribed opioids. In Group B, participants not already prescribed opioids, the higher
the level of depression and the higher the level of ethnic identity, the more likely the
patient is at risk for aberrant drug-related behavior. Conversely, in this group of
participants, the higher the reported levels of perceived social support the less likely the
patient is at risk for aberrant drug-related behavior.
In summary, level of depression was a predictor for both groups. However, in
patients already prescribed opioids, level of pain self-efficacy was an additional
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predictor, and in patients not already prescribed opioids for chronic pain, level of
perceived social support and level of ethnic identity were additional predictors.
Qualitative Results
Following in-depth analyses of the 10 interviews, 43 open, 9 axial, and 5 selective
categories emerged (see Tables 14, 15, and 16). There were three important domains that
emerged to describe this complex phenomenon. These include (1) Coping with Chronic
Pain, (2) Professional Treatment used for the Management of Chronic Pain, and (3) the
Nature of Chronic Pain. To review, open coding is the part of analysis concerned with
identifying, naming, categorizing and describing phenomena found in the text. Dialogue
is examined line by line in this open coding process. Axial coding is the process of
relating codes (categories and properties) to each other, via a combination of inductive
and deductive thinking. To simplify this process, rather than looking for any and all kind
of relations, grounded theorists emphasize causal relationships, and fit data into a basic
frame of relationships. Finally, selective coding is the process of recognizing an
emerging core category and relating all other categories to that category.
Table 14 describes the open, axial, and selective categories that reflect coping
with chronic pain. Table 15 describes the open, axial, and selective categories that reflect
professional treatment used for chronic pain. Table 16 describes the open, axial, and
selective categories that reflect the nature of chronic pain. These tables are shown
following the subsequent domains’ section. All of these categories contributed to the
formation of the final grounded theory. Table 13 displays the demographics of the ten
participants. Tables 14, 15 and 16 are displayed following the subsequent domains and
categories.
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From these categories, a grounded theory was formulated and is described in the
Balanced Scale Image (see Figure 1) and in a tentative grounded theory that follows the
image description. Based on the data that emerged, it was determined that chronic pain is
a complex phenomena with many dynamic factors affecting how one manages chronic
pain. Throughout the study it became clear that there were unexpected influences that
impacted chronic pain patients’ functioning.
Table 13
Participant Self-Reported Demographic Information

Part. Age Sex

Ethn

Status

A

41

F

Latina

Widowed

C

44

F

Mixed

Single

E

51

M

White

H

43

F

J

55

B

Pain
CP- knee, back, legs

Longevity

Opioids

7 years

Yes

LBP

16 years

Yes

Married

CP- shoulders, knee

10 years

Yes

White

Widowed

Fibromyalgia

10 years

Yes

M

White

Single

CP- back, knees

31 years

Yes

36

F

White

Married

Fibromyalgia

8 years

No

D

41

F

White

Divorced

Osteoarthritis

2 years

No

F

55

F

White

Divorced

Fibromyalgia

4 years

No

G

54

M

White

Divorced

CP- back, shoulders

20 years

No

I

46

M

Mixed

Married

LBP

10 years

No

_______________________________________________________________________
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As the findings suggest, coping with chronic pain, the nature of chronic pain, and
treatments used for chronic pain are influenced by many factors. Major themes emerged
across the three domains. To begin, the first domain of coping with chronic pain is
described beginning with the first selective category from the data.
Coping with Chronic Pain
Social Support (Selective)
Social support was described as a main coping strategy for chronic pain amongst
all participants. Relationships that were perceived as a positive support were either a
helpful distraction, displayed understanding, and/or were useful in finding purpose and
meaning in life. Types of positive social support (Axial) described included familial
relationships (Open), relationships with faith and/or God (Open), pets (Open), therapists
(Open) and support groups (Open). All but two participants described their positive
relationships with family members as a major coping strategy for dealing with chronic
pain. Family members were influential in helping participants cope with the day to day
challenges of chronic pain and provided emotional and physical support. Family
members described as positive supports were a spouse/partner, parents and/or children.
H: I only have the one child and I only have the one grandchild, so uh, those,
having those as a distraction at times has been very good, I think very good for
me in the last, especially since I’ve been visiting with them consistently now since
January. Hugs and kisses from baby girl are some of the best medicine I get.
The two participants that did not mention family members as positive supports
were both homeless. One homeless male participant, participant F, described his social
worker and his physicians as his main positive supports. The other homeless male
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participant, participant K, who resided on the streets, described his dog as his main
positive support. In addition, several participants who highlighted familial support as
their most positive support also mentioned pets as additional supports for coping.
I: I have a service dog and she’s a 140lb Saint Bernard-Shepherd mix and when I
go fishing I tie myself to her at around my waist and she, cause she knows before
I’ll have a seizure, 10 minutes before I’ll have a seizure… That, I mean, she’s a
companion that lives for me and I live for her and we take care of each other and
that we have a very good relationship. You know? That I don’t think there would
be any human or any other type of animal that I could make that connection with
or that could do that for me...
The most preferred overall positive social support from participants was a friend
or family member who also suffered from a chronic illness (Open). Participants stated
that the feeling of validation, empathy and understanding from someone who also
suffered from a chronic condition was the type of positive support from a family member
or friend that was most beneficial.
A: Um, I only have one really close friend and she seems to understand but she is
going through cancer right now. She's got breast cancer. She's only thirty-two
years only. She has one baby and we seem to communicate really good. The
other person would be my mom. She has chronic arthritis.
C: Yeah. All of my family is very supportive. Um, one of my sisters has a few
medical issues also. So she kind of knows where I'm at with my pain sometimes.
And other than that, anytime we go to a family affair or anything where we have
friends and family, everybody tries to do something for me. Ya know. "Can I get
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you something to drink?" or "Do we need to help you to your car?" So I have
everybody really helping me.
E: You know what I mean. It’s, you know, I mean, half the guys I run around
with, you know been in motorcycle accidents, or a war vet, or you know lift
weights, or you know been in, or had some kinda trauma in their life that, you
know, it, you know, I would assume everybody’s in some degree of pain.
Many participants spoke about God, faith, church and/or Jesus as a positive social
support for coping with chronic pain. A few of these participants who found religion as a
positive support, were also recovering alcoholics and additionally mentioned Alcoholics
Anonymous support groups as a positive coping strategy for dealing with chronic pain.
G: I enjoy my walk with Jesus. Yeah, I ask him, you know, help this pain go
away. I talk to him about it occasionally. He knows everything, but you know
it’s nice to be able to vent to somebody that doesn’t talk back to you that way. He
just, you know, kinda keeps me in my place I guess you could say.
I: I go to Alcohol’s Anonymous and I believe in it intensely that I believe that’s
the only thing that has ever stopped me from drinking [mmm] and that um, I
believe in the lord. That I have deep faith in the lord and my family [mm-hmm]
you know? That helps me cope a lot.
Strategies for coping with chronic pain were described as being heavily
influenced by messages from the participant’s family of origin (Axial). An influential
familial message or belief mentioned by over half of the participants was the importance
of being portrayed as strong versus weak (Open). This belief was described as
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originating from messages given by family members during childhood that translated into
beliefs as a young adult about what how one “should” behave and be portrayed. Many
participants described the value of being portrayed as strong as very important and being
portrayed as weak as unacceptable.
B: Um, I don’t know that I necessarily cope with it very well, because I was
brought up in my family that you don’t have pain and you don’t have illness and
you are a strong person… Yeah, yeah that is my worry that she, again, will see me
as being weak and not a strong person.
In addition, several participants stated that asking for help was challenging
(Open). These participants stated that this challenge was related to the value of being
portrayed as strong, as being valued as a person who cares for others, and someone who
others can depend on. The experience of pain made these participants feel ashamed
about having to ask for help. These messages impacted participants’ choices for how to
engage in relationships and utilize social support as a strategy for coping with chronic
pain.
B: I feel a little overwhelmed that I’m just feeling like I’m bombarding people
with my problems. And I’m not a big one for that, I’m a big one on helping other
people, not people helping me…That’s a big one for me, is I’m not very good at
asking for help.

C: And I also think that people who tend in be in a state of pain for many years,
like me, they are afraid to ask or they get tired of asking people for help and they
are like, "I'm always asking for help. I'm always asking for something."
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Moreover, societal gender influences impacted the use of social support. Several
male participants stated that men must be portrayed as strong and that expressing that one
was in pain was not something a man “should” do (Open). These societal and social
gender influences were mentioned by several male participants.
E: I think dudes do it different than chicks anyway, you know, I mean... Unless
I’ve been, you know I’ve been in situations where I’ve overheard some men, I use
that word lightly, that just sitting there crying like a couple a kids, you know
about shit that I wouldn’t even think twice about… I mean if you’ve got a dude
over here in a room full of girls and, you know, he’s hurting he may not act like
he would if he was by himself, you know, with a doctor.
G: I guess that’s my biggest worry is being a crybaby. That’s how, instead of
wimp, a crybaby. I got other terminology. (Laughing.) You know, I’ve been
through motorcycle accidents, car wrecks, you know, and fights and I’ve been
through a lot. And I’ve got a lot of reasons to be in pain but I really don’t want
anybody to know about it. (I see.) You know, I’ve had a lot of pain in my life, but
I’m not a crybaby.
(Selective) Self-Management
Medication management (Axial) was a main source of coping for many chronic
pain participants. Five out of ten participants were prescribed opioids for chronic pain.
All five participants prescribed opioids stated that at some point during their course of
treatment for chronic pain, either currently or in the past, they felt unhappy about having
to take opioids for chronic pain (Open). All of these patients stated that they wished they
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didn’t need to take these medications but stated that they could not manage their
condition without the use of them.
C: Yeah, a lot of frustration because I don't like taking it, but I know I have too.
Ya know, and that's very frustrating.
C: I would love to be off the pills. I would love that and they're hard on your
liver, ya know, and I already have kidney problems and gallbladder problems, I
really don't need that on top of it and that is the reason why I really watch my
medication now and in addition, my doctor, the doctor that I have, he is
wonderful, and he monitors me very closely. Like the doctor that I had before
him, he um would prescribe me, and I knew it was a lot at the time because I need
these medications. I'm not going to say anything about it and get it taken from
me, ya know? So that is another, ya know, can't say anything because something
might come out of it. But he used to prescribe me 100-10 Vicodins, which is the
10 milligrams, 100 with them with 5 refills, so that was 600 pills right there for 6
months. And my doctor now there is no way that he would do something like
that, and he monitors, I'm on a narcotics agreement him.
Most participants prescribed opioids had mixed emotions about being on the
medications long-term for pain management. Several participants prescribed opioids for
chronic pain stated that they felt ashamed or that they feared addiction. Others stated that
while they used to feel shameful to take opioids for chronic pain, they noticed that they
developed into a place where they were able to accept being on the medication because it
allowed them to function at a higher level. Medication treatment assisted them in
accomplishing chores, work and/or hobbies, falling asleep and maintaining relationships.
86

H: I have mixed emotions about it. Um, one of the things that my pain management
doctor had explained to me before has to do with that you have to get the relief from
the pain or the pain will get worse. Being that the neuro-pathways between what’s
creating the pain in your brain is like a two-lane highway, and if you’re always
skipping pain medicine, that type of thing, that two-lane highway becomes a
freeway. And the pain message gets there more readily and faster and that type of
thing. So...but I also grew up with people that had addiction problems. Uh,
stepfather was horrible, uh drug, not drug but alcoholic. And I’ve seen what that
does to people and because of that I always tend to err on the low side of whatever
and that’s one of the things that they’ve cautioned me against that it will make it get
worse if I don’t take enough of the pain medicine so that it’s always okay, well how
much is enough and how far gone does the pain really have to be? Because to me,
it’s never really gone 100%, ever. But, you know, if you don’t notice it so much, to
me that’s taken care of. You know, if you get rid of that nagging part of it, then it’s
okay… To me, I consider that good pain management. You know, I don’t have the
expectation that the pain is gonna be gone, gone. So, from that standpoint, I don’t
mind taking the heavier drugs in order for that to take place. But I don’t want to get
to the point where it’s...not a benefit...that the benefits don’t outweigh the negative
portions of it... Okay, I’m gonna take it. You know because at least I can be up and
functional some hours of the day.
Several participants were aware that they were now addicted (Open) to pain medication.
C: I don't like being on the medication, number 1, because it is addictive. I am
addicted. Anybody that says they are not are lying. I've been on it for 15 years,
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I'm addicted. Even if I'm not in pain and I am having a really good day and things
are going smoothly, if I lay in bed and start to, ya know, want to relax my nerves
just like, they are like on end because they need to be, I called "feed."… It just
feels like my nerve endings are at the top of my skin and they are raw and they are
going nuts. So even if I am not in pain, I have to take at least a half a pill… That's
exactly what it is for. It's not because I am in pain, it's because if I don't I won't
sleep all night because my nerves just feel like they are raw. Ya know, like they
are poking up, so it is definitely addiction.
Interestingly, many participants mentioned that they tried using street drugs (Open) and
alcohol (Open) to cope with chronic pain but found these methods unsuccessful.
I: I don’t think anybody who is in constant pain wouldn’t get depressed. And I
use to cope with that depression by drinking alcohol. Well I learned really quick
that doesn’t work. You know, so when they did put me on antidepressant and
they work, I couldn’t believe the difference. You know? So it is a big part of the
treatment program, you know? That they go hand and hand.
A: Um, besides medication. Um, I'm not going to lie to you. I've even tried drugs
to see if the drugs would take the pain away. All they do is just make me grouchy
and sleepy.
Several participants disclosed the current use of marijuana (Open) as a strategy for
coping with chronic pain. All participants who used Cannabis found this treatment
helpful.
I: And ah, I’m glad that Colorado passed the medical marijuana bill so that people
can smoke it because I do think that it physically helps with pain but mentally
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keeps your brain, or mind off of it and helps you relax enough to where you can
eat or sleep you know?
G: And he’s like, “You know, I tell you what, I’ll give you Codeine. I’ll give you
whatever you want. Because I know you’re in a lot of pain.” I says, “No, that’s
alright, doc. That stuff’s addictive.” He says, “What do you do for pain?” I says,
“Smoke marijuana.” “Does it help?” I says, “Well no, not really. It just alters my
mind so it don’t bother me.” He didn’t have a problem with it, so. But, uh, I don’t
smoke a lot of marijuana, too damn expensive anymore. And my lungs aren’t in
that good of shape.
Five out of ten participants were not using opioids but three were using high doses
of NSAIDs (Open), three were prescribed muscle relaxants, and three were taking an
antidepressant (Open).
F: …when it gets really bad, I take ibuprofen, because ibuprofen helps it. But I
have not pursued any other pain, because that’s my personal choice, is if I can
possibly avoid it I don’t want to do it. I don’t react well to pain meds, I never
have, you know. I don’t want to take them… When the achiness is bad enough,
that’s what will cut it, and I mean I’m talking 600 to 800 milligrams, I have to
take, to knock it back.
Participants prescribed antidepressants felt that these medications were helpful in
managing their chronic pain and mood instability regardless of whether they were also
taking an opioid medication.
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H: Now, since Lyrica, that has been toned down. It still gets sometimes that bad,
where it still feels like its tearing but its not as....piercing or uh, sharpness is taken
away from it. And the Lyrica also does that for the sciatica pain as well. It seems
to keep a lot of that to more of a dullness instead of the really sharp pain that it
has been in the past.
Two participants were not taking any form of medication. The participants who were not
taking opioids stated that they feared addiction and feared the side effects of these
medications (Open).
B: Um, I have tried several different things. Um, I tried narcotics. Um, Vicodin
tends to make me really, like wired and I can’t sleep. And it, I just don’t like the
effects of it, um and I like to be able to function for the most part and I get very
drowsy on a lot of pain medication.
Non-medication methods (Axial) of coping that were the most popular amongst
participants were the use of heat (Open), (either baths, hot showers or heating pads),
pacing of activities, and increased exercise (Open).
B: Heat is my number one, I am a huge heating pad user. I use that every single
day. And I sleep with it, even though you’re not supposed to, but that’s the most,
that’s how I can get my body to relax and decompress.
C: I live with my heating pad… If my lower back is hurting a lot and I put the
heating pad and lay up against it, ya know, sitting up, it helps a lot.
D: Hot showers, take a lot of hot showers, let the hot water run but that only takes
the pain way for like 20 minutes
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Participants who mentioned pacing (Open), made efforts to not lead sedentary
lives and focused on balancing physical activity with inactivity in their management of
chronic pain. Many patients who were overweight described wishes of focusing on
weight management (Open) and noted that increasing physical exercise (Open) was a
goal for them to assist in decreasing their weight and consequently their experience of
pain.
G: To cope with the pain? Well, I ride my bike sometimes when the pain gets to
be, I don’t know, I’ll go for a ride. Not a real long ride, I mean, I don’t know...it
kinda helps.
F: I need to walk a certain amount, you know, to make it okay, to make it better.
But then if I go beyond a certain point, it makes it worse… So I need to keep up
short walks because I know that it gets worse if I don’t do anything and then I try
to do something, it’s much worse than if I on a daily basis walk a little bit.
C: And exercise is also very important. You have to know what kinds of
exercises are good for your body though.
I: And I exercise as much as I can because I don’t want anything to atrophy.
Several pain patients utilized a cane (Open) to assist with balance, standing and
walking to cope with chronic pain and/or a brace to assist with instability.
H: So I actually get tendonitis really bad in that foot. I have a leg brace and
everything else. So it’s, you know, it’s best if I get up and walking ‘cause it
stretches that tendon out, you know
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In addition, several chronic pain patients mentioned the importance of engaging
in pleasurable activities (Open) and alluded to how this assisted in distracting them from
their experience of pain.
H: I will actually play video games because I’ve found that if I just lay there and
think about the pain it just makes it worse. So I will try to distract my mind, and I
use video games, or I’ll use reading...
I: Yeah, I can still fish. I can still take long walks and, you know, I spend a lot of
time with my dog. I mean all my time with my dog… laughter
Moreover, many patients described massage as a helpful strategy for managing
chronic pain (Open). Several patients stated, however, that massage was too expensive
for them to engage in this treatment regularly.
F: Just wishing that I could do stuff like massage and stuff (laughing). Massage
therapy, because you know, I will like, you know rub on my legs just massage the
muscles because it seems to be more in the muscles than anything else. But I
don’t have money for that. See that’s, I’m on disability and social security. So
I’m lucky if I have food in my house.

Table 14
Selective, Axial and Open Categories for Coping with Chronic Pain
Selective
Axial
Open_____________________
1. Social Support 1. Types of Positive Support 1. Confidant with Chronic Illness
2. Parent/Partner/Child
3. Religion
4. Alcoholics Anonymous
5. Pet
6. Therapist
2. Messages- Family of Origin 1. Strong versus Weak
2. Asking for Help
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3. Societal Gender Influences
2. Self-Management 1. Medication

1. Men “should” feel shame
1. Opioids
2. Antidepressants
3. Trial of Street Drugs
4. Medicinal Marijuana
5. NSAIDS
6. Alcohol
7. Addiction

2. Non-Medication

1. Heat
2. Addiction/Side Effects- Fears
3. Activities/Distraction
4. Pacing
5. Increased Physical Activity
6. Massage
7. Cane or Brace
8. Weight Management

Professional Treatment for Chronic Pain
(Selective) Physical Health
Physical health treatment (Axial) methods were tried by many participants. Out
of the three participants that underwent a surgery for chronic pain, all stated that the
surgeries were unsuccessful (Open). Injections were found to be helpful by two
participants (Open) and physical therapy (Open) was found to be helpful by three
participants (Open). Chiropractic treatment (Open) was tried by several patients. All but
one participant who tried this treatment found that it made their chronic pain worse.
C: I have had two back surgeries and on-going medical issues due to the
surgeries.
H: …the epidural steroid injections have worked very well for me. Um, I get ‘em
maybe two times a year, sometimes three if I’ve really been bad. But you’re
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limited to three a year, so I usually try to reserve that third injection for if
something really bad happens.
I: …they are pain injections. I mean it with a really small needle so then it
doesn’t ever penetrate the rib cage or anything. It just goes into the muscles itself
that need it and he marks it with an “x” before hand and so on so that he only hits
the parts that are hurting. Which it really does help a lot and they last for 2, 3
weeks. So you know that helps a lot with my pain also.
D: …and then she took me to this Chiropractor afterwards and he did insurance
fraud on me. He took the curve the rest of the way out of my neck and f’d up my
back even worse …to get more money so I would have to see him longer and the
insurance company. So I would cry afterwards. My mom is all, “You're going to
hurt worse for a while afterwards and then you'll get better." And I never did, I
got worse and worse and worse.
Most patients mentioned that they felt at some point in their treatment for chronic
pain that physicians didn’t listen to them (Open), suspecting that they were pill seeking
(Open). They stated that these barriers were significant in them receiving sound and
effective chronic pain treatment.
C: I understand that there are people who have drug seeking behaviors and they
go to multiple doctors and hospitals to get medications, I understand that and I
know that exists, but I truly believe that doctors have stopped listening to the
patient. And especially somebody like me, who has a proven history of back
surgeries, accidents, ya know? I've been seen constantly by the same doctors, ya
know? I don't jump around… One time I told a doctor, at the emergency room, "I
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don't even want drugs from you. I'm not looking for that. I'm hurting. I need you
to figure out what is going on." And that was very frustrating because I don't want
to be looked at like that…? And I understand that that is something that they're
kind of being taught to watch out for, but they're no longer talking to the patient
like they are a patient, like they actually have a problem. Ya know? They talk to
the patient like they're a drug user.
I: Some physicians haven’t really responded to it (pain) hardly at all and have
thought that I was drug seeking and so on…
Many patients stated that they experienced greater success and overcame these
barriers in their relationships with physicians when they could be strong and assertive in
their conversations with them (Open).
B: I think just the biggest thing is getting doctors to realize that not everybody is
after pain medication. Not everybody is, you know, coming to the doctor
because, ‘well, I stubbed my toe and now I need Vicodin.’ There are people out
there that are in real pain… So it’s that kind of stuff, of actually getting down to
the source of what’s really wrong and, and a lot of times I walk into the doctor’s
office and they’re like, ‘oh, you’re just here for pain, so go away.’
B: So, I think that’s a big part, is speaking up for myself, and being willing to
speak up for myself and say what’s going on. And then also being willing to not
say, ‘hey, um, I’m really am in pain, this is what’s going on.’ So just sharing
that…
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(Selective) Mental Health
Four out of ten participants were in individual counseling treatment (Axial) for
chronic pain. These four participants reported that counseling was helpful and was a
significant part of their management and treatment for chronic pain (Open). All four
participants engaged in therapy reported that their relationships with their therapists were
strong (Axial) and that their therapists listened to their concerns (Open).
B: Yes, so, yeah, that has helped. It has definitely, to have an outside perspective,
somebody that is willing to talk to me about it and say, ‘okay,’ you know, ‘how
are you dealing with this?
I: Well I think that counseling treatment is a big part of it. That without
counseling treatment you really don’t understand a lot of what’s going on and you
can’t get a lot of the concerns that you have off of your chest. Because a lot of
times doctors don’t have time to listen to you.
The remaining participants had not considered counseling therapy as an option for the
management and treatment for chronic pain (Open).
Table 15
Selective, Axial and Open Categories for Professional Treatment for Chronic Pain
Selective
Axial
Open_____________________
1. Physical Health 1. Physical Health Treatments 1. Injections and PT helpful
2. Surgeries unsuccessful
3. Chiropractic Txt unhelpful
2. Relationship with Providers 1. Physicians don’t listen
2. Healthy assertion
3. Pill Seeking
2. Mental Health

1. Counseling Treatment
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1. Psychotherapy is helpful
2. Psychotherapy is helpful?

2. Relationship with Providers 1. Therapists listen

Nature of Chronic Pain
(Selective) Experience of Chronic Pain
Participants displayed varied experiences of chronic pain including the origin
(Axial), pain sites (Axial), diagnoses and longevity (Axial). Seven out of ten participants
had a clear onset to their experience of pain; for example, an acute injury as a result of a
specific accident that developed into a chronic condition. These patients found their
diagnoses for chronic pain satisfying (Open). However, patients without clear knowledge
of the reasoning for their pain or the onset of their pain experience were concerned about
receiving an accurate diagnosis of chronic pain and felt unsettled with their associated
diagnoses (Open). These three out of ten participants without a clear onset of chronic
pain were diagnosed with fibromyalgia. These patients described their diagnosis of
fibromyalgia as a “catch all” diagnosis and asserted that they were unsure if this was their
accurate diagnosis.
F: They diagnosed, okay so they checked me for RA any other kinds of arthritis
and they ruled arthritis out. So then, they put me under the umbrella, you know,
of um, fibromyalgia. Because they didn’t know what else it was, they didn’t
really pursue, you know, that’s something I brought up today with the doctors that
they didn’t send me to a neurologist. She’s going to, you know, so... all they did
was send me to a... the arthritis specialist. And then she’s the one that ruled it out
and said fibromyalgia. So yeah, and it got dropped and my legs have gotten
progressively worse since then.
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B: It’s just figuring out is this from the fibromyalgia, is this because of the Celiac,
is this, you know? That’s I guess, what I keep looking at, is what is ultimately
causing all this pain? Is it an overall one thing, or is it multiple things? And so just
trying to figure out… And then you go to the physical therapist or go to the back
doctor and they’re saying, ‘there’s nothing wrong with your back.’ Well then why
am I in so much pain? And I think that’s the most frustrating is every doctor I go
to is saying, ‘there’s nothing wrong with you.’ Well then I wouldn’t be in pain if
there really wasn’t nothing wrong with me. So, you know, I wonder, am I being
really weak because I’m in all this pain and people are feeling like I shouldn’t be
in all this pain.
Four participants had multiple pain sites. All four of these participants had either
a history of alcoholism or a chronic illness (Open). The longer the longevity of chronic
pain, the more likely the participant was prescribed an opioid medication for chronic pain
(Open). Four out of five participants prescribed opioids for chronic pain experienced
chronic pain for ten years or more. Two out of five participants not prescribed opioids
for chronic pain experienced chronic pain for ten years or more. These two participants
not prescribed opioids with a longer longevity of chronic pain were prescribed
antidepressants for chronic pain.
(Selective) Relationship with Chronic Pain
Participants described varied relationships with chronic pain including
descriptions of chronic pain (Axial) and associated mood (Axial). Participants who
developed chronic pain out of a traumatic injury such as a domestic violence incident or a
motor vehicle accident, or had a significant substance abuse history, tended to describe
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their pain in more vivid, violent descriptions (Open). Participants who did not experience
co-morbid trauma with the onset of their pain experience and denied a history of drug or
alcohol abuse described their experience of pain with descriptors of a non-violent nature
(Open).
A: I've had domestic violence, let's put it that way. Um, I was kicked in the leg by
a Mexi, you know those cowboy boots… Um, on this leg I had a boyfriend again
stab me in the leg with a screwdriver. And I've been beaten down. Um he
smashed a full can of beer on my forehead twice.
Later during the interview this participant described her experience of chronic pain as:
A: Um, on my leg it feels like their sticking a bunch of needles in there or
sometimes it feels like you are sticking a knife in there and just twisting it. My
back feels like somebody is kicking me. I feel heat sensation coming from my leg
depending on how bad it hurts. My shoulders… it just feels like somebody just
tied me up to something and it is just stretching me. The headaches, it’s like the
plague, like somebody is just sticking something in there and running right
through my eyes and across. Yeah.
C: It was primarily the car accident. Overall, probably it has happened from the
last twenty years I have been in 7 car accidents…
Later on she described her experience of pain as:
C: The pain in my neck is like a squeezing, like somebody is squeezing it except I
get really bad headaches. So it feels like somebody is squeezing my neck and, ya
know, when your blood is pumping in that heart beat type feeling.
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Several participants described their experience of chronic pain with non-violent
descriptors.
F: …it slowly started out with a little bit of pain in my knees, and just my legs in
general when I overworked them. They would start… the muscles would start
feeling weak and my legs would ache. And um, it just progressed from there so
that now my legs ache every single day all the time, and it’s just a very dull, low
level. So I block it out. I don’t pay much attention to it. But I’ve noticed, the
more I work my legs, the worse it is. I can’t do things like I used to. I can’t
crouch down or anything because my legs will start going numb and I’ll get the
stabbing pains. So it’s mostly achiness, stabbing pains, weakness, that kind of
thing.
H: …it varies. I have the kind of chronic thing that is just...um, a deep ache that
is all over from the fibromyalgia, they’re telling me from fibromyalgia or
whatever. Um, I have...a nagging pain that’s in the lower back, all the time. And
then I have...um, intermittent sciatica pain, which is sharp pain that goes down my
leg usually only to my knees but sometimes all the way to my toes.
Almost all participants reported that their experience of pain increased symptoms of
depression (Open) and irritability (Open).
C: My pain definitely impacts my mood because I am usually pretty mellow and
ya know, not like high-strong and overbearing or anything, but once my pain
starts and start feeling really uncomfortable, I have no patience. No patience at all
and I'm quick to lash out at somebody and, um, quick to respond in a negative
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fashion to anything, ya know, that may not have even come to me negative [mm],
but it will go out negative… Yeah because, um, for example I got really upset
some lady the other day, then threw an ash tray at her.
I: I don’t think anybody who is in constant pain wouldn’t get depressed.
Additionally, all participants stated that feeling stressed (Open) increased their level of
pain. Outside of recognizing that stress increased their level of pain, only a few
participants recognized that negative mood, either depression or anger, increased their
experience of pain.
F: I’ve already made those connections that, you know, trying to um, take care of
the emotional stuff. I mean, because mind-body connection, you know. I know
that those affect, and when I do get upset, it can, it makes everything worse, of
course. So if you have pain going on in your body on a low level at all times that
level’s gonna raise up under stress. And that just makes sense to me, so...
keeping stress levels low is a biggie.
H: When my mood is worse, I notice that it’s harder not to focus on the pain. And
that makes it worse, because when you focus on the pain it’s like giving it energy
and it just gets worse… when you’re depressed I think you tend to focus more on
the pain and it’s also harder to get yourself to go do stuff that would maybe help
you feel better.
All but two participants felt that they were aging faster or feeling much older due to their
experience of chronic pain (Open).
B: And so then I feel like, gosh I’m 35-years-old and I feel like I’m 80 some days.
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D: She's like, "You're such an old lady already mom." (Laughter). I'm like, "Tell
me about it. I feel like I am 80 years old or something."
Table 16
Selective, Axial and Open Categories for the Nature of Chronic Pain
Selective
Axial
Open_____________________
1. Experience of Chronic Pain
1. Origin
1. Clear Onset/Diagnosis
2. No Clear Onset/Fibromyalgia
2. Multiple Sites

1. Co-morbid Illness/ETOH

3. Longevity

1. 10 yrs, likely uses opioids

2. Relationship w/ Chronic Pain 1. Pain Description 1.Violent- trauma/sub use
2. Non-Violent
2. Mood

1. Pain increases irritability
2. Pain increases depression
3. Stress increases pain
4. Pain makes you feel older

Saturation of Themes and Categories
The previously detailed open, axial, and core categories were derived during the
data collection and finalized after saturation was reached. In grounded theory
methodology, data collection ceases when additional interviews do not produce any new
categories or codes and no new characteristics of the existing codes are elicited (Glaser &
Strauss, 1967). When saturation is achieved, the researcher can discontinue further
interviews and focus on defining the emerging theory with the data that have been
obtained.
In this study, saturation was believed to be achieved after nine interviews. As an
example, one theme which was prevalent in several of the earlier interviews which was
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also reflected by Participant 9 was in the area of having to taking pain medication to
function and fulfill life responsibilities. This participant reported that he used to feel
ashamed about being on opioid medication. However, due to his success with increasing
physical activity, engaging in hobbies and helping his family, he began to accept that he
needed the assistance of opioid medication and didn’t feel shameful about taking it
anymore. In addition, he mentioned the importance of physical exercise in managing
chronic pain. Participant 5 shared similar responses about having to take pain medication
for years to manage chronic pain and noticing that he has been able to accept that the
medication helps him function at a higher level and not to be sedentary. In addition, both
of these participants mentioned the importance of exercise as a means of coping with
chronic pain.
9/ I: And I do exercise a lot because I know that if I just sit there and don’t move
and so on, that I stiffen up and things like that and that if I walk, it makes my
serotonin levels in my brain go higher and it does help with the um, oh it’s like a
type, endorphin, that it’s a natural type of morphine that, you know, it can ascend
to higher levels and so on. So, I know that helps, you know?... And I exercise as
much as I can because I don’t want anything to atrophy.
5/E : Well, I mean the Percocet’s, you know, like immediate, you know what I
mean. You know, if you’re hurting and you want it to stop within the next half an
hour, sure. You know? But uh, you know, probably exercising. I mean it hurts
when you exercise, but you feel better later. I do anyway, you know.
A few other examples of areas in which saturation was observed, occurred when
Participant 9 spoke about his acknowledgement that pain can cause depression, that
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counseling has been helpful in his treatment of chronic pain, that physicians viewed him
as drug seeking, that he enjoyed pleasurable activities despite pain, and that his family,
dog and faith in God were positive social supports. All of these themes and ideas had
been mentioned by previous participants. In comparing the transcript of responses from
Participant 9 to several other interviews, no new categories or themes were introduced.
In order to ensure that saturation was achieved, the primary researcher completed
one additional interview. This final participant, Participant 10, also had similar responses
to the previous participants’ responses and did not give any responses which led to the
creation of new codes or categories. The responses of Participant 10 also yielded similar
responses to Participant 9 in several areas. For example, in speaking about increased
exercise to help manage chronic pain, Participant 10 stated:
The only thing that I really do is try to walk. You know, I can’t really, I
can’t run because I run out of breath and I have the inhaler that I use too…
I’ve been trying to lose a lot of weight and that’s one of my important
things right now, to lose weight. Cause I was over 300 lbs. I weigh 276
now.
Participant 10 disclosed that weight management was a goal of his not only for
pain management but also for diabetes management. Additional responses that
Participant 10 shared that were similar to Participant 9 were how he felt that he was
viewed negatively for being on pain medication but felt it was necessary, that
antidepressants and counseling were beneficial for pain management, that he enjoyed
pleasurable activities despite pain, that stress affected his levels of pain and that pain
caused irritability, and that his family were his main supports.
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10/J: Just really that I’m on pain pills. I have to take them because that is
the only way that I can cope with this pain and just hope that my health
gets better. You know? …I just take them because I need them. It helps
my pain a lot. Without them I wouldn’t, I would constantly be in pain.
10/J: …but other times you could feel that, you know, that the meds are
helping the pain or just stopping the thoughts, what’s going through you
mind. You know, it’s not really that painful. That you are thinking about
the pain, but it’s just, but when I’m off the meds it’s just like pain all the
time.
Moreover, even when probed, Participant 10 did not give any responses which
were novel. Therefore, saturation was determined to be achieved and the remaining data
were analyzed to determine its relationship to the previously collected data, themes, and
codes in order to complete the emerging theory.
The Balanced Scale Image
The 43 open, 9 axial, and 5 selective qualitative categories described above
produced a descriptive image of non-cancer chronic pain patients’ ability to manage their
chronic pain while living the fullest and most balanced life as possible. The experience
of managing chronic pain is extremely complex, influenced by many factors regarding
the nature of chronic pain, physical and mental health professional treatment for chronic
pain, and coping strategies for chronic pain. The relationship between these categories is
reflected in the image of the balanced scale (see Figure 1.).
Within the image, the selective categories are juxtaposed elements to keeping the
scale, or the participant’s body balanced. These selective categories are shown
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juxtaposed, helping the person manage chronic pain effectively. If these elements are
weighted heavily one way more than another, challenges may arise that thus “tip the
scale” and create more problems managing chronic pain. Issues that may arise when the
pain scale is unbalanced may include: depression, addiction, dependence on a provider,
fear of providers, lack of trust in others, isolation, a sedentary lifestyle, obesity etc. On
the exact opposing side of the scale is the corresponding selective code from the same
domain category. For example, social support and self-management are opposing on the
figure. Thus, if a chronic pain patient is heavily dependent on social support, he or she
may then become less focused on the importance of self-management strategies for
coping with pain and thus, tip the scale. Additionally, if a chronic pain patient utilizes
physical health treatment more heavily than mental health treatment, or vice a versa, that
patient may become more focused on one element of functioning over the other and miss
opportunities to have more balanced, healthier pain management, and thus, tip the scale.
Moreover, relationship with chronic pain and experience of chronic pain are juxtaposed.
Seemingly when chronic pain patients focus heavily on their experience of chronic pain,
such as diagnosis, sensations, and pain sites, they are less likely to become aware of their
relationship with chronic pain and how stress and mood states affect their level of chronic
pain. Keeping the juxtaposed elements balanced assists chronic pain patients in more
effectively managing their experience of chronic pain, receiving the best treatment
possible and functioning at their highest level possible.
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Figure 1
Relationship between Categories

Summary of Qualitative Results
Participants identified several key influences in their management of chronic pain.
First, participants’ nature of their chronic pain experience, including onset, pain sites,
diagnoses, longevity, description of sensations, associated mood, and ability to recognize
stress and how this impacts their level of pain, contributed to their descriptions of their
satisfaction with treatment and the management of chronic pain. Patients reported they
were content with their diagnoses and treatment of chronic pain when there was a clear
onset to the origin of their pain experience. This clear onset seemingly contributed to a
clearer understanding of treatment and patient satisfaction of the treatment as compared
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to pain patients who were unclear about the onset and ambivalent about their chronic pain
diagnoses. Additionally, participants who experienced pain in multiple pain areas were
more likely to have a co-morbid chronic health condition or to have had a drug/alcohol
history. Participants suffering from chronic pain for ten years or more were more likely
prescribed opioids for chronic pain. Participants who experienced trauma in conjunction
with their onset of chronic pain, or who reported a significant drug/alcohol history,
described their experience of pain with more violent descriptors. Moreover, all
participants recognized that pain caused greater irritability and depression and all
participants recognized that stress increased their experience of pain. Alternatively, only
a few participants reported a connection between negative mood and greater severity of
chronic pain.
Second, participants’ professional treatment for chronic pain influenced their
ability to manage their chronic pain effectively. Patients tried varying physical health
treatments for chronic pain including surgeries, injections, chiropractic treatment,
physical therapy and massage. Participants found surgery unhelpful and injections and
physical therapy helpful. Participants felt that their primary care doctors, had at times,
been poor listeners and viewed them as drug seeking. Participants felt that learning to
assert their needs and “speak up” for themselves with physicians assisted them in
receiving more sound treatment. Several participants were in mental health treatment for
chronic pain. All of these patients found psychotherapy to be a significant aspect to their
management of chronic pain. These participants found that therapists listened well to
their struggles and found this helpful.

108

Finally, all participants reported that social support was a positive coping strategy
for chronic pain and all participants described varying attempts at self-management
strategies for coping with chronic pain. The most preferred social support was a friend or
family member who also suffered from a chronic condition and almost all participants
received positive support from family. Several mentioned that they received positive
support from God/faith, from a pet, from a therapist and from a relapse prevention group
such as Alcoholics Anonymous. Almost all participants discussed familial messages and
influences from a young age impacting their beliefs about coping with chronic pain and
how to utilize social support for chronic pain. The most common familial message was
the importance of being portrayed as strong versus weak. In addition, in relation to this,
participants often felt uncomfortable asking for help due to their belief of the importance
of being portrayed as strong and as someone who others can rely on. Moreover, societal
gender influences seemingly impacted male chronic pain patients’ pain behaviors, beliefs
about what was an appropriate “manly” expression of pain was, and increased feelings of
shame around having pain.
Participants utilized medication and non-medication means of self-managing their
chronic pain conditions. Half of the participants’ utilized opioid medication for the
treatment of chronic pain and at some point in treatment felt guilty or ashamed for having
to take opioids for pain. However, several patients expressed acceptance around having
to take pain medication and expressed clearly how it increased their ability to function at
work, at home, and in relationships. Several patients prescribed opioids for many years,
recognized that they were now addicted to opioid medication. Participants not prescribed
or taking opioids for chronic pain described fear around taking these medications and
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mentioned fears around side effects that could result from taking these medications.
Many participants tried street drugs and alcohol for coping with chronic pain but found
these treatments unhelpful. The few participants prescribed and taking antidepressants
for chronic pain management found these medications helpful. The few participants
using medicinal marijuana for chronic pain, found cannabis to be helpful in managing
chronic pain. Heat was the most effective localized treatment for chronic pain and the
pacing of activities, increased physical exercise, weight management, the use of a can or
brace, and pleasurable activities, as a use of distraction, were the most effective selfmanagement strategies for chronic pain. Massage was the most common alternative
treatment for chronic pain that was beneficial for patients. However, most participants
could not afford on-going massage therapy.
Integrative Findings
Table 17 displays the total scores of participants’ measures from the quantitative
findings. A few trends were found when integrating the data. Higher scores on the painself efficacy questionnaire (PSE-Q), a measure of chronic pain patients’ confidence to
perform tasks despite pain, were associated with lower scores of depression as measured
by the patient health questionnaire (PHQ-9). For example, participants D, E, F and I
reported sub-threshold symptoms of depression and reported high levels of pain selfefficacy. Correspondingly, participant H reported the highest levels of depression as
compared to other qualitative participants including suicidal ideation and also reported
the lowest pain-self efficacy on the (PSE-Q) as compared to other qualitative participants.
The evidence from previous research on pain self-efficacy suggests that clients with
persisting pain scoring 40 or above on the PSE-Q are likely to sustain or build on their
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functional gains (Nicholas, 2007). Alternatively, low pain self-efficacy has been found to
be a predictor of people being at risk of long-term disability and depression (Arnstein et
al., 1999).
Interestingly, in the multiple hierarchical regression analyses from Hypotheses 3,
level of pain self-efficacy and level of depression were statistically significant predictors
for the group of patients already prescribed opioids to be at risk of aberrant drug-related
behavior. Participant A and Participant E demonstrated evidence of this phenomenon.
Participant A had the highest score on the outcome measure (the COMM, measuring the
risk for aberrant drug-related behavior in patients taking opioids for chronic pain) as
compared to all other qualitative participants and reported moderate symptoms of
depression on the PHQ-9 and low pain-self efficacy on the PSE-Q. Moreover,
Participant E had the lowest score on the outcome measure (the COMM) as compared to
other qualitative participants and reported no symptoms of depression and had high pain
self-efficacy. In addition, Participant E had the lowest level of depression, lowest level
of risk for aberrant drug-related behavior, and the highest score on the Social Provisions
Scale, a measure of a patients’ perceived social support, as compared to the other
qualitative participants in this study.
Four out of the top five participant scores for perceived social support as
measured by the Social Provisions Scale were associated with the lowest participant
scores on depression. Research suggests that high levels of social support are associated
with lower levels of reported symptoms of depression (Barrera, 2000; Berkman & Glass,
2000; Cutrona & Russell, 1987; Israel & Schurman, 1990; Weinert & Tilden, 1990; Yang
& Clum, 1995). Levels of severity of depression in both males and females have also
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been associated with social support (Rizwan & Syed, 2010; Zlotnick, Shea, Pilkonis,
Elkin, & Ryan, 1996).
All participants on opioids but one, participant E, were at risk for aberrant drugrelated behavior based on their total outcome scores on the COMM. The cutoff score for
the COMM is a score of 9. All participants not on opioids but one, participant B, were at
risk for opioid misuse based on their total outcome scores on the SOAPP®-R. The cutoff
score on the SOAPP®-R is 22.
The statistically significant predictors found for the hierarchical multiple
regression, for participants not already prescribed opioids (level of depression, level of
social support and level of ethnic identity) were not corroborated in the qualitative subset
of the larger quantitative sample. Correspondingly, the only statistically significant
predictor for distinguishing whether participants were prescribed opioids or not (level of
pain self-efficacy) was not found in this smaller subset of participants.
Overall, level of social support, level of depression, and level of pain self-efficacy
seemed to be the strongest predictors in statistical analyses and influences on coping in
qualitative analysis. All participants offered examples of the importance of social
support, how mood and stress impacted their level of pain, and how pacing and/or
increasing activities and behavioral activation were important despite pain. Participants
who mentioned the importance of physical activity and pleasurable activities despite pain
thus displayed some level of pain self-efficacy. Ethnic identity was a significant
predictor in participants not already prescribed opioids but was not significant in
qualitative findings. In addition, significant predictors for aberrant drug-related behavior
were not found in the qualitative sample, thus these findings cannot directly add to the
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statistical predictors found. Participants interviewed for the qualitative portion of this
study were asked open-ended questions to gain a comprehensive understanding of their
primary means for the management of chronic pain and its contributing factors.
Table 17
Participant Results on Quantitative Measures
Part. Age Sex
COMM

PHQ-9

SPQ

PSE-Q

MEIM-R

SOAPP-R

A

41

F

13

61 (N, G, RA)

21

34

35

B

36

F

17

62 (G, N, SI)

29

27

17

C

44

F

13

86 (G, RA, N, A)

29

23

18

D

41

F

4

77 (RA, RW, SI)

44

38

32

E

51

M

0

94 (RA, N, A, SI)

50

40

8

F

55

F

8

87 (G, A, SI)

51

37

24

G

54

M

4

55 (RA, N, G)

14

32

29

H

43

F

22 (SI)

66 (RA, A, SI)

7

32

15

I

46

M

8

87 (RA, A, G)

44

40

28

J

55

M

11

68 (RA, G, A, N)

48

34

10

The highest rated perceived social support subscale provisions were listed for each
participant. The six perceived social support provisions include Guidance (advice or
information; G), Reliable Alliance (assurance that others can be counted on in times of
stress; RA), Reassurance of Worth (recognition of one’s competence; RW), Attachment
(emotional closeness; A), Social Integration (a sense of belonging to a group of friends;
SI), and Opportunity for Nurturance (providing assistance to others; N; Rizwan & Syed,
2010; Weiss, 1974).
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CHAPTER FIVE: DISCUSSION AND IMPLICATIONS
In this chapter, the research problem is reviewed, the methodology is summarized,
and the findings are integrated and discussed within the context of the current research in
the field. The quantitative and qualitative findings are compared to findings in the
present literature. Subsequently, aspects of how these findings lend support to previous
research, refute previous studies, or present evidence for new theories are discussed. The
chapter concludes with limitations, researcher reflections, future implications, and
conclusions of the present study.
Overview
As aforementioned, Turk and colleagues (2008) highlighted a plea for further
research on predictors of aberrant drug-related behavior in CNCP patients (Gatchel,
2001). Few studies have examined predictors of aberrant drug-related behavior in
chronic pain populations (Passik & Kirsh, 2003). Researchers have suggested that the
majority of research conducted in this area has been based on retrospective chart reviews
and cross-sectional data, and that large-scale, prospective studies are needed (Turk,
Swanson, & Gatchel, 2008). In addition, they suggested that future studies should
carefully define the criteria that are used to permit replication and comparison with other
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studies and that the population used must be clearly articulated to permit
determination of the representativeness of the sample and generalizability of results.
Moreover, no studies examine solely new referrals to pain clinics or patients who were
not already taking opioids. The current study included participants both on opioids and
those who were not at a large, diverse, federally funded clinic. The participants included
both old and new referrals, male and female, and White and Hispanic individuals across
the lifespan. Thus, the results may extend to a relatively broad sample.
This was the first study of its kind to assess the role of self-efficacy of pain,
severity of depressive symptoms, perceived social support, and ethnic identity as
predictors of the risk of aberrant drug-related behaviors in CNCP patients. In addition, it
was the first study to explore these variables with the support of quantitative and
qualitative methods. Mixed methods provide a better understanding of a research
problem by combining numeric results with specific details from qualitative data (Brewer
& Hunter, 1989; Hanson, Creswell, Plano Clark, Petska & Creswell, 2005; Tashakkori &
Teddlie, 1998). Collecting and integrating both quantitative and qualitative data further
enriched results in ways that one form of data collection does not allow. Additionally,
mixed methods designs convey the needs of individuals or groups of individuals who are
marginalized or underrepresented (Mertens, 2003; Newman & Benz, 1998).
Quantitative and qualitative data were collected and analyzed separately and then
compared and contrasted. The interview data were used to corroborate, refute, or
augment findings found from the survey data. Qualitative research questions were
employed to gain further comprehension of what drug-related aberrant behavior in CNCP
patients encompasses in comparison to low risk populations, amongst those already on
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opioid treatment and those who were not. The aim of the study was to learn more about
chronic pain patients’ experiences, expectations of pain management, expectations of the
use of opioids, and coping skills for chronic pain in the two groups.
Discussion of Quantitative Results
As noted earlier in this paper, it is urgent to learn how to select CNCP patients for
opioid therapy who are likely to achieve improvement in pain, function, and quality of
life, without interference from addiction (Ballayntyne, 2006). Experts advocate the use
of opioid therapy but in carefully selected patients (Kalso, Edwards, Moore et al., 2004;
Katz & Fanciullo, 2002; Zancy, Bigelow, Compton, et al., 2003). The medical
community aims to learn of common predictors of aberrant drug-related behaviors and
utilize this knowledge through the adequate screening for these predictors in CNCP
patients (Friedman, Li & Mehrotr, 2003; Turk, Swanson, & Gatchel, 2008). The
knowledge gained about common predictors will assist providers in more effectively
selecting individuals that will most benefit from opioid therapy and consequently instill
comprehensive non-opioid therapy management to those most at risk for displaying
aberrant drug-related behaviors in the CNCP population. If providers can predict those
patients who will be most at risk, efficacious changes in chronic pain management could
be initiated and fewer patients potentially at risk for addiction.
Hypothesis One of this study determined whether Group A (CNCP patients
prescribed opioids) and Group B (CNCP patients not prescribed opioids) were
significantly differentiated when gender, age, ethnicity, level of education, perceived
social support, self-efficacy of pain, depression, and level of ethnic identity were used as
predictors. The results from the hierarchical logistic regression analysis found that
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participants’ level of pain self-efficacy was the only individual predictor that
distinguished whether participants were prescribed opioids or not. Low pain self-efficacy
is characterized by a feeling that pain is uncontrollable and unmanageable, given the
physical demands of daily life (Linton & Shaw, 2011). Chronic pain patients not
prescribed opioids for chronic pain were .12 times more likely to have a moderate score
on the pain self-efficacy questionnaire than chronic pain patients already taking opioids.
However, extreme values on the measure were not predictive, indicating that the
relationship between pain self-efficacy and group was complex. Furthermore, .12 is a
minimal differentiation between the two groups. These findings suggest that chronic pain
patients’ not taking opioids for chronic pain have moderate confidence in successfully
engaging in activities despite pain, and in successfully managing their chronic pain.
Chronic pain patients on opioids, may have extremely high or low levels of pain selfefficacy but not moderate levels.
Perhaps chronic pain patients not prescribed opioids are reporting moderate levels
of pain self-efficacy and an ability to do more despite pain because their co-morbid mood
symptoms are better managed. Chronic pain patients commonly experience co-morbid
symptoms of depression and anxiety. Many chronic pain patients may request opioids to
avoid or relieve mental health symptoms as well as attempting to reduce physical pain.
Physicians typically have chronic pain patients rate their level of chronic pain and utilize
these subjective reports to assess whether prescribing opioid medication is indicated.
However, how accurate are these self-reports, and are pain suffering and co-morbid
mental health symptoms being included in these subjective pain scale self-ratings?
Moreover, long-term opioid use can result in hyperalgesia (an increased experience of
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pain), side effects (constipation, sleep disturbance, hormone and immune system
abnormalities), tolerance, physical dependence, and addiction. These side-effects most
likely affect the chronic pain patient’s level of pain self-efficacy, mood symptoms, and
level of functioning. Hence, chronic pain patients who reported extremely low levels of
pain self-efficacy who were on opioids may have poorly managed mood symptoms.
Moreover, chronic pain patients on opioids who reported extremely high levels of pain
self-efficacy may be displaying an addiction or dependence on pain medication.
Are opioids causing a decrease in functioning among chronic pain patients as well
as a decrease in their ability to do activities despite pain over time? Are opioids causing
chronic pain patients to become more disabled with long-term use? These questions
would be interesting to evaluate in detail in future research and are pertinent to the
current opioid epidemic. These questions were similarly posed in a recent article in
Psychology Today written by Dr. Mel Pohl, a psychiatrist, entitled, Opioids Don’t
Always Make Chronic Pain Better (They May Make it Worse): an Opioid-Free Way of
Treating Chronic Pain on June 15, 2012. Moreover, many randomized clinical trials
(RCT’s) on opioid efficacy for chronic pain patients have been conducted since the early
1990s. However, because RCTs cannot be conducted over prolonged periods of time,
this methodology is not useful for assessing long-term effects of the treatment. Openlabel follow-up studies in association with some RCTs have provided some insight into
longer-term opioid utility (Kalso, Edwards, Moore et al., 2004; Moore & McQuay, 2005).
These studies have reported satisfactory analgesia for all patients who stay on the
treatment. Reviews of the open-label follow-up studies, however, have shown that up to
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56% of patients abandon the treatment because of lack of analgesic efficacy or side
effects (Kalso, Edwards, Moore et al., 2004; Furlan, Sandoval, & Mailis-Gagnon, 2006).
Hypothesis Two of this study examined if gender, ethnicity and the interaction
between gender and ethnicity would be significant predictors of aberrant drug-related
behaviors (positive screening on the COMM in Group A) or high risk of opioid misuse
(high results on the SOAPP®-R in Group B). The two-way ANOVA found
nonsignificant effects of sex, ethnicity, and the interaction between sex and ethnicity for
Group A and Group B. Given that there were no differences between sex, and between
White or Hispanic populations, all statistical findings within this study are found
generalizable amongst these populations given the criteria for sample selection. While
other ethnically diverse patients were collected, there were not enough patients within
each of these subgroup samples to be included in the full sample and data analysis.
However, these results may still generalize to a fairly broad population.
Hypothesis Three was the main focus of this study. It was hypothesized that after
controlling for contributions of demographic variables (age, gender, ethnicity, and level
of education), perceived social support, self-efficacy of pain, depression, and level of
ethnic identity would be significant predictors of aberrant drug-related behaviors
(positive screening on the COMM in Group A) or high risk of opioid misuse (high results
on the SOAPP®-R in Group B). Results from the hierarchical multiple regression
indicated that two predictor variables (level of depression and level of pain self-efficacy)
in participants on opioids, and three predictor variables (level of depression, level of
perceived social support, and level of ethnic identity) in participants not prescribed
opioids, contributed significantly to the explanation of patients being at risk for aberrant
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drug-related behavior. The more severe the symptoms of depression, the more likely
chronic pain patients were at risk for aberrant drug-related behavior. This finding was
significant for both groups of patients, both those already taking opioids and those not
taking opioids.
This finding provides significant clinical screening implications and is aligned
with recent literature. Chronic pain patients diagnosed with major depression and other
psychiatric disorders have been found to be more likely than their counterparts to initiate
and continue opioid therapy (Sullivan, Edlund, Zhanf, Unutzer, & Wells, 2006) and to
more likely misuse medication (Edlund, Steffick, Hudson, Harris, Sullivan & Rick, 2007;
Wasan, Butler, Budman, & Benoit, 2007). In addition, these individuals are less likely to
experience analgesic benefits from opioid therapy (Wasan, Davar & Jamison, 2005).
Manchikanti and colleagues (2007) found from an assessment of 500 CNCP patients
prescribed and receiving stable doses of opioids, that drug abuse was significantly higher
in patients with depression as compared to patients without depression (12% with
depression versus 5% without). The patients were evaluated for psychopathology, opioid
abuse, and illicit drug use during the course of regular pain management treatment. Turk,
Swanson, and Gatchel (2008), after conducting a thorough review of the existing
literature available on the risk for opioid misuse, found that a history of polysubstance
abuse, presence of a mood disorder (especially unipolar depression), younger age, and a
history of legal problems were the most significant predictors. In addition, Sullivan and
fellow researchers (2006) found from a meta-analytic review that CNCP patients carrying
a mental health diagnosis of major depression, dysthymia, generalized anxiety disorder or
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panic disorder in 1998 were more likely to report opioid use in 2001 than CNCP patients
not carrying one of these diagnoses.
It is of great importance for providers to assess for depressive symptoms at the
onset of the treatment for chronic pain and ongoing throughout pain management, since
severity of depression is a strong risk factor for the likelihood of aberrant drug-related
behavior. Prior to treatment decision-making, between provider and chronic pain patient,
an assessment for depression and a discussion around the management of depressive
symptoms should be initiated. This strong risk factor should be communicated with pain
patients. Providers should be cautious about prescribing opioid medication for chronic
pain for patients with severe depressive symptoms, or, if considering prescribing opioids,
depressive symptoms should be treated with concurrent psychotherapy and antidepressant
medication (the gold standard for depression treatment).
In addition to higher levels of reported depression, participants not already
prescribed opioids were found to be at risk for aberrant drug-related behavior when they
reported higher levels of ethnic identity and lower levels of perceived social support.
These findings shed light on psychosocial elements of a chronic pain patient’s
functioning that are helpful to assess prior to opioid treatment. These three psychological
variables, severe depression, low social support, and high ethnic identity, put a nonprescribed chronic pain patient at risk for aberrant-drug related behavior and potentially,
abuse of these medications.
Higher levels of ethnic identity indicate that a person holds strongly to their
cultural values and beliefs regardless of how these beliefs may affect health behaviors.
Higher levels of ethnic identity suggest that cultural group norms take precedence over
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mainstream cultures’ beliefs. If one’s culture supports unhealthy eating or that one must
be strong at all times, these behaviors are often adopted automatically. The study of the
association between ethnic identity and opioid use in CNCP patients is limited in present
research. Wong and Longshore (2008) assessed the impact of ethnic identity spirituality,
and self-efficacy on methadone treatment outcomes for heroin use among Hispanic
Americans. Researchers found that greater levels of ethnic identity were related to a
greater number of drugs used at one-year follow-up. In addition, James, Kim and Armijo
(2000) assessed the impact of ethnic identity on drug use among ethnic minority
adolescents. James, Kim and Armijo (2000) found that higher ethnic identity levels were
associated with heavy drug use. These findings support the results found in the current
study. These patients most likely are focused on their cultural group norms and are not
seeking other non-medication means of coping outside of what is accepted by their
cultural group. However, while the results of this study are synonymous with limited
studies in the related ethnic identity literature, it is plausible that the significance of
results found for high levels of ethnic identity in the non-prescribed group could be
related to the ethnic identity variable capturing the significance and contribution of a
latent variable.
In the present study, level of perceived support was a significant predictor of
drug-related behavior in pain patients not already prescribed opioids. The study of the
association between social support and opioid use in CNCP patients is minimal in present
research. This predictive finding is a strong addition to the current literature. LopezMartinez and colleagues (2008) found that high levels of social support correlate with
less pain and distress while solicitous attention from spouses regarding pain behavior
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may actually increase pain interference. CNCP patients who reported more satisfaction
with their social support network also reported lower levels of depression and less pain.
Patients with satisfactory levels of social support were more likely to choose active
coping strategies for dealing with their pain, such as trying to distract themselves by
doing something pleasant, rather than passive strategies like complaining about their pain
to others. Active coping strategies were also linked to lower levels of depressed mood
and better functioning, while patients who coped with their pain passively tended to be
more depressed and to have more severe pain (Lopez-Martinez et al., 2008).
Chronic pain patients not already prescribed opioids, with limited or poor social
support, are more at risk for aberrant drug-related behavior. Prior to prescribing opioids
for chronic pain patients, providers would benefit from assessing a chronic pain patient’s
perceived social support. If a pain patient’s support is limited or poor, the patient could
benefit from the provider making efforts to encourage the patient to increase supports.
For example, providers could encourage these patients to build stronger relationships
with family and friends and prioritize these patients for subsequent referrals for group
therapy and other resources. Additionally, providers could utilize psychologists and
mental health therapists to bolster chronic pain patients’ social support, decrease their
symptoms of depression, and provide psycho-education to preventively put these patients
at less risk for aberrant drug-related behavior. Moreover, psychologists typically have
more availability and time to monitor chronic pain patients in ways that primary care
physicians working in a population-based model do not have, i.e., these psychologists
could employ chronic pain groups at the clinic or health center or provide individual
therapy for the most high risk patients.
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Furthermore, in addition to higher levels of depression, participants already
managing their chronic pain with the use of opioids were found to be at risk for opioid
misuse when they reported higher levels of pain self-efficacy. These findings suggest
that during the course of opioid treatment for chronic pain, patients may feel that they can
confidently do things despite their experience of pain, but that these levels of confidence
or pain self-efficacy can actually put chronic pain patients at risk for misuse. This may
be related to an already potential dependence on opioid treatment for chronic pain and/or
a potential addiction to opioid medication. In addition, this suggests that the use of pain
self-efficacy as a screener for aberrant drug-related behavior would not be useful for
physicians. Pain self-efficacy was not a significant predictor for aberrant drug-related
behavior in chronic pain patients not prescribed opioids but was a positive predictor for
opioid misuse in patients already on opioids.
While little research has been conducted in the area of pain self-efficacy as a
predictor for aberrant drug-related behavior, the present findings refute existing literature.
Wong and Longshore (2008) assessed the impact of ethnic identity spirituality and selfefficacy on methadone treatment outcomes for heroin use among Hispanic Americans.
Researchers found that higher levels of self-efficacy reported at intake were related to
increased odds of abstinence of heroin use and a lower number of drugs used at one-year
follow-up. In addition, Warren, Stein & Grella (2007) assessed the role of social support
and self-efficacy in treatment outcomes among patients with co-occurring substance
abuse and psychiatric disorders in residential drug treatment programs. These researchers
found that greater reports of self-efficacy predicted less alcohol and cocaine use. While
these results differed from the present study’s findings, they were not assessing outcomes
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in chronic pain patients on opioid treatment, and thus, significantly different populations
were being assessed.
Providers should be cautious in prescribing opioids and should be concerned
about potential misuse and addiction in chronic pain patients. In addition, pain selfefficacy as a predictor alone is insufficient in predicting misuse or aberrant drug-related
behavior in chronic pain patients. Self-efficacy beliefs have contributed to the
development of self-management interventions for chronic pain that focus on teaching
pain coping skills, educating patients about pain, and providing social support (Foster,
Taylor, Eldridge, et al., 2007; Nicholas, Molloy, Tonkin, & Beeston, 2003). Enhancing
self-efficacy is potentially helpful for chronic pain patients in both camps, those who are
prescribed opioids and those who are not.
Discussion of Qualitative Results
After a review of the existing literature, three qualitative studies indeed found
similar results. Crowe, Whitehead, Gagan and Avin (2010) found medication, exercise,
and the application of heat to be the most common strategies used by participants to
manage their chronic low back pain. The strategies reflected an active process of
decision-making that combined personal experience with professional recommendations.
Healthcare professionals who were invited by their pain patients to participant in this
study were physiotherapists and general practitioners. Physiotherapists described
increased exercise, preferably exercises aimed at increasing core strength, as the main
strategy recommended to pain patients. In addition, general practitioners regarded
themselves as primarily having three roles: prescription of pain medication, dispensing of
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sickness certificates, and referral to specialists (Crowe, Whitehead, Gagan & Avin,
2010).
In the present study, chronic pain patients were similarly found to report that
methods of heat were beneficial and a common strategy that was used. In addition,
increasing physical activity and medication management benefited most participants in
managing their experience of chronic pain. Moreover, participants in the present study
did not find primary care physicians to be strong at listening to their concerns.
Participants felt that they were often viewed as pill seeking. The role that primary care
physicians, or general practitioners play may be a more medication management role and
referral source, as found by Crowe and colleagues (2010). Moreover, there may be
mismatched expectations of treatment and management of chronic pain between that of
the pain patient and the primary care provider. These mismatched expectations of
treatment may increase pain patients’ feelings that physicians are not listening to their
concerns, that they are being viewed as pill seeking, and that they are not satisfied with
their diagnoses and treatment.
A qualitative study conducted by Bair, Matthias, Nyland, Huffman, Stubbs,
Kroenke, and Damush (2009) found barriers to pain self-management included: 1) lack of
support from friends and family; 2) limited resources (e.g., transportation, financial); 3)
depression; 4) ineffectiveness of pain-relief strategies; 5) time constraints and other life
priorities; 6) avoiding activity because of fear of pain exacerbation; 7) lack of tailoring
strategies to meet personal needs; 8) not being able to maintain the use of strategies after
study completion; 9) physical limitations; and 10) difficult patient-physician interactions.
Ways to improve pain self-management included: 1) the treatment and relief of
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depression symptoms; 2) having support from family, friends, care managers, and
coworkers (e.g., social support); 3) comparing one’s pain with that of others (i.e., social
comparison); 4) being a proactive patient; 5) having a positive attitude and using positive
thinking/affirmations; 6) setting and achieving goals; and 7) having a menu of selfmanagement strategies from which to choose. Interestingly, issues such as depression
and social support were viewed as both barriers and facilitators. For example, untreated
or suboptimal treatment of depression interfered with the use of self-management
practices, whereas the effective treatment of depression facilitated their use. Likewise,
lack of social support hindered patients’ use of self-management strategies, whereas the
presence of social support facilitated self-management (Bair, Matthias, Nyland, Huffman,
Stubbs, Kroenke, & Damush, 2009).
Bair et al.’s (2009) qualitative findings bore many similarities to this present
study’s findings. The treatment and relief of depression, perceived social support, social
influences, and healthy assertion were also major findings that influenced participants
ability to successfully manage chronic pain in the present study. Participants mentioned
an awareness of how pain increases depressive symptoms and many patients were on
antidepressants or in counseling treatment. All participants mentioned the importance of
social support in their management of chronic pain and several mentioned how
respectfully asserting their needs with physicians increased their satisfaction with the
patient/physician relationship. Moreover, several participants in the present study
described how societal gender influences and messages from childhood, influenced their
coping strategies and ability to ask for help.
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Moreover, Matthias, Parpart, Nyland, Huffman, Stubbs, Sargent, and Bair (2010)
conducted a qualitative study with primary care physicians of chronic pain patients and
found that these providers described numerous relational difficulties when caring for
patients with pain. They described feeling pressure from patients to prescribe opioids,
that they questioned the credibility of patients’ pain reports, and worried about secondary
gain and diversion. These challenges took a toll on the patient–provider relationship,
leading to strained, even hostile interactions, and ultimately to provider frustration, stress,
and burnout. Stress and burnout, in turn, can compromise effective patient care and
reduce physicians’ capacity to show empathy to patients (Banja, 2006; 2008; du Pre,
2005; Matthias, Parpart, Nyland, Huffman, Stubbs, Sargent, & Bair, 2010).
Chronic pain patients in the present study who were in mental health treatment
stated that their therapists were strong listeners and that therapy was an important aspect
to their treatment. Mental health providers are trained to provide empathy and actively
listen, and thus, provide a different role in the chronic pain patients’ treatment than that
of the primary care physician. Empathy is an important ingredient in patient-centered
care (Fiscella, Meldrum, Franks et. al, 2005; Mead & Bower, 2000; Tait, 2008) and has
been recognized as essential when treating chronic pain (Banja, 2006; 2008; Gallagher,
2006; Tait; 2008). Empathic, patient-centered care is associated with better health
outcomes (Banja, 2006; Di Blasi, Harkness, Ernst Georgiou & Kleijnen, 2001; Mead &
Bower, 2000; Stewart, Brown, Donner et al, 2000; Tait, 2008; Tait & Chibnail, 1997).
Research suggests that PCPs need interdisciplinary support beyond opioid prescribing
(Franstve & Kerns, 2007; Sullivan, Leigh & Gastor, 2006; Turk & Okifuji, 1999). For
example, since chronic pain and mental health conditions are often co-morbid (Bair,
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Robinson, Katon & Kroenke, 2005) involving psychologists or other mental health
professionals may help to alleviate some of the PCP’s burden, as well as provide more
comprehensive care to patients with these conditions. Another clear implication is that
efforts to improve patient-centered care are needed and hold promise to improve pain
care for both patients and providers (Matthias, Parpart, Nyland, Huffman, Stubbs,
Sargent, & Bair, 2010).
Literature strongly acknowledges the importance of social support, mood
management, empathic patient/provider encounters, localized heat remedies, healthy
assertion, medication management and increased physical activity in successful
management of chronic pain. This qualitative study added to these findings by
uncovering several other influences on chronic pain patients. Results of this study
indicated that chronic pain patients not prescribed opioids fear addiction and the side
effects of opioids. Many chronic pain patients reported that cannabis assists in pain
management and assists in distracting one’s mind from the experience of pain.
Antidepressants were found to be beneficial, as well as massage, physical therapy, and
injections. The most beneficial social support reported was that of a friend or family
member who also struggled with managing a chronic illness or chronic pain experience.
Child, partner, religion, pet, therapist or relapse prevention group were the most common
forms of efficacious social support. Chronic pain patients who were unclear about the
onset of their pain experience were the most dissatisfied with treatment. The longer the
experience of pain, the more likely the chronic pain patient was prescribed opioids. In
addition, societal gender norms appeared to influence male pain patients’ ways of coping
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and feelings of shame. Moreover, messages regarding strong versus weak behaviors
were learned from childhood and impacted chronic pain patients coping.
Conclusions from Qualitative Results
Clinical implications of these findings suggest that pain patients might benefit
from chronic pain support groups, psycho-educational groups, antidepressant medication
and individual therapy. Additionally, chronic pain patients could benefit from PCP’s
recommending an increase in exercise, heat remedies, physical therapy, injections,
massage and mental health treatment for chronic pain, either in addition to medication
management or before initiating opioid treatments for pain. Moreover, providers could
benefit from operating in an integrated care model of treatment. Many primary care
clinics around the U.S have adopted an integrated primary care model where physicians
are supported by having psychologists’ presently on-site provide consultation, support,
assessment, diagnostic clarification, individual behavioral health treatment, and group
psychotherapy treatment in caring for patients with chronic illness and chronic pain
(Blount & Miller, 2009; Blount et al., 2007; McDaniel, Belar, Schroeder, Hargrove, &
Freeman, 2002).
Limitations of the Present Study
Sample for Quantitative Data
A greater sample size for this study may have produced more significant results.
Studies with a larger sample size would allow for more generalizable findings and
potentially demonstrate stronger relationships between the constructs of depression, selfefficacy, perceived social support, and ethnic identity. The sample size for this study was
also smaller than the primary researcher aimed for. The initial G*power analysis
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required 170 participants total with at least 85 participants within each of the two groups
to achieve a medium effect size and adequate power of 0.80 with four predictor variables.
However, after collecting the present sample of 102, preliminary analyses were run and
since some targeted findings were significant, quantitative data collection was
discontinued.
While the primary researcher aimed to collect the most diverse sample possible,
the predominant racial population compilations at this large community clinic were
Caucasian and Hispanic and the demographics of the sample reflect this. In the future, a
sample size with more cultural diversity may allow for better understanding of how these
constructs impact other ethnic and racial cultures. However, this study was moderately
diverse across gender, age, marital status, and education. The majority of participants
were unemployed, receiving disability funds or applying for disability, or a student or
retired. Many fewer participants were working full-time or part-time. The majority of
participants in this study were from lower socio-economic groups.
Both Spanish speaking and English speaking Hispanic pain patients were
recruited and included in this study. The primary researcher aimed to include more
Spanish speaking patients than were recruited. These patients appeared to be not
interested in participating in this study, or upon reviewing the number of measures,
decided against participation. Given the primary researcher’s limitation of speaking
English only, measures could not be read to patients who may have had challenges with
reading and writing. In the future when collecting data from Spanish speaking migrant
workers, having measures translated in Spanish alone is not sufficient. Future replication
of this study which includes Spanish speaking populations would benefit from having at
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least one Spanish speaking research assistant available to read the measures to patients.
Medical assistants were helpful in describing the study to Spanish speaking participants
in the present study but were not available to assist with other aspects of this study.
Sample for Qualitative Data
In utilizing grounded theory, which is an exploratory, qualitative methodology,
limitations are to be expected. Firstly, in keeping with the recommended sample size of
grounded theory, this current study included ten non-cancer chronic pain participants.
The generalizability of these results are limited , although this limitation is offset by the
diversity of the sample with thorough saturation of emergent themes. Participants
included in this study were diverse across gender, opioid pain medication, experience and
diagnosis of pain, longevity of pain, marital status and ethnicity. However, participants’
backgrounds were not diverse across age, employment and socio-economic status.
Researcher Bias
Secondly, researcher bias is a relevant concern in qualitative research. In this
study, the primary researcher conducted all interviews. Two research assistants served as
auditors and assisted with transcription of data and coding. The primary researcher
followed all recommendations for the exploratory process of grounded theory including
memo writing, constant comparative method, theoretical sampling, gathering data until
saturation occurred, and formulating theory which is derived from data. Adhering to
grounded theory recommendations bolsters the rigor of the study, although limitations
remain a possibility. While measures were taken to limit bias, it is still possible that the
lead researcher’s own perceptions may shape probing follow-up questions during the
semi-structured interview. In the research team’s review of all the transcripts, this did not
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appear to be the case, but it remains a potential limitation. Researchers may have
allowed their own perceptions to influence the interpretation of findings during the
coding process. This limitation is offset by this study’s use of three researchers within
the research team to help in auditing the codes. There is also the possible limitation
associated with difficulties accurately conceptualizing theory. There was a concerted
effort, however, to minimize this possible limitation. For instance, the use of two
additional auditors, consistent support from faculty who provided grounded theory
mentorship, and the consistent review of literature during the emerging theory process
helped ensure the accurate formulation of the grounded theory.
Voluntary Nature of Participation
Another possible limitation of this study includes the voluntary nature of
participation. As is the case with any study of a voluntary nature, only participants who
are willing and open to participation were included in the study. This has the possibility
of presenting a limited sample, in that only those who are comfortable enough to disclose
personal and clinical information were included in the study. Given that the participants
volunteered to take part in this research study, they may have chosen to participate
because of their discontent with chronic pain management, or disappointment with
physical health treatments, medications and coping.
Self-report
Finally, participants self-reported all information both in quantitative and
qualitative data collection. The interview protocol was semi-structured and purely based
on self-reported data and information. As is the case with self-reports, the results may be
affected by participants’ accuracy of reported feelings, behaviors, and perceptions.
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Results may be affected by participants’ willingness to disclose, honesty, and the
researcher’s ability to establish a trusting rapport with the participant. Disadvantages of
self-report data include participant bias, potential for answering in a way that may
“please” the researcher or therapist, and inaccurate data (Chan, 2009). Chan (2009)
described the advantages of self-report measures as they are easy to complete, they obtain
the participants’ view most directly, and are a means of gathering information about the
person’s opinion when observational data or outside observer ratings would not be
sufficient.
Researcher Reflections
Throughout the study, the lead researcher bracketed personal experiences and
engaged in memo writing to help support the research methodology and to help in
awareness of biases. The following is a compilation of thoughts and feelings derived
from the memos, in an effort to help illustrate the lead researcher’s bracketing of her
personal reflections throughout the study.
The discovery and exploration within this study produced many reactions in me
throughout. One of my most significant personal learnings was my own surprise at how
profoundly personal this research became to me throughout the course of the study. The
many elements that I love about conducting therapy -- development of insight,
exploration, discovery, relationship -- were, surprisingly, extremely important to the
interviews that I conducted. I felt my clinical skills were a tremendous asset to my
developing skills in grounded theory methodology. I felt guilty about this at first. Having
been trained in so many quantitative research methods classes, I felt like I should not
allow myself to become so engrossed in the research. I felt a pull to remain outside of the
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research, in an effort to remain a totally objective researcher. As the study progressed,
though, I understood that becoming lost in the research was one of the important
hallmarks of grounded theory. In allowing myself access to the lived experiences of the
participants, I believe the grounded theory was generated from the participants’ views
and ideologies, so that it was objectively subjective.
It did not take long for me to become lost in the research. During the first
interview I conducted, the participant so appreciated being heard that she began to cry
while describing her experiences of domestic violence that led to her experience of
chronic pain. I was so tremendously moved, that I became attentive to the possibility of
this study producing something new and profound theoretically that was going to give
voice to many unspoken or unheard thoughts and feelings of chronic pain patients. That
newness also encouraged a confidence in the exploration of my own challenges as a
patient with chronic illness, and an acceptance and understanding that many other
patients felt confused and overwhelmed at times, and that this was a part of themselves
that was often ignored, or neglected in patient care. In sitting with this patent, a
Hispanic, obese, single mother in her early forties, co-morbidly diagnosed with diabetes
and COPD, and who had been dealing with chronic pain for over ten years; and hearing
how alone and overwhelmed she felt as an abused Hispanic woman with severe health
complications who felt ashamed and scared about her health and chronic pain, I started
to wonder.
And my questions mounted with each new interview. How could it be that this
interview produced so much discovery for participants? It seemed almost absurd at
times. Could it be that after years of chronic pain management, some patients were
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newly discovering their strengths and weaknesses related to their coping with chronic
pain and the factors that might influence this? Sometimes I would ask a question, based
on what seemed to me to be a very simple connection about social support, or the use of
pain medication, and time would stand still for a moment. It seemed as though they had
not been invited to reflect on that part of their life and coping – or, that they were busy
coping with their chronic pain solely through the use of medication or means that
appeared normative based on society or their culture, or familial messages from
childhood, that thinking differently about coping was profound for them. I felt foolish
during those silences – I felt myself wanting to make light of it, somehow, but I knew that
the time elapsing was about a new experience. I was often stunned as the interviews
unfolded.
Quite honestly, when I first began the interviews I was nervous. I was meeting
with low-income, underserved chronic pain patients, who are at times easily irritable and
frustrated, and collecting data in an already established clinic where I didn’t know the
staff and providers. I felt very much like the neophyte psychology student, with my
clipboard and tape recorder. And in the first to the last interview, with very few
exceptions, I determined that my anxiety was shared by the other. It wasn’t easy to ask
the question, but it wasn’t easy to answer it either. About half way through the study, I
learned not to turn the tape recorder off until after I left the office. In the early
interviews, when I would turn the tape recorder off at the end to debrief, then the
participant would continue to share and reflect on the process. It often felt to me, like the
time of the interview was over, the anxiety abated a bit, and then there was another level
of reflection that followed.
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In conducting these interviews, I also recognized how difficult it was for me to ask
people for their time. It was uncomfortable for me to ask patients to give up at least half
an hour, but usually an hour, to meet with me, a total stranger. I was aware of how busy
one’s personal and professional life can be. If patients were employed, they needed to
get back to work because money was scarce. Many were caretakers for other family
members or their own caretakers were waiting for them to provide a ride back home.
Offering a thank you note and a 20 dollar gift card to Target seemed insignificant at first.
However, I quickly learned that for some participants this gift card was quite beneficial.
Later on in the process, seeing the discovery that emerged from the patients, I became
less hesitant and less uncomfortable. Throughout the interviews, I truly felt that the
experience was mutually beneficial. And unsuspectingly, participants often left with a
sense that the experience was meaningful to them, and that some change, albeit often
small, had occurred. It was not uncommon for a participant to share, “You know, I never
thought of it before, but I am glad you asked…” and then to later describe that the
interview itself had caused them to contemplate, explore, or consider something new
regarding their chronic pain or mood. This type of discovery was extremely exciting to
watch.
Conclusion
To conclude, patients with low or well controlled depression, strong social
support, and low to moderate ethnic identity are less likely to be at risk for aberrant drug
related behavior and more likely to have success taking opioid medications for chronic
pain management while functioning at a high level.

Screening patients for these

symptoms and psychosocial influences may assist providers to more effectively select
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chronic pain patients for opioid treatment. These known markers or guidelines for
chronic pain may greatly assist physicians. Physicians are often overwhelmed by chronic
pain patients, feel pressure to prescribe opioids, question the credibility of pain reports,
and worry about secondary gain and diversion. By providing guidelines for how to
approach treatment with these patients and how to know which patients might be more
likely to display true diversion and opioid misuse, providers should gain confidence and
increase their ability to provide empathy with these patients. Moreover, integrating
behavioral health therapy and antidepressant medication into treatment will assist pain
patients in controlling their mood and decreasing symptoms of depression, the number
one risk factor for opioid misuse and aberrant drug-related behavior. Primary care
physicians could benefit from consulting with psychologists and calling upon these
professionals to assist with the screening for risk factors and providing additional support
to chronic pain patients and the provider.

Psychologists can carry some of the

responsibility and burden of these patients by providing efficacious individual and group
therapy. Mood management, increasing social support, and increasing an individual’s
awareness of his or her beliefs about health outside of his or her culture, will assist in
safer outcomes for chronic pain patients and increase the confidence in pain management
for all who are involved.
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APPENDIX A - INFORMED CONSENT-1
Dear Madam/Sir:
I would like to invite you to participate in a research study which is being led by
Courtney Morris, MSEd, a doctoral student in the department of Counseling Psychology
at the University of Denver. This project is being supervised by Dr. Cynthia McRae, a
faculty member in Counseling Psychology with the Morgridge School of Education at the
University of Denver. The study is entitled: “Predictors of drug-related aberrant
behaviors in chronic pain patients: a mixed methods design.” The purpose of this study is
to explore predictors for the risk of drug-related aberrant behavior related to pain
medication used for treatment of chronic pain.
Participation in this study is completely voluntary and you can terminate your
participation at any time during the research without penalty. If you agree to participate,
you will be asked to fill out one demographic questionnaire and five additional measures
which may take from 15 - 35 minutes to complete. At any time during your participation,
you may withdraw, or you may simply omit any questions you do not feel comfortable
answering.
For your privacy, your responses will be kept confidential and will be identified by code
number only and kept separate from information that could identify you. Only the
researcher will have access to your individual data and any reports generated as a result
of this study. However, should any information contained in this study be the subject of a
court order or lawful subpoena, the University of Denver might not be able to avoid
compliance with the order or subpoena. Although no questions in this interview address
it, we are required by law to tell you that if information is revealed concerning suicide,
homicide, or child abuse and neglect, it is required by law that this be reported to the
proper authorities.
Your results from the measures will also be kept in your medical records at Salud so that
your primary care physician may follow up with you if necessary. Specifically, this is to
ensure safety and to allow your physician to have the opportunity to provide further
treatment recommendations if new information about your health is obtained from these
results.
If you have any questions about this study, or would like additional information to assist
you in reaching a decision about participation, please contact the principal investigator at
(917) 747-4293 or at corymor@gmail.com at anytime. If you have any concerns or
complaints about how you were treated during the interview, please contact Paul Olk,
Chair, Institutional Review Board for the Protection of Human Subjects, at 303-8714531, or Sylk Sotto-Santiago, Office of Research and Sponsored Programs at 303-8714052.
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If you agree to participate, please sign, and date page 2. You may keep page 1 for your
records. Thank you for your time.

AGREEMENT TO PARTICIPATE IN STUDY

If you agree to participate in the study described on page 1, please sign your name and
date below. Thank you.
Study: Predictors of drug-related aberrant behaviors in chronic pain patients: a mixed
methods design

I agree to participate:

_____________________________
Print Name
_____________________________
Signature

_____________________
Date

By completing and signing this letter the participant has given her or his consent to
participate
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INFORMED CONSENT-2
Dear Madam/Sir:
I would like to invite you to participate in a second part of a research study which is
being led by Courtney Morris, MSEd, a doctoral student in the department of Counseling
Psychology at the University of Denver. This project is being supervised by Dr. Cynthia
McRae, a faculty member in Counseling Psychology with the Morgridge School of
Education at the University of Denver. The study is entitled: “Predictors of drug related
aberrant behaviors in chronic pain patients: a mixed methods design.” The purpose of this
study is to explore predictors for the risk of drug-related aberrant behavior related to pain
medications used for treatment of chronic pain.
.
Participation in this study is completely voluntary and you can terminate your
participation at any time during the research without penalty. If you agree to participate,
you will be asked to meet with me, and possible a translator, for an audio taped face-toface interview. If you agree to participate you will be provided with a twenty dollar gift
certificate to Target. During the interview you will be asked a number of questions
regarding your treatment for chronic pain. The interview may last from 35 - 50 minutes,
depending on your responses.
Following the interview, responses will be transcribed and you will have an opportunity
to view the transcript once completed. For your privacy, audiotapes and transcripts will
be kept confidential and your name will not appear in any report resulting from this
study. However, should any information contained in this study be the subject of a court
order or lawful subpoena, the University of Denver might not be able to avoid
compliance with the order or subpoena. Although no questions in this interview address
it, we are required by law to tell you that if information is revealed concerning suicide,
homicide, or child abuse and neglect, it is required by law that this be reported to the
proper authorities.
If you have any questions about this study, or would like additional information to assist
you in reaching a decision about participation, please contact the principal investigator at
(917) 747-4293 or at corymor@gmail.com at anytime. If you have any concerns or
complaints about how you were treated during the interview, please contact Paul Olk,
Chair, Institutional Review Board for the Protection of Human Subjects, at 303-8714531, or Sylk Sotto-Santiago, Office of Research and Sponsored Programs at 303-8714052.
If you agree to participate, please sign, and date page 2. You may keep page 1 for your
records. Thank you for your time.
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AGREEMENT TO PARTICIPATE IN STUDY

If you agree to participate in the study described on page 1, please sign your name and
date below. Thank you.
Study: Predictors of drug related aberrant behaviors in chronic pain patients: a mixed
methods design.
I agree to participate in the interview portion of this study and be audio taped:

_____________________________
Print Name
_____________________________
Signature

_____________________
Date

By completing and signing this letter the participant has given her or his consent to
participate.
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APPENDIX B
INTERVIEW PROTOCOL
1. What caused your experience of pain?
2. How long have you experienced pain?
3. What are the primary pain sites or areas you experience pain?
4. What does your experience of pain feels like?
5. In what ways do you cope with your experience of pain?
6. What methods are the most helpful?
7. In what ways do you cope with your experience of pain without the use of
medications?
8. Have you noticed if your experience of pain impacts your mood? In what ways
have you noticed this happening for you?
9. Have you noticed if your mood influences your severity of experience of pain?
Can you describe some examples of when you noticed this happening for you?
10. Who are the people who are closest to you in your life and your primary social
support?
11. How have your doctors responded to your management of chronic pain?
12. How have they responded to your experience of pain?
13. Have you ever been in counseling or therapy for helping with your management
of chronic pain? Was this helpful?
14. Have you ever been prescribed an antidepressant for assisting with the
management of chronic pain?
15. Is there anything else that I didn’t ask that you think would be helpful to share in
helping me understand how you cope with managing your experience of chronic
pain?
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APPENDIX C
DEMOGRAPHIC QUESTIONNAIRE
Instructions: Please put a check mark next to all that apply or fill in the answer with what
you feel best answers the question.
1. In what year were you born? __________ (please put a year)
2. What is your gender? ___________ (please put male, female or other)

3. What is your chronic pain condition?
__________________________________ (please list all that apply)
_________________________________________________________________
4. If you are currently take pain medications, what are you currently
prescribed? (please list all that apply)
__________________________________________________________________
5. How many other people do you live with?___________
6. How would you describe your current status? (please put a check mark next to
one that applies the most for you)
• Single____________
• Married/Partnered_____________
• Widowed_____________
• Divorced _____________
7. How would you describe your current employment status? (please put a
check mark next to one that applies the most for you)
• Employed full time ________
• Employed part time ________
• Unemployed/Looking for work ________
• Student Homemaker Retired ________
• Unemployed/Receiving SSI services ________
8. How many years of education do you have? _________
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9. What is your race/ethnicity? (please put a check mark next to one that applies
the most for you)
___________• Asian or Pacific Islander: Persons having origins in any of the
peoples of the Far East, Southeast Asia, the Indian subcontinent, or the Pacific
Islands. This area includes, for example, China, Japan, Korea, the Philippine
Islands and Samoa.
___________• African American/Black (not of Hispanic origin): Person having
origins in any of the black ethnic groups
____________• Hispanic - Persons having origins in any of the Mexican, Puerto
Rican, Cuban, Central or South American or other Spanish Cultures, regardless of
ethnicity
___________ • Native American or Alaskan Native: Persons having origins in
any of the original peoples of North America, and who maintain cultural
identification through tribal affiliation or community recognition
____________ • Caucasian/White (not of Hispanic origin): Persons having
origins in any of the original peoples of Europe, North Africa or the Middle East
____________ • Mixed: (Please specify)
_________________________________
__________________________________________________________________
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APPENDIX D
The Patient Health Questionnaire (PHQ-9)
Over the past 2 weeks, how often have you been bothered by any of the following
problems?
0= Not at All 1= Several Days 2=More than Half the Days 3=Nearly Every Day
1. Little interest or pleasure in doing things?
0
1
2
3
2. Feeling down, depressed or hopeless?
0

1

2

3

3. Trouble falling asleep, staying asleep, sleeping too much?
0
1
2
3
4. Feeling tired or having little energy?
0
1
2
3
5. Poor appetite or overeating?
0
1
2
3
5. Feeling bad about yourself - or that you’re a failure or have let yourself or your
family down?
0
1
2
3
6. Trouble concentrating on things, such as reading the newspaper or watching
television?
0
1
2
3
7. Moving or speaking so slowly that other people could have noticed. Or, the
opposite - being so fidgety or restless that you have been moving around a lot
more than usual?
0
1
2
3
8. Thoughts that you would be better off dead or of hurting yourself in some way?
0
1
2
3
Column Totals ______ + _____ + ____
Add Totals Together ______________________
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APPENDIX E

PAIN SELF EFFICACY QUESTIONNAIRE (PSEQ)
M.K.Nicholas (1989)
NAME: __________________________________________ DATE: __________________
Please rate how confident you are that you can do the following things at present, despite the pain. To
indicate your answer circle one of the numbers on the scale under each item, where 0 = not at all confident
and 6 = completely confident.
For example:
0
1
2
3
4
5
6
Not at all Confident
Completely Confident
Remember, this questionnaire is not asking whether of not you have been doing these things, but rather
how confident you are that you can do them at present, despite the pain.

1. I can enjoy things, despite the pain.
0
Not at all

1

2

3

4

Confident

5
6
Completely
Confident

2. I can do most of the household chores (e.g. tidying-up, washing dishes, etc.), despite the pain.
0
Not at all

1

2

3

4

Confident

5
6
Completely
Confident

3. I can socialise with my friends or family members as often as I used to do, despite the pain.
0
Not at all
Confident

1

2

3

4

5
6
Completely
Confident

1

2

3

4

5
6
Completely
Confident

4. I can cope with my pain in most situations.
0
Not at all
Confident

Turn over
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5. I can do some form of work, despite the pain. (“work” includes housework, paid and unpaid
work).
0
1
2
3
4
5
6
Not at all
Completely
Confident
Confident
6. I can still do many of the things I enjoy doing, such as hobbies or leisure activity, despite pain.
0
1
2
3
4
5
6
Not at all
Completely
Confident
Confident
7. I can cope with my pain without medication.
0
Not at all
Confident

1

2

8. I can still accomplish most of my goals in life, despite the pain.
0
1
2
Not at all
Confident
9. I can live a normal lifestyle, despite the pain.
0
Not at all
Confident

1

2

10. I can gradually become more active, despite the pain.
0
1
2
Not at all
Confident

3

4

5
6
Completely
Confident

3

4

5
6
Completely
Confident

3

4

5
6
Completely
Confident

3

4

5
6
Completely
Confident

Source: Nicholas M.K. Self-efficacy and chronic pain. Paper presented at the annual conference of the
British Psychological Society. St. Andrews, 1989.
Reprinted with permission from the author
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APPENDIX F
The Multigroup Ethnic Identity Measure (MEIM-R)
In this country, people come from many different countries and cultures, and there are
many different words to describe the different backgrounds or ethnic groups that people
come from. Some examples of the names of ethnic groups are Hispanic or Latino, Black
or African American, Asian American, Chinese, Filipino, American Indian, Mexican
American, Caucasian or White, Italian American, and many others. These questions are
about your ethnicity or your ethnic group and how you feel about it or react to it.
Please fill in: In terms of ethnic group, I consider myself to be ____________________
Use the numbers below to indicate how much you agree or disagree with each statement.
(4) Strongly agree

(3) Agree

(2) Disagree

(1) Strongly disagree

1- I have spent time trying to find out more about my ethnic group, such as
its history, traditions, and customs. _____
2- I am active in organizations or social groups that include mostly members
of my own ethnic group.
_____
3- I have a clear sense of my ethnic background and what it means for me. _____
4- I think a lot about how my life will be affected by my ethnic group membership. _____
5- I am happy that I am a member of the group I belong to. _____
6- I have a strong sense of belonging to my own ethnic group. _____
7- I understand pretty well what my ethnic group membership means to me. _____
8- In order to learn more about my ethnic background, I have often talked
to other people about my ethnic group. _____
9- I have a lot of pride in my ethnic group. _____
10- I participate in cultural practices of my own group, such as special food,
music, or customs. _____
11- I feel a strong attachment towards my own ethnic group. _____
12- I feel good about my cultural or ethnic background. _____
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13- My ethnicity is
(1) Asian or Asian American, including Chinese, Japanese, and others
(2) Black or African American
(3) Hispanic or Latino, including Mexican American, Central American, and others
(4) White, Caucasian, Anglo, European American; not Hispanic
(5) American Indian/Native American
(6) Mixed; Parents are from two different groups
(7) Other (write in): _____________________________________
14- My father's ethnicity is (use numbers above) _____
15- My mother's ethnicity is (use numbers above) _____
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APPENDIX G
Social Provisions Scale
Instructions
In answering the next set of questions I am going to ask you, I want you to think about
your current relationship with friends, family members, coworkers, community members,
and so on. Please tell me to what extent you agree that each statement describes your
current relationships with other people. Use the following scale to give me your opinion.
(Hand a response card.) So, for example, if you feel a statement is very true of your
current relationships, you would tell me “strongly agree”. If you feel a statement clearly
does not describe your relationships, you would respond “strongly disagree”. Do you
have any questions?

Strongly Disagree
1

Disagree
2

Agree

Strongly Agree

3

4

1. There are people I can depend on to help me if I really need it. _____
2. I feel that I do not have close personal relationships with other people. _____
3. There is no one I can turn to for guidance in times of stress. _____
4. There are people who depend on me for help.

_____

5. There are people who enjoy the same social activities I do. _____
6. Other people do not view me as competent.

_____

7. I feel personally responsible for the well-being of another person. _____
8. I feel part of a group of people who share my attitudes and beliefs. _____
9. I do not think other people respect my skills and abilities. _____
10. If something went wrong, no one would come to my assistance. _____
11. I have close relationships that provide me with a sense of emotional security
and well-being. _____
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12. There is someone I could talk to about important decisions in my life.

_____

13. I have relationships where my competence and skills are recognized. _____
14. There is no one who shares my interests and concerns. _____
15. There is no one who really relies on me for their well-being. _____
16. There is a trustworthy person I could turn to for advice if I were having
problems. _____
17. I feel a strong emotional bond with at least one other person. _____
18. There is no one I can depend on for aid if I really need it. _____
19. There is no one I feel comfortable talking about problems with. _____
20. There are people who admire my talents and abilities.
21. I lack a feeling of intimacy with another person.
22. There is no one who likes to do the things I do.
23. There are people I can count on in an emergency.
24. No one needs me to care for them.

_____
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_____

_____
_____
_____

APPENDIX H
COMM™
Current Opioid Misuse Measure
Please answer each question as honestly as possible. Keep in mind that we are only
asking about the past 30 days. There are no right or wrong answers. If you are unsure
about how to answer the question, please give the best answer you can.
Never Seldom Sometimes Often
0
1
2
3

Very Often
4

1. In the past 30 days, how often have you had trouble with thinking clearly or
had memory problems? _____
2. In the past 30 days, how often do people complain that you are not completing
necessary tasks? (i.e., doing things that need to be done, such as going to class, work
or appointments) _____
3. In the past 30 days, how often have you had to go to someone other than your
prescribing physician to get sufficient pain relief from medications? (i.e., another
doctor, the Emergency Room, friends, street sources) _____
4. In the past 30 days, how often have you taken your medications differently from how
they are prescribed? _____
5. In the past 30 days, how often have you seriously thought about hurting yourself?
_____
6. In the past 30 days, how much of your time was spent thinking about opioid
medications (having enough, taking them, dosing schedule, etc.)? _____
7. In the past 30 days, how often have you been in an argument? _____
8. In the past 30 days, how often have you had trouble controlling your anger (e.g., road
rage, screaming, etc.)? _____
9. In the past 30 days, how often have you needed to take pain medications belonging to
someone else? _____
10. In the past 30 days, how often have you been worried about how you’re handling
your medications? _____
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11. In the past 30 days, how often have others been worried about how you’re handling
your medications? _____
12. In the past 30 days, how often have you had to make an emergency phone call or
show up at the clinic without an appointment? _____
13. In the past 30 days, how often have you gotten angry with people? _____
14. In the past 30 days, how often have you had to take more of your medication than
prescribed? _____
15. In the past 30 days, how often have you borrowed pain medication from someone
else? _____
16. In the past 30 days, how often have you used your pain medicine for symptoms other
than for pain (e.g., to help you sleep, improve your mood, or relieve stress)? _____
17. In the past 30 days, how often have you had to visit the Emergency Room? _____
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APPENDIX I
SOAPP®-R
Screener and Opioid Assessment for Patients with Pain
The following are some questions given to patients who are on or being considered for
medication for their pain. Please answer each question as honestly as possible. There are
no right or wrong answers.
Never Seldom Sometimes Often
0
1
2
3

Very Often
4

1. How often do you have mood swings? _____
2. How often have you felt a need for higher doses of medication to treat your pain?
_____
3. How often have you felt impatient with your doctors? _____
4. How often have you felt that things are just too overwhelming that you can't handle
them? _____
5. How often is there tension in the home? _____
6. How often have you counted pain pills to see how many are remaining? _____
7. How often have you been concerned that people will judge you for taking pain
medication? _____
8. How often do you feel bored? _____
9. How often have you taken more pain medication than you were supposed to? _____
10. How often have you worried about being left alone? _____
11. How often have you felt a craving for medication? _____
12. How often have others expressed concern over practitioners in clinical practice?
_____
13. How often have any of your close friends had a problem with alcohol or drugs?
_____
14. How often have others told you that you had a bad temper? _____
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15. How often have you felt consumed by the need to get pain medication? _____
16. How often have you run out of pain medication early? _____
17. How often have others kept you from getting what you deserve? _____
18. How often, in your lifetime, have you had legal problems or been arrested? _____
19. How often have you attended an AA or NA meeting? _____
20. How often have you been in an argument that was so out of control that someone got
hurt? _____
21. How often have you been sexually abused? _____
22. How often have others suggested that you have a drug or alcohol problem? _____
23. How often have you had to borrow pain medications from your family or friends?
_____
24. How often have you been treated for an alcohol or drug problem? _____
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APPENDIX J
Overview of Demographic Variables: Raw Frequencies of Variables
Demographics
Opioids

Frequency Total

Group A: Opioids

Group B: No

102

46

56

Gender
Male
Female

34
68

13
30

18
38

Age
18-25
25-35

4
15

1
7

3
8

21
36
22
4

11
16
9
2

10
20
13
2

37
3
1
15

16
0
0
6

21
3
1
7

Multiple Pain Sites
Hip

36
1

20
1

16
0

Ear
Abdomen
Osteoarthritis
Neuropathy

1
3
4
1

0
2
0
1

1
1
4
0

Longevity of Pain
6 Months- 1 Year
1-2 Years
3-5 Years
6-10 Years
11-15 Years
16-20 Years
21 Years or More

6
8
35
28
9
7
9

3
3
13
13
4
6
4

3
5
22
15
5
1
5

Language
English
Spanish

96
6

35-45
45-55
55-65
65 and older
Pain
Lower Back Pain
Leg
Knee
Fibromyalgia

44
2
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52
4

Ethnicity
Hispanic
Caucasian
African American
Native American
Asian
Mixed

24
60
2
3
2
10

10
29
2
1
0
4

14
31
0
2
2
6

Marital Status
Married/Partnered
Separated
Divorced
Widowed
Single

13
25
18
7
39

8
9
9
4
16

5
16
9
3
23

Roommates
None
One
Two
Three or More

17
29
13
41

9
14
6
17

8
15
7
24

Education
Under 12 Years
12/High School Grad
13-15 Years
15-20 Years
GED

35
33
21
6
7

15
16
9
3
3

20
17
12
3
4

Employment
Full- Time
Part- Time
Unemployed
Student/Retired
SSI Funds

6
13
28
6
49

0
5
11
2
28

6
8
17
4
21

Medication
None
Marijuana
Neurontin
NSAIDS
Antidepressant
Flexeril
Floricit
Vicodin

8
2
1
6
28
7
4
9

0
0
0
0
0
0
0
9

8
2
1
6
28
7
4
0
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Percocet
MS Contin
Oxycontin
Morphine
Methadone
Tramadol
Fetanyl Patch

18
1
2
7
2
7
1

18
1
2
7
2
7
1
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0
0
0
0
0
0
0

APPENDIX K
PRIVILEGED AND CONFIDENTIAL - CONTENT LICENSING AGREEMENT
Agreement dated as of September 12, 2011 between Inflexxion, Inc., with a principal
place of business at 320 Needham St, Suite 100, Newton, MA 02464 (“Inflexxion”) and
Courtney Morris, MSEd., a counseling psychology doctorate student at the University of
Denver, with a principal place of business at 3700 E. Jewell Avenue, #321, Denver, CO
80210 (the “Licensee”).
1. Definitions. The following terms have the following meanings when used in this
Agreement:
(a) “Material” means the Revised Screen and Opioid Assessment for Patients with Pain
(SOAPP versions and associated documentation to be supplied by Inflexxion without
charge, as described in Exhibit A of this Agreement, attached hereto and incorporated
herein.
(b) “Project” means the Licensee’s project related to or incorporating the Material, as
described
in Exhibit A.
2. License.
a. Subject to the terms and conditions of this Agreement, Inflexxion grants to Licensee a
nonexclusive, non-transferable, limited license (with no right to sublicense) to reproduce
and distribute the Material solely as part of the Project for the express and limited
purposes set forth in Exhibit A.
b. The Material may be used only as part of the Project; Licensee shall not use, publish
or make the Material available in any other manner or medium. Licensee shall not
modify or create derivative works of the Material. Licensee agrees not to post the
Material on the Internet or otherwise make the Material available electronically other
than for the purposes expressed in Exhibit A. Licensee also agrees not to remove any
Inflexxion proprietary notices from the Material.
c. The Project, including Licensee’s use of the Material in the Project, shall comply with
all applicable laws. Licensee shall not use the Material in any manner that could harm
the reputation of Inflexxion. In addition to any other termination rights in this
Agreement, Inflexxion may terminate this Agreement or the license to one or more
Material immediately upon notice to Licensee if Inflexxion in its sole discretion deems
Licensee’s use of the Material to be inappropriate or harmful to the reputation of
Inflexxion, in which case Licensee will promptly remove the affected Material from the
Project.
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3. Limited Grant; Reservation of Rights. Inflexxion grants no license or rights to
Licensee other than the non-exclusive license expressly set forth in this Agreement.
Nothing in this Agreement shall limit Inflexxion’s rights in the Material, including the
right to allow others to use the Material.
4. Copyright Notice and Credits. In every copy of the Material, Licensee agrees to
include Inflexxion’s copyright notice and to give credit to Inflexxion, in the form
specified in Exhibit A, in the same manner as it accords credit to all other authors and
copyright owners whose works are included in or distributed as part of the
Project.SOAPP®- R and the Current Opioid Misuse Measure (COMM)®, both English
and Spanish
5. Disclaimer of Warranties.
The Material is provided “AS IS.” Inflexxion, to the fullest extent permitted by law,
disclaims all warranties of any kind (express, implied or otherwise) regarding the
Material, including but not limited to any implied warranties of merchantability, fitness
for a particular purpose, ownership, and non-infringement. Inflexxion does not make any
warranty about the accuracy, reliability, completeness or quality of the Material.
6. Limitation of Liability and Remedies
a. Licensee’s use of the Material is at its own sole risk. If Licensee is dissatisfied with
the Material, its exclusive remedy is to stop using the Material.
b. IN NO EVENT SHALL INFLEXXION BE LIABLE, IN CONTRACT, TORT
(INCLUDING NEGLIGENCE) OR OTHERWISE, FOR ANY DIRECT, INDIRECT,
SPECIAL, INCIDENTAL, CONSEQUENTIAL, PUNITIVE OR OTHER SUCH
DAMAGES (INCLUDING, WITHOUT LIMITATION, DAMAGES OR COSTS
RESULTING FROM LOSS OF PROFITS OR BUSINESS, OR RESULTING FROM
ANY ERRORS IN THE MATERIAL, OR RESULTING FROM ANY DECISION
MADE OR ACTION TAKEN BY LICENSEE IN RELIANCE ON THE
MATERIAL)ARISING OUT OF OR IN CONNECTION WITH THIS AGREEMENT
OR LICENSEE’S USE OF THE MATERIAL, EVEN IF INFLEXXION IS
NEGLIGENT OR OTHERWISE AT FAULT, AND REGARDLESS OF WHETHER
INFLEXXION IS ADVISED OR SHOULD KNOW OF THE POSSIBILITY OF SUCH
DAMAGES.
7. Indemnification. Subject to the constitution and laws of the State of Texas, the
Licensee agrees to indemnify and hold harmless Inflexxion, and its officers, employees
and agents, from and against all claims, actions, suits, damages, liabilities and costs
(including, without limitation, attorneys’ fees) resulting from or based upon (i) the
Project, including but not limited to Licensee’s use of the Material in the Project, or (ii)
Licensee’s breach of any provision of this Agreement.
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8. Publications and Results. Licensee agrees to provide Inflexxion with a written
summary of research results related to the Material, including findings and copies of any
external publications,involving data related to the Material.
9. Use of Name. Licensee shall not use any name, emblem, logo, or trademark of
Inflexxion in any manner, except in the credit line as permitted in Exhibit A. The
Licensee shall not imply that the Project is endorsed or sponsored by Inflexxion, or
connected in any way with Inflexxion.
10. Termination of License.
a. If Licensee breaches this Agreement and fails to remedy the breach within fifteen (15)
days after written notice thereof by Inflexxion, then Inflexxion may terminate this
Agreement by written notice. Notwithstanding the foregoing, Inflexxion shall have the
right to terminate this Agreement and require Licensee to immediately cease distributing
the Material or any part(s) thereof, if (i) Inflexxion notifies
Licensee that Inflexxion no longer has the necessary rights to the Material or any part(s)
thereof; (ii) Inflexxion believes cessation is necessary to avoid liability, or (iii) Inflexxion
determines in its discretion that law or court order requires such cessation.
b. Upon any termination of this Agreement, all licenses granted hereunder shall
terminate, and Licensee shall remove the Material from the Project, cease reproducing
and distributing the Material, and not make any further use of the Material. No
termination of this Agreement shall affect any liabilities of the parties which may have
accrued prior to the date of termination. Upon any expiration of the license or
termination of this Agreement, the provisions of Sections 5, 6, 7, 9, 10, 11 and 12 shall
survive and continue in effect.
11. Governing Law. All disputes hereunder shall be resolved exclusively in the
applicable state of federal courts of Massachusetts. The parties consent to the jurisdiction
of such courts and waive any jurisdictional or venue defenses otherwise available.
12. Entire Agreement. This Agreement constitutes the entire agreement between the
parties pertaining to the subject matter contained herein and supersedes all prior
agreements related thereto. IN WITNESS WHEREOF, the parties have executed this
Agreement as of the date specified below.
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LICENSEE: INFLEXXION, INC.:
EXHIBIT A
1. Licensee’s Project

Inflexxion, Inc. gives Courtney Morris, MSEd. permission to use the Revised Screen
and Opioid Assessment for Patients with Pain (SOAPP(COMM)®, both English and
Spanish versions at the University of Denver as part of her psychology doctorate
program. The title of the research project is "Predictors of Aberrant DrugRelated
Behavior in Chronic Pain Patients: A Mixed Methods Design". The duration of the
project is anticipated to be from October 1, 2011 to September 1, 2012. This permission
does not include modifying the SOAPP-R and/or COMM tools, both English and Spanish
versions, the scoring, or instructions for use in any way.
Permission does not extend to other uses of these tools, including additional research
studies or publications, presentations, or symposia that are not related to this study.
Permission also does not extend to the use of additional Inflexxion tools.
2. Requested Inflexxion Material Revised Screen and Opioid Assessment for Patients
with Pain (SOAPP)Spanish versions Current Opioid Misuse Measure (COMM)® :
English and Spanish versions
3. Credit
© 2011 Inflexxion, Inc. All rights reserved.®
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